0001493152-17-009154.txt : 20170814 0001493152-17-009154.hdr.sgml : 20170814 20170814145735 ACCESSION NUMBER: 0001493152-17-009154 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170814 DATE AS OF CHANGE: 20170814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRASCIENCE INC CENTRAL INDEX KEY: 0000727672 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411448837 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13092 FILM NUMBER: 171029521 BUSINESS ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 847-0200 MAIL ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC /MN DATE OF NAME CHANGE: 19931119 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC DATE OF NAME CHANGE: 19920703 10-Q 1 form10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2017

Commission file number 0-13092

SPECTRASCIENCE, INC.

(Exact name of registrant

as specified in its charter)

Minnesota

41-1448837

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification Number)

11568 Sorrento Valley Rd., Suite 11

San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 847-0200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]		Accelerated filer	[ ]

Non-accelerated filer [ ]	(Do not check if a smaller reporting company)	Smaller reporting company	[X]

		Emerging growth company	[X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES [ ] NO [X]

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding on August 14, 2017 was 2,685,830,579.

SPECTRASCIENCE, INC.

FORM 10-Q

For the Six Months Ended June 30, 2017

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION:

Item 1.	Financial Statements (Unaudited)	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25

Item 4.	Controls and Procedures	25

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	25

Item 1A.	Risk Factors	26

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26

Item 3.	Defaults Upon Senior Securities	26

Item 4.	Mine Safety Disclosures	26

Item 5.	Other Information	26

Item 6.	Exhibits	26

SIGNATURES		27

PART I FINANCIAL INFORMATION:

Item 1. Financial Statements

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

	June 30, 2017			December 31, 2016
	(unaudited)
ASSETS
Current assets:
Cash	$	25		$	3,550
Accounts receivable, net		-			950
Inventory		97,423			90,594
Prepaid expenses and other current assets		191,322			266,749
Total current assets		288,770			361,843

Patents, net		944,851			1,024,524
	$	1,233,621		$	1,386,367

LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	1,773,561		$	1,318,737
Accrued expenses		2,608,116			2,278,042
Notes payable- related parties		35,000			35,000
Note payable		112,982			137,982
Convertible debt, net of discounts of $249,988 as of June 30, 2017 and $203,444 as of December 31, 2016		6,199,543			6,211,861
Derivative liability		1,223,250			819,928
Total current liabilities		11,952,452			10,801,550

Long-term secured convertible debt		1,410,000			1,100,000

COMMITMENTS AND CONTINGENCIES

Mezzanine equity
Series B Convertible Preferred Stock, $.01 par value; 2,585,000 shares authorized, issued and outstanding as of June 30, 2017 and December 31, 2016; liquidation value of $517,000 plus accumulated and unpaid dividends of $106,931 as of June 30, 2017 and December 31, 2016		25,850			25,850
Series C Convertible Preferred Stock, $.01 par value; 500,000 shares authorized, issued and outstanding as of June 30, 2017 and December 31, 2016; liquidation value of $100,000 as of June 30, 2017 and December 31, 2016		5,000			5,000
Total mezzanine equity		30,850			30,850

Shareholders' deficit
Series A Convertible Preferred Stock, $.01 par value; 0 shares authorized, issued and outstanding as of June 30, 2017 and December 31, 2016		-			-
Series AA Super Voting Preferred Stock, $.001 par value; 3,000 shares authorized, issued and outstanding as of June 30, 2017 and December 31, 2016		3			3
Common stock, $.01 par value; 2,996,000,000 shares authorized; 1,962,785,579 and 883,671,222 shares issued and outstanding as of June 30, 2017 and December 31, 2016		19,627,855			8,836,712
Additional paid in capital		24,432,963			34,582,771
Accumulated deficit		(56,220,502	)		(53,965,519	)
Total shareholders' deficit		(12,159,681	)		(10,546,033	)
	$	1,233,621		$	1,386,367

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Operation

(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016

Revenue	$	-		$	950		$	-		$	950
Cost of revenue		-			868			-			868
Gross profit		-			82			-			82

Operating expenses:
Research and development		128,660			194,155			259,501			388,162
General and administrative		305,560			306,213			585,292			614,054
Sales and marketing		73,780			101,214			148,634			180,627
		508,000			601,582			993,427			1,182,843

Loss from operations		(508,000	)		(601,500	)		(993,427	)		(1,182,761	)

Other income (expense)
Interest expense		(266,496	)		(208,347	)		(815,230	)		(579,299	)
Change in fair value of derivative and warrant liabilities		(452,019	)		624,873			(284,232	)		(262,621	)
Amortization of derivative and warrant liabilities discount		(137,618	)		(94,735	)		(268,026	)		(236,296	)
Amortization of deferred debt issuance costs and original issue discount		(7,978	)		(62,920	)		(14,712	)		(125,450	)
Gain on extinguishment of debt		161,573			245,908			172,124			247,074
Income (loss) on foreign exchange transactions		(32,436	)		13,616			(38,529	)		4,691
Other income (expense), net		(8,233	)		(5,077	)		(12,951	)		(9,854	)
		(743,207	)		513,318			(1,261,556	)		(961,755	)

Net loss	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)

Basic and diluted loss per share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average common shares outstanding:
Basic and diluted		1,490,570,290			668,866,352			1,291,451,398			640,797,803

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statement of Shareholders' Deficit

For the six months ended June 30, 2017

(unaudited)

	Series AA Super Voting Preferred				Common Stock				Additional Paid-In			Accumulated			Total Shareholders'
	Shares		Amount		Shares		Amount		Capital			Deficit			Deficit

Balance December 31, 2016		3,000	$	3		883,671,222	$	8,836,712	$	34,582,771		$	(53,965,519	)	$	(10,546,033	)

Non cash issuance of stock options		-		-		-		-		80,002			-			80,002
Conversion of convertible debt		-		-		1,079,114,357		10,791,143		(10,230,394	)		-			560,749
Non cash issuance of warrant for consulting services		-		-		-		-		584			-			584
Net loss		-		-		-		-		-			(2,254,983	)		(2,254,983	)

Balance June 30, 2017		3,000	$	3		1,962,785,579	$	19,627,855	$	24,432,963		$	(56,220,502	)	$	(12,159,681	)

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Six Months Ended June 30,
	2017			2016
Operating activities:
Net loss	$	(2,254,983	)	$	(2,144,516	)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization and depreciation		79,673			80,789
Non-cash interest		16,648			31,364
Non-cash issuance of stock options and warrants		80,002			80,003
Non-cash expense related to commitment of common stock in excess of authorized shares		(39,397	)		132,130
Loss on issuance of variable rate notes		428,367			84,434
Amortization of derivative and warrant liabilities discount		268,026			236,296
Amortization of deferred debt issuance costs and original issue discount		14,712			125,450
Issuance of debt for services		22,250			-
Issuance of common stock for services		1,400			700
Change in fair value of derivative and warrant liabilities		284,232			262,620
Gain on extinguishment of debt		(172,124	)		(247,073	)
Changes in assets and liabilities:
Accounts receivable		950			6,111
Inventory		(6,829	)		(47,845	)
Prepaid expense and other assets		75,427			71,073
Accounts payable		454,821			173,391
Accrued expenses		357,470			274,152
Net cash used in operating activities		(389,355	)		(880,921	)

Investing activities:
Net cash used in investing activities		-			-

Financing activities:
Proceeds from issuance of convertible notes payable		123,750			300,000
Proceeds from issuance of notes payable to related parties		-			35,000
Proceeds from issuance of secured note payable		299,000			500,000
Payments on convertible notes payable in cash		(669	)		-
Debt issuance costs		(36,251	)		(53,712	)
Net cash provided by financing activities		385,830			781,288

Net decrease in cash		(3,525	)		(99,633	)

Cash, beginning of year		3,550			127,493

Cash, end of period	$	25		$	27,860

Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for:
Interest	$	1,000		$	-
Income taxes	$	-		$	-
Non Cash Investing and Financing Activities:
Conversion of convertible notes and accrued interest to common stock	$	178,565		$	88,550
Exchange of convertible notes and accrued interest to new notes	$	25,000		$	42,896
Conversion of accrued interest to note payable	$	13,767		$	-

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Nature of Business and Basis of Presentation

Description of Business

SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).

The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.

On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.

The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the six month period ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Going Concern

Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

As of June 30, 2017, the Company had a working capital deficit of $11,663,682 and cash of $25, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company uses agents to assist it with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2017, the Company raised $386,499, net of transaction costs of $36,251, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of June 30, 2017, Convertible Debentures with a face value of $6,068,243 held by 83 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

2. Summary of Significant Accounting Policies

Revenue recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

Consolidation

The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

Risks and Uncertainties

The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

Use of Estimates

The Company prepares its unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

Inventory Valuation

The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Valuation of Long-lived Assets

The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

Variable Conversion Rate Debentures

Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

Over Commitment of Shares

Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes option pricing model and a liability is recorded as though the obligations would be settled using some means other than stock.

Stock-Based Compensation

The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option pricing model (the “Black Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.

As of June 30, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 28,058,674 shares were exercisable. Awards under the Company’s EIP generally vest over four years.

The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the six month periods ended June 30, 2017 and 2016.

Earnings (Loss) Per Share

Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

	June 30, 2017		June 30, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		4,594,144,575		247,559,219
Options		34,168,800		34,168,800
Warrants		114,750,650		132,875,170
Total		4,746,149,025		417,688,189

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)
Net loss for diluted earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)

Denominator:
Weighted average basic shares outstanding		1,490,570,290			668,866,352			1,291,451,398			640,797,803
Denominator for diluted earnings per share- Adjusted weighted average shares		1,490,570,290			668,866,352			1,291,451,398			640,797,803

Loss per share
Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Inventory

Inventory consisted of the following at June 30, 2017 and December 31, 2016:

	June 30, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.

Recently Adopted and Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), an updated standard on revenue recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported by companies while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards or GAAP. The main purpose of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively and improve guidance for multiple-element arrangements. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for the Company in the first quarter of fiscal 2018. The Company is currently expecting to use the modified retrospective method to adopt this standard and is continuing to assess all of the potential impacts of the new standard on its consolidated financial statements and related disclosures, although we do not expect the implementation to have a material impact.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases (with the exception of short term leases) at the commencement date. Lessor accounting under ASU 2016-02 is largely unchanged. ASU 2016-02 is effective for annual and interim periods beginning on or after December 15, 2018 and early adoption is permitted. Under ASU 2016-02, lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The ASU will be effective for the Company starting on January 1, 2019. The Company is continuing to evaluate the impact of the application of this ASU on our consolidated financial statements and disclosures. We expect to recognize right of use assets and lease liabilities.

In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.

Reclassifications

Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

3. Liabilities

Note Payable

In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest accrues at 20% from October 1, 2015 until paid. During the six months ended June 30, 2017, $25,000 principal of this note was assigned to a third party who paid a like amount to the holder of the note. The balance of the note outstanding at June 30, 2017, $112,982, continues to accrue interest at 20%.

Notes Payable- Related Parties

During the six months ended June 30, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remain $35,000 at June 30, 2017.

Convertible Debentures

As of June 30, 2017, the Company has issued and outstanding fixed rate Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share.

The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through June 30, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to June 30, 2013 do not contain such an exchange clause. During the six months ended June 30, 2017, Debentures with an accumulated principal balance of $150,000 and $13,767 of accrued interest were assigned to a third party note holder. The new notes contain variable conversion rates discussed below. The gross amount of Debentures with fixed conversion rates outstanding is $5,977,082 as of June 30, 2017.

During the six months ended June 30, 2017, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $472,449 as of June 30, 2017.

As of June 30, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

	June 30, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		123,750			320,000
Issuance of debentures for services		21,250			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(164,936	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,449,531			6,415,305
Less unamortized costs of financing		249,988			203,444
Convertible debt, net of unamortized costs	$	6,199,543		$	6,211,861

Convertible debt in default	$	6,068,243		$	5,991,570

Secured Convertible Note

During the six months ended June 30, 2017, the Company issued for cash of $300,000 Secured Convertible Debentures (the “Secured Debentures”) to two accredited investors. The terms of the Debentures are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company. In addition, the Company issued to the holder of $150,000 Secured Debentures, five year common stock purchase warrants to purchase up to 8,000,000 shares of common stock with exercise prices of $0.02 per share. The value of these warrants, $584, was determined using the Black Sholes option pricing model and was reflected as a discount to the Secured Debenture.

Derivative Liability

Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using the Black Scholes option pricing model. The period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.

The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.

The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under the Company’s control. Therefore, the resulting effect on net loss is subject to significant fluctuation and

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.

In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes option pricing model and a liability is recorded as though the obligations would be settled using some means other than stock. For the six months ended June 30, 2017, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 3,706,000,000 shares.

As of June 30, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

							Commitment
							In Excess of
	Warrants			Conversion Feature			Authorized Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402
Change in fair value at year end		(71,602	)		355,833			-			284,231
Elimination of liability on conversion		-			(607,914	)		-			(607,914	)
Over commitment of stock		-			-			(39,397	)		(39,397	)
Balance at June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

Debentures with warrants attached issued subsequent to June 30, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

4. Shareholders’ Deficit

Common Stock

During the six months ended June 30, 2017, holders of Convertible Debentures with a face value of $164,938 and accrued interest of $13,629 converted their debentures into 1,079,114,357 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $172,124.

Warrants

During the six months ended June 30, 2017, in conjunction with the sale of Convertible Debentures, the Company issued five-year common stock purchase warrants to acquire up to 8,000,000 shares to holders of the Debentures. In addition, the Company issued five-year common stock purchase warrants to acquire up to 1,050,000 shares to an agent who assisted in this financing. These warrants have an exercise price of $0.02 per share. The value of the warrants was determined using the Black Sholes option pricing model.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

The value of the warrants issued to the note holder, $4,386, were reflected as a discount to the notes and the value of the warrants issued to the agent, $584, were reflected as a non-cash operating expense.

In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black Scholes option pricing model and was included as non-cash expense and additional paid-in capital during the six months ended June 30, 2016.

The balance of all warrants outstanding as of June 30, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		9,050,000		$	0.0200	$	0.0005
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at June 30, 2017		114,750,650		$	0.0725

Exercisable at June 30, 2017		114,750,650		$	0.0725

Stock Options

Options outstanding as of June 30, 2017 are as follows:

			Weighted Average		Weighted Average Remaining		Aggregate
			Exercise Price		Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at June 30, 2017		34,168,800	$	0.02		6.54	$	-

Exercisable at June 30, 2017		28,058,674	$	0.02		6.54	$	-

Weighted average fair value of options granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

At June 30, 2017, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $93,322, which we expect to be recognized over the next year.

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

Series AA Preferred Shares

On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.

Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors. The Company recorded a special dividend and valued the Series AA Super Voting Preferred Stock at $25,000 as of June 30, 2017 and December 31, 2016.

5. Fair Value Measurements

Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.

The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: uses unobservable inputs that are not corroborated by market data.

The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. The Black Sholes option pricing model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2017:

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

	Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of June 30, 2017
Derivative liability	$	-	$	-	$	1,189,089	$	1,189,089
Warrant liability		-		-		15,102		15,102
Commitment in excess of authorized stock		-		-		19,059		19,059
Total	$	-	$	-	$	1,223,250	$	1,223,250

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the six months ended June 30, 2017:

							Commitment
							In Excess of
	Warrant Liability			Derivative Liability			Authorized Stock			Total Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402

Elimination of liability on conversion		-			(607,914	)		-			(607,914	)

Change in estimated fair value (1)		(71,602	)		355,833			-			284,231

Change in commitment in excess of authorized stock		-			-			(39,397	)		(39,397	)

Balance June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 251%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.24%	1.78% to 1.93%
Forfeitures	None	None

SpectraScience, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements (continued)

In computing the fair value of the derivative and warrant liability at June 30, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

6. Contingencies

Legal Proceedings

On July 7, 2016, Oakmore Opportunity Fund I LP, a variable rate noteholder of SprectraScience, filed for a preliminary judgement of $116, 500 in the Superior Court for the County of Los Angeles, case number BC622542, related to a Convertible Note. Oakmore asserts that SpectraScience breached the terms of the Convertible Note due to not having sufficient authorized shares to enable Oakmore to convert its Note with a balance of $22,500. The Company did not object to the preliminary judgement. On October 19, 2016, the Judge issued a final judgement of $521,100. The Company is retaining litigation counsel and intends to vigorously defend the amount of the judgement. The amount of ultimate liability with respect to the foregoing cannot be determined, however, the Company has established a $150,000 contingency to cover the costs of litigation and the judgement. Despite the inherent uncertainties of litigation, the Company at this time does not believe that Oakmore’s claim will have a material adverse impact on its financial condition, results of operations, or cash flows.

7. Subsequent Events

Variable Rate Convertible Debentures

In July and August 2017, holders of Variable Rate Convertible Debentures with principal of $37,774 and accrued interest of $528 converted a portion of their debentures into 723,045,000 shares of common stock.

In July 2017, the Company issued a $35,000 Variable Rate Convertible Debenture (the “Debenture”) to an accredited investor for cash consideration of $20,000. The Debenture matures on December 2, 2017, has a variable conversion rate of 50% discount to the lowest trade 20 days previous to conversion, and an annual interest rate of 8%.

In August 2017, the Company issued a $43,000 Variable Rate Convertible Debenture (the “Second Debenture”) to one accredited investor for cash consideration of $0, payment of fees of $39,000 and an original issue discount of $4,000. The Second Debenture matures on May 9, 2018, has a variable conversion rate of 45% discount to the lowest trade 25 days previous to conversion, and an annual interest rate of 12%.

Increase in Authorized Shares

On July 27, 2017, the Company’s shareholders approved an increase in authorized capital stock from 3 billion shares to 5 billion shares. The increase in authorized shares will become effective 20 days after the mailing of a Definitive 14C to shareholders.

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements that are not related to historical results, including, without limitation, statements regarding our business strategy and objectives, our anticipated duration of periods of net loss, our near term operating goals, our expectations regarding the market for our products, the introduction of our products in new international markets and our beliefs with respect to opportunities and industry conditions in those markets, our beliefs about our products, product development, acquisition or licensing of complementary technologies and expectations with respect to our products’ performance and acceptance, the results of and our intentions with respect to our distribution agreement with PENTAX Europe GmbH, our beliefs about the strengths of our intellectual property portfolio, our regulatory goals and developments, anticipated clinical trials and research, our agreements with Laidlaw and other agents and their effect on our future capital resources and future financial position, our expectations with respect to stock option expense recognition, our future cash needs, the sufficiency of our working capital and our operating losses for the remainder of the current fiscal year. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, there can be no assurance that such assumptions will prove to be accurate and actual results could differ materially from those discussed in the forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause or contribute to such differences, including, but not limited to, changes in law or regulatory policies, unanticipated competition from other similar businesses, adverse outcomes from litigation, unexpected employee departures or disruptions, adverse market and general economic factors and other factors described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. Such forward-looking statements are qualified in their entirety by the cautions and risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Business

SpectraScience, Inc. (the “Company,” “SpectraScience,” “we,” “our,” or “us”) develops and manufactures innovative Laser Induced Fluorescence spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without removing tissue from the body. The WavSTAT Optical Biopsy System (the “WavSTAT System”) is SpectraScience’s first product to incorporate its proprietary fluorescence technology for clinical use. The WavSTAT System carries the CE mark designation which allows for the sale and marketing in the European Union for the diagnosis of cancer. We are developing light-based diagnostics for additional indications including inflammatory bowel disease and esophageal cancer. Once these additional applications are developed we plan to self-certify for CE mark approval for sale in the European Union and then file an application with the FDA seeking permission to begin marketing for that indication for use in the United States. We believe we have a strong intellectual property portfolio that will allow us to continue to expand our WavSTAT cancer diagnosis platform to address the diagnosis of multiple cancers, utilize additional proprietary bio-photonic techniques to improve the WavSTAT’s overall diagnostic performance and ultimately allow for the detection of cancer and pre-cancer over a relatively large area of examined tissue.

Our principal executive offices are located at 11568 Sorrento Valley Rd., Suite 11, San Diego, CA 92121. We can be reached by telephone at (858) 847-0200; by fax at (858) 847-0880; or by email at info@spectrascience.com. We have a Web site at http://www.spectrascience.com. The information contained on our Web site shall not be deemed to be a part of this Report.

Plan of Operation

During the six month period ended June 30, 2017, SpectraScience carried forward on the improvements made to the WavSTAT4 in fiscal 2011 and continued working with PENTAX Europe, GmbH (“PENTAX”) and other distributors, for distribution of its products in Europe, the Middle East and Africa.

Over the next 12 months, SpectraScience intends to:

●	Market and sell the WavSTAT4 Optical Biopsy System colon cancer diagnostic application through PENTAX and other distribution channels in the European Union;

●	Conduct country-specific evaluation trials to demonstrate the effectiveness and cost benefit of the WavSTAT4 Optical Biopsy System in each relevant European jurisdiction;

●	Coordinate the creation and publication of scientific papers and presentations related to the country-specific evaluation trials to support widespread education and adoption of the WavSTAT4;

●	Pursue the introduction of the WavSTAT4 colon cancer application in other international markets, in particular China, Saudi Arabia and India;

●	Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA and plan for additional clinical trials to support eventual approval for sale in the United States;

●	Begin the design and planning for the next generation of multi-modal fluorescence and broadband spectroscopy systems at our facility in San Diego, California.

●	Continue to expand and refine our intellectual property portfolio.

Results of Operations

Comparison of the Three Months Ended June 30, 2017 and 2016

	Three Months Ended June 30,						Favorable
	2017			2016			(Unfavorable)			%

Revenue	$	-		$	950		$	(950	)		-100.0	%
Cost of revenue		-			868			868			100.0	%
Gross profit		-			82			(82	)		-100.0	%

Operating expenses:
Research and development		128,660			194,155			65,495			33.7	%
General and administrative		305,560			306,213			653			0.2	%
Sales and marketing		73,780			101,214			27,434			27.1	%
		508,000			601,582			93,582			15.6	%

Loss from operations		(508,000	)		(601,500	)		93,500			15.5	%

Other income (expense)		(743,207	)		513,318			(1,256,525	)		NM

Net loss	$	(1,251,207	)	$	(88,182	)	$	(1,163,025	)		1318.9	%

Gross Profit

There were no sales or associated cost of sales during the three months ended June 30, 2017 compared to minor sales for the three months ended June 30, 2016. We anticipate that revenue and cost of revenue will increase as we proceed with the introduction of the WaveSTAT4 in Europe.

Research and Development Expenses

Research and development expenses decreased by $65,495, 33.7%, to $128,660 for the quarter ended June 30, 2017 from $194,155 for the three months ended June 30, 2016. This decrease was due to a decrease in clinical costs. We anticipate that clinical costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

General and Administrative Expenses

General and administrative expenses decreased by $653, 0.2%, to $305,560 for the quarter ended June 30, 2017 from $306,213 for the three months ended June 30, 2016. We anticipate that costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

Sales and Marketing Expenses

Sales and marketing expenses decreased by $27,434, 27.1%, to $73,780 for the quarter ended June 30, 2017 from $101,214 for the quarter ended June 30, 2016. We anticipate that sales and marketing expenses will increase as we increase our activity in Europe.

Other Income (Expense)

Other income (expense) for the quarter ended June 30, 2017 was expense of $743,207 compared to income of $513,318 for the quarter ended June 30, 2016. This change was due primarily to a change in valuation of our derivative liabilities. We anticipate continued large fluctuations in other income (expense)

Comparison of the Six Months Ended June 30, 2017 and 2016

	Six Months Ended June 30,						Favorable
	2017			2016			(Unfavorable)			%

Revenue	$	-		$	950		$	(950	)		-100.0	%
Cost of revenue		-			868			868			100.0	%
Gross profit		-			82			(82	)		-100.0	%

Operating expenses:
Research and development		259,501			388,162			128,661			33.1	%
General and administrative		585,292			614,054			28,762			4.7	%
Sales and marketing		148,634			180,627			31,993			17.7	%
		993,427			1,182,843			189,416			16.0	%

Loss from operations		(993,427	)		(1,182,761	)		189,334			16.0	%

Other income (expense)		(1,261,556	)		(961,755	)		(299,801	)		-31.2	%

Net loss	$	(2,254,983	)	$	(2,144,516	)	$	(110,467	)		-5.2	%

Gross Profit

There were no sales or associated cost of sales during the six months ended June 30, 2017 compared to minor sales for the six months ended June 30, 2016. We anticipate that revenue and cost of revenue will increase as we proceed with the introduction of the WaveSTAT4 in Europe.

Research and Development Expenses

Research and development expenses decreased by $128,661, 33.1%, to $259,501 for the six months ended June 30, 2017 from $388,162 for the six months ended June 30, 2016. This decrease was due to a decrease in clinical costs. We anticipate that clinical costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

General and Administrative Expenses

General and administrative expenses decreased by $28,762, 4.7%, to $585,292 for the six months ended June 30, 2017 from $614,054 for the six months ended June 30, 2016. This decrease was due primarily to a decrease in travel and convention costs. We anticipate that costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

Sales and Marketing Expenses

Sales and marketing expenses decreased by $31,993, 17.7%, to $148,634 for the six months ended June 30, 2017 from $180,627 for the six months ended June 30, 2016. The primary reason for the decrease was a decrease in payroll costs related to the change in foreign currency values. We anticipate that sales and marketing expenses will increase as we increase our activity in Europe.

Other Income (Expense)

Other income (expense) for the six months ended June 30, 2017 was expense of $1,261,556 compared to expense of $961,755 for the six months ended June 30, 2016. This change was due primarily to a change in valuation of our derivative liabilities. We anticipate continued large fluctuations in other income (expense)

Liquidity and Capital Resources

	As of						Increase
	June 30, 2017			December 31, 2016			(Decrease)
Working Capital

Current assets	$	288,770		$	361,843		$	(73,073	)
Current liabilities		11,952,452			10,801,550			1,150,902
Working capital deficit	$	(11,663,682	)	$	(10,439,707	)	$	1,223,975

Long-term debt	$	1,410,000		$	1,100,000		$	310,000

Stockholders' deficit	$	(12,159,681	)	$	(10,546,033	)	$	1,613,648

	Six Months Ended June 30,						Increase
	2017			2016			(Decrease)
Statements of Cash Flows Select Information

Net cash provided (used) by:
Operating activities	$	(389,355	)	$	(880,921	)	$	(491,566	)
Investing activities	$	-		$	-		$	-
Financing activities	$	385,830		$	781,288		$	(395,458	)

	As of				Increase
	June 30, 2017		December 31, 2016		(Decrease)
Balance Sheet Select Information

Cash	$	25	$	3,550	$	(3,525	)

Accounts receivable	$	-	$	950	$	(950	)

Inventory	$	97,423	$	90,594	$	6,829

Accounts payable and accrued expenses	$	4,381,677	$	3,596,779	$	784,898

Historically, the Company’s sources of cash have come from the issuance and sales of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 Systems in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

As of June 30, 2017, the Company had a working capital deficit of $11,663,682 and cash of $25, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company has engaged other agents to assist it Company with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2017, the Company raised $386,499, net of transaction costs of $36,251, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not required

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this Report (the “Evaluation Date”). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date.

Changes in Internal Financial Controls

There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II

OTHER INFORMATION

Item 1.

Legal Proceedings

Oakmore Suit

Item 1A.

Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Number of

Date of

Common Shares

Source of

Common Stock

Issuance

Issued

Payment

Amount

Various

549,465,520

Conversion of debt

94,434

Common Stock Purchase Warrants

Date of

Issued With Convertible Debentures

Issuance

Number of Shares

Exercise Price

Expiration Date

5/18/2017

3,000,000

0.02

5/18/2022

Common Stock Purchase Warrants

Date of

Issued For Services

Issuance

Number of Shares

Exercise Price

Expiration Date

4/24/2017

250,000

0.02

4/24/2022

5/18/2017

300,000

0.02

5/18/2022

With respect to the above issuance of securities during the three months ended June 30, 2017, the Company relied on exemptions provided by Sections 4(a)(2) and 3(a)9 of the Securities Act of 1933, as amended (the “Securities Act”). No advertising or general solicitation was employed in offering the securities. The securities were issued to a limited number of persons all of whom were accredited investors as that term is defined in Rule 501 of Regulation D under the Securities Act. All were capable of analyzing the merits and risks of their investment, acknowledged in writing that they were acquiring the securities for investment and not with a view toward distribution or resale, and understood the speculative nature of their investment. All securities issued contained a restrictive legend prohibiting transfer of the shares except in accordance with federal securities laws.

Item 3.

Defaults Upon Senior Securities

As of August 14, 2017, there are Unsecured Convertible Debentures with a face value of $6,068,243 held by 83 individual Holders in default. As a result, the outstanding principal amount of these Debentures, plus accrued but unpaid interest, liquidated damages and other amounts owing shall become immediately due and payable in cash at the election of the Holders. As of August 14, 2017, none of the Holders of these Debentures have elected to provide notice of default.

Item 4.

Mine Safety Disclosures

None

Item 5.

Other Information

None

Item 6.

Exhibits

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101	Financial statements from the quarterly report on Form 10-Q of the Company for the quarter ended June 30, 2016, formatted in XBRL; (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statement of Shareholders’ Equity, (iv) the Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SpectraScience, Inc. (Registrant)

Date: August 14, 2017		/s/ Michael P. Oliver
		Michael P. Oliver
		President and Chief Executive Officer
		(Principal executive officer)

Date: August 14, 2017		/s/ Lowell W. Giffhorn
		Lowell W. Giffhorn
		Chief Financial Officer

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael P. Oliver, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Michael P. Oliver
	Name:	Michael P. Oliver
	Title:	Chief Executive Officer
	Date:	August 14, 2017

EX-31.2 3 ex31-2.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lowell W. Giffhorn, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

	(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

	(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Lowell W. Giffhorn
	Name:	Lowell W. Giffhorn
	Title:	Chief Financial Officer
	Date:	August 14, 2017

EX-32.1 4 ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael P. Oliver, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Michael P. Oliver
	Michael P. Oliver
	Chief Executive Officer
	Date: August 14, 2017

EX-32.2 5 ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lowell W. Giffhorn, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Lowell W. Giffhorn
	Lowell W. Giffhorn
	Chief Financial Officer
	Date: August 14, 2017

EX-101.INS 6 scie-20170630.xml XBRL INSTANCE FILE 0000727672 2017-01-01 2017-06-30 0000727672 2016-12-31 0000727672 2017-06-30 0000727672 us-gaap:SeriesBPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesBPreferredStockMember 2017-06-30 0000727672 us-gaap:SeriesCPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesCPreferredStockMember 2017-06-30 0000727672 us-gaap:SeriesAPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesAPreferredStockMember 2017-06-30 0000727672 us-gaap:CommonStockMember 2016-12-31 0000727672 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000727672 us-gaap:RetainedEarningsMember 2016-12-31 0000727672 SCIE:EngagementAgreementMember 2017-01-01 2017-06-30 0000727672 SCIE:OncoscopeIncMember 2016-12-31 0000727672 us-gaap:PreferredStockMember 2017-01-01 2017-06-30 0000727672 us-gaap:PreferredStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2016-01-01 2016-06-30 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-30 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-01 2014-11-30 0000727672 SCIE:PromissoryNotesMember SCIE:TwoAffiliatesMember 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember 2017-01-01 2017-06-30 0000727672 us-gaap:MinimumMember SCIE:ConvertibleDebentures1Member 2017-01-01 2017-06-30 0000727672 us-gaap:MaximumMember SCIE:ConvertibleDebentures1Member 2017-01-01 2017-06-30 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MinimumMember 2017-06-30 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MaximumMember 2017-06-30 0000727672 SCIE:ConvertibleDebentures1Member 2017-01-01 2017-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-06-30 0000727672 us-gaap:WarrantMember 2017-01-01 2017-06-30 0000727672 SCIE:ConversionFeatureMember 2017-01-01 2017-06-30 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-01-01 2017-06-30 0000727672 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2016-01-01 2016-12-31 0000727672 SCIE:ConversionFeatureMember 2016-01-01 2016-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-01-01 2016-12-31 0000727672 us-gaap:WarrantMember 2016-12-31 0000727672 us-gaap:WarrantMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2015-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2016-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-12-31 0000727672 us-gaap:WarrantMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2017-06-30 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2017-01-01 2017-06-30 0000727672 SCIE:WarrantLiabilityMember 2017-01-01 2017-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2017-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2017-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2017-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:WarrantLiabilityMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:WarrantLiabilityMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:WarrantLiabilityMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 SCIE:EquityIncentivePlan2011Member 2017-06-30 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2017-01-01 2017-06-30 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2017-06-30 0000727672 us-gaap:CommonStockMember 2017-01-01 2017-06-30 0000727672 us-gaap:CommonStockMember 2017-06-30 0000727672 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-06-30 0000727672 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000727672 us-gaap:RetainedEarningsMember 2017-01-01 2017-06-30 0000727672 us-gaap:RetainedEarningsMember 2017-06-30 0000727672 2016-01-01 2016-12-31 0000727672 2015-12-31 0000727672 us-gaap:WarrantMember 2017-01-01 2017-06-30 0000727672 us-gaap:WarrantMember 2017-06-30 0000727672 us-gaap:WarrantMember 2017-01-01 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember 2017-01-01 2017-06-30 0000727672 SCIE:ConvertibleDebenturesMember 2016-01-01 2016-06-30 0000727672 SCIE:OptionsMember 2017-01-01 2017-06-30 0000727672 SCIE:OptionsMember 2016-01-01 2016-06-30 0000727672 SCIE:ThirdPartyMember 2017-06-30 0000727672 SCIE:ThirdPartyMember 2017-01-01 2017-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember 2017-01-01 2017-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember 2017-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember SCIE:HolderMember 2017-01-01 2017-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember SCIE:HolderMember 2017-06-30 0000727672 us-gaap:WarrantMember 2017-06-30 0000727672 SCIE:ConversionFeatureMember 2017-06-30 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-01-01 2016-12-31 0000727672 SCIE:ConvertibleDebenturesMember 2017-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:CommonStockMember 2017-01-01 2017-06-30 0000727672 us-gaap:WarrantMember us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-06-30 0000727672 us-gaap:WarrantMember us-gaap:ConvertibleDebtSecuritiesMember 2017-06-30 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2016-03-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-01-01 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-01-01 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-06-30 0000727672 us-gaap:FairValueInputsLevel3Member 2017-06-30 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-07-06 2016-07-07 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-07-07 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-10-18 2016-10-19 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-07-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-07-01 2017-07-31 0000727672 us-gaap:SubsequentEventMember us-gaap:MinimumMember 2017-07-27 0000727672 us-gaap:SubsequentEventMember us-gaap:MaximumMember 2017-07-27 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-02-17 2015-02-18 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-09-28 2015-10-01 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-10-01 0000727672 us-gaap:WarrantMember SCIE:HolderMember 2017-01-01 2017-06-30 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2016-01-01 2016-06-30 0000727672 2017-04-01 2017-06-30 0000727672 2016-04-01 2016-06-30 0000727672 2017-08-14 0000727672 2016-06-30 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-08-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-08-01 2017-08-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesOneMember 2017-07-01 2017-07-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesOneMember 2017-07-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesSecondMember 2017-08-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesSecondMember 2017-08-01 2017-08-31 0000727672 us-gaap:StockOptionMember 2017-01-01 2017-06-30 0000727672 us-gaap:StockOptionMember 2017-06-30 0000727672 us-gaap:StockOptionMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SCIE:IndividualInvestors SCIE:IntellectualProperty 10-Q 2017-06-30 false --12-31 Smaller Reporting Company 2017

3550

127493

27860

25850 25850 5000 5000

8836712

19627855

-10546033

-12159681

8836712

34582771

-53965519

19627855

24432963

-56220502

203444

249988

4000

0.01

.001

0.001

2585000

500000

3000

2585000

500000

3000

2585000

500000

3000

517000

100000

106931 106931

0.01

2996000000

3000000000

5000000000

883671222

1962785579

883671222

1962785579

172124

247074

172124

161573

245908

-2254983

-2144516

-2254983

-1251207

-88182

560749

10791143

-10230394

3706000000

-1079114357

584

883671222

3000

1962785579

79673

80789

-1400

-700

284232

262620

-950

-6111

6829

47845

-75427

-71073

454821

173391

357470

274152

-389355

-880921

123750

300000

385830

781288

-3525

-99633

1000

For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Preferred Stock</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debentures</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,594,144,575</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">247,559,219</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">132,875,170</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">4,746,149,025</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">417,688,189</td> <td style="line-height: 107%"> </td></tr> </table>

Options outstanding as of June 30, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Aggregate</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Remaining Contractual</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Intrinsic</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Per Share</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Term (years)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value (1)</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%">34,168,800</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">0.02</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%">7.03</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Cancelled</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.02</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.54</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">28,058,674</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.02</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.54</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Weighted average fair value of options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">granted during the period</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%">(1)</td> <td style="text-align: justify; line-height: 107%">These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.</td></tr> </table>

386499

5991570

6068243

34168800

256163

40000

4746149025

3085000

132875170

417688189

114750650

4594144575

247559219

34168800

-2254983

-2144516

-1251207

-88182

-2254983

-2144516

-1251207

-88182

1291451398

640797803

1490570290

668866352

1291451398

640797803

1490570290

668866352

-0.00

30868

37697

287031

293860

100000

164938

37774

35000

43000

P5Y P5Y P5Y P5Y 0.09 0.0745 0.1287 0.02 50000

0.10

0.20

0.00

0.10

0.08

0.20

0.05 0.10 0.00 0.10

0.01

0.099

0.01

0.02 0.1287 0.40 0.50

5977082

472449

150000

P9M

P1Y

P3Y

0.00 0.50

6174760

6415305

320000

123750

65282 16064 -291754 -164936 132017 38767

6415305

6449531

203444 249988

819928

1223250

82436

60420

495473

64428

679036

58456

82436

679036

819928

58456

620321

15102

1189089

19059

15102

1189089

19059

1223250

766402 4268 762134 44394 697256 741650

-284231

71602

-355833

22378

-718458

-696080

-71602

355833

284231

607914

1232151

-39397 -39397 -5972 -5972

1050000

8000000

1000000

93322

9050000

114750650 0.0200 0.0725

132278221

114750650

0.0765 0.0725

34168800

28058674

0.02

P6Y6M14D

1189089

15102

1223250

1189089

15102

19059

1223250

19059

P5Y

P6M

P2Y

0.074

0.0001

0.1287

0.02

2.16

2.40

2.42

2.51

0.00

0.0079

0.0124

0.0178

0.0193

0.00 0.00

35000

SPECTRASCIENCE INC 2685830579 0000727672 SCIE

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2017:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr> <td colspan="14" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Fair Value Measurements Using</td> <td style="vertical-align: bottom; line-height: 107%"> </td> <td colspan="2" style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Quoted Prices in</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Significant Other</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Significant</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Active Markets for</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Observable</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Unobservable</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Identical Assets</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Inputs</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Inputs</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 1)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 2)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 3)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">As of June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt; line-height: 107%">Derivative liability</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">1,189,089</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">1,189,089</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Warrant liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Commitment in excess of authorized stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>

287031 293860

115000

13767

0.02

0.0005

361843

288770

266749

191322

90594

97423

950

1386367

1233621

1024524

944851

196437

10801550

11952452

2278042

2608116

819928

1223250

6211861

6199543

137982

112982

1318737

1773561

585292

614054

305560

306213

259501

388162

128660

194155

14712

125450

7978

62920

268026 236296 137618 94735

1291451398

640797803

1490570290

668866352

1. Nature of Business and Basis of Presentation   Description of Business   SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).   The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.   On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.   The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.   Basis of Presentation   The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the six month period ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.   Going Concern   Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.   As of June 30, 2017, the Company had a working capital deficit of $11,663,682 and cash of $25, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company uses agents to assist it with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2017, the Company raised $386,499, net of transaction costs of $36,251, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.   The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of June 30, 2017, Convertible Debentures with a face value of $6,068,243 held by 83 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.   The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2. Summary of Significant Accounting Policies   Revenue recognition   The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.   Consolidation   The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.   Risks and Uncertainties   The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.   Use of Estimates   The Company prepares its unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.   Inventory Valuation   The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.   Valuation of Long-lived Assets   The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.   Variable Conversion Rate Debentures   Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.   Over Commitment of Shares   Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes option pricing model and a liability is recorded as though the obligations would be settled using some means other than stock.   Stock-Based Compensation   The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option pricing model (the “Black Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.   The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards.   granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.   All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.   As of June 30, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 28,058,674 shares were exercisable. Awards under the Company’s EIP generally vest over four years.   The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the six month periods ended June 30, 2017 and 2016.   Earnings (Loss) Per Share   Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.   For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Preferred Stock</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debentures</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,594,144,575</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">247,559,219</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">132,875,170</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">4,746,149,025</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">417,688,189</td> <td style="line-height: 107%"> </td></tr> </table>   The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Three Months Ended</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Six Months Ended</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Numerator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; line-height: 107%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,251,207</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(88,182</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,254,983</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,144,516</td> <td style="width: 1%; line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Net loss for diluted earnings per share</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(1,251,207</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(88,182</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,254,983</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,144,516</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Weighted average basic shares outstanding</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator for diluted earnings per share-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Adjusted weighted average shares</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Loss per share</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Basic</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> Diluted</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> </table>   Inventory   Inventory consisted of the following at June 30, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Raw materials</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Finished goods</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">37,697</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">30,868</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Reserve for obsolescence</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less long-term portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">97,423</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">90,594</td> <td style="line-height: 107%"> </td></tr> </table>   During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.   Recently Adopted and Issued Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), an updated standard on revenue recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported by companies while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards or GAAP. The main purpose of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively and improve guidance for multiple-element arrangements. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for the Company in the first quarter of fiscal 2018. The Company is currently expecting to use the modified retrospective method to adopt this standard and is continuing to assess all of the potential impacts of the new standard on its consolidated financial statements and related disclosures, although we do not expect the implementation to have a material impact.   In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases (with the exception of short term leases) at the commencement date. Lessor accounting under ASU 2016-02 is largely unchanged. ASU 2016-02 is effective for annual and interim periods beginning on or after December 15, 2018 and early adoption is permitted. Under ASU 2016-02, lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The ASU will be effective for the Company starting on January 1, 2019. The Company is continuing to evaluate the impact of the application of this ASU on our consolidated financial statements and disclosures. We expect to recognize right of use assets and lease liabilities.   In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.   Reclassifications   Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

4. Shareholders’ Deficit   Common Stock   During the six months ended June 30, 2017, holders of Convertible Debentures with a face value of $164,938 and accrued interest of $13,629 converted their debentures into 1,079,114,357 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $172,124.   Warrants   During the six months ended June 30, 2017, in conjunction with the sale of Convertible Debentures, the Company issued five-year common stock purchase warrants to acquire up to 8,000,000 shares to holders of the Debentures. In addition, the Company issued five-year common stock purchase warrants to acquire up to 1,050,000 shares to an agent who assisted in this financing. These warrants have an exercise price of $0.02 per share. The value of the warrants was determined using the Black Sholes option pricing model.   The value of the warrants issued to the note holder, $4,386, were reflected as a discount to the notes and the value of the warrants issued to the agent, $584, were reflected as a non-cash operating expense.   In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black Scholes option pricing model and was included as non-cash expense and additional paid-in capital during the six months ended June 30, 2016.   The balance of all warrants outstanding as of June 30, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Fair</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; line-height: 107%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 14%; text-align: right; line-height: 107%">132,278,221</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">0.0765</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 14%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">9,050,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.0200</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.0005</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Cancelled</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(26,577,571</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">0.0745</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0725</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0725</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>   Stock Options   Options outstanding as of June 30, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Aggregate</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Remaining Contractual</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Intrinsic</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Per Share</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Term (years)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value (1)</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%">34,168,800</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">0.02</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%">7.03</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 11%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Cancelled</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.02</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.54</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">28,058,674</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.02</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.54</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Weighted average fair value of options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">granted during the period</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 107%">(1)</td> <td style="text-align: justify; line-height: 107%">These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.</td></tr> </table>   At June 30, 2017, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $93,322, which we expect to be recognized over the next year.   Series AA Preferred Shares   On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.   Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors. The Company recorded a special dividend and valued the Series AA Super Voting Preferred Stock at $25,000 as of June 30, 2017 and December 31, 2016.

5. Fair Value Measurements   Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.   The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:   Level 1: uses quoted market prices in active markets for identical assets or liabilities.   Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.   Level 3: uses unobservable inputs that are not corroborated by market data.   The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. The Black Sholes option pricing model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.   The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2017:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr> <td colspan="14" style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Fair Value Measurements Using</td> <td style="vertical-align: bottom; line-height: 107%"> </td> <td colspan="2" style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Quoted Prices in</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Significant Other</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Significant</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Active Markets for</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Observable</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Unobservable</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Identical Assets</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Inputs</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Inputs</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 1)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 2)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(Level 3)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">As of June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt; line-height: 107%">Derivative liability</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">1,189,089</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">1,189,089</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Warrant liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Commitment in excess of authorized stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>   The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the six months ended June 30, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Commitment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">In Excess of</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrant Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Derivative Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Authorized Stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total Liability</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Balance December 31, 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">82,436</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">679,036</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">58,456</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">819,928</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,268</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">762,134</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">766,402</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Change in estimated fair value (1)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(71,602</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">355,833</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">284,231</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Change in commitment in excess of authorized stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1,189,089</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>   (1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”   Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Derivative Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrant Liability</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 34%; line-height: 107%">Expected term</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 30%; text-align: center; line-height: 107%">6 months to 2 years</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 30%; text-align: center; line-height: 107%">5 years</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Exercise price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">$0.0001 - $0.074</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">$0.02 - $0.1287</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected volatility</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">216% to 240%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">242% to 251%</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Expected dividends</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Risk-free interest rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">0.79% to 1.24%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">1.78% to 1.93%</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Forfeitures</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td></tr> </table>   In computing the fair value of the derivative and warrant liability at June 30, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

7. Subsequent Events   Variable Rate Convertible Debentures   In July and August 2017, holders of Variable Rate Convertible Debentures with principal of $37,774 and accrued interest of $528 converted a portion of their debentures into 723,045,000 shares of common stock.   In July 2017, the Company issued a $35,000 Variable Rate Convertible Debenture (the “Debenture”) to an accredited investor for cash consideration of $20,000. The Debenture matures on December 2, 2017, has a variable conversion rate of 50% discount to the lowest trade 20 days previous to conversion, and an annual interest rate of 8%.   In August 2017, the Company issued a $43,000 Variable Rate Convertible Debenture (the “Second Debenture”) to one accredited investor for cash consideration of $0, payment of fees of $39,000 and an original issue discount of $4,000. The Second Debenture matures on May 9, 2018, has a variable conversion rate of 45% discount to the lowest trade 25 days previous to conversion, and an annual interest rate of 12%.   Increase in Authorized Shares   On July 27, 2017, the Company’s shareholders approved an increase in authorized capital stock from 3 billion shares to 5 billion shares. The increase in authorized shares will become effective 20 days after the mailing of a Definitive 14C to shareholders.   Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

As of June 30, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="9"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Balance at beginning of period</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">6,415,305</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">6,174,760</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Issuance of debentures for cash</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">123,750</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">320,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Issuance of debentures for services</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,250</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Issuance of debentures for forbearance</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">16,064</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">65,282</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Debentures repaid in cash</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(669</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Debentures converted to common stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(164,936</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(291,754</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Debentures exchanged for new debentures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">38,767</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">132,017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6,449,531</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6,415,305</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Less unamortized costs of financing</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">249,988</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">203,444</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt, net of unamortized costs</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,199,543</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,211,861</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt in default</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,068,243</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">5,991,570</td> <td style="line-height: 107%"> </td></tr> </table>

As of June 30, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Commitment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">In Excess of</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Conversion Feature</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Authorized Stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Balance at January 1, 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">60,420</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">495,473</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">64,428</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">620,321</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">44,394</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">697,256</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">741,650</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in fair value at year end</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(22,378</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">718,458</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">696,080</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(1,232,151</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(1,232,151</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Over commitment of stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(5,972</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(5,972</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance at December 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">82,436</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">679,036</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">58,456</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">819,928</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,268</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">762,134</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">766,402</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in fair value at year end</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(71,602</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">355,833</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">284,231</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Over commitment of stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,189,089</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>

The balance of all warrants outstanding as of June 30, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Weighted</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Average</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Exercise</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Fair</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Value</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; line-height: 107%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 14%; text-align: right; line-height: 107%">132,278,221</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">0.0765</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 14%; text-align: right; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Granted</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">9,050,000</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.0200</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.0005</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Cancelled</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(26,577,571</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">0.0745</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%">Exercised</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Outstanding at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0725</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Exercisable at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">0.0725</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table> 10439707 11663682

1100000

1410000

30850 30850

80002

116500

34582771

24432963

-53965519

-56220502

1386367

1233621

16648

31364

35000

669

36251

53712

178565

88550

34 28

36251

40000000

112982

25000

35000

8000000

13629

1079114357

25000

-26577571 0.0745 P7Y11D

4268 762134 766402

-607914

-39397 -39397

22500

521100

150000

528

Revenue recognition   The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Three Months Ended</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Six Months Ended</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Numerator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; line-height: 107%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,251,207</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(88,182</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,254,983</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,144,516</td> <td style="width: 1%; line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Net loss for diluted earnings per share</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(1,251,207</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(88,182</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,254,983</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,144,516</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Weighted average basic shares outstanding</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator for diluted earnings per share-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Adjusted weighted average shares</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Loss per share</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Basic</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> Diluted</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> </table>

Inventory consisted of the following at June 30, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Raw materials</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Finished goods</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">37,697</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">30,868</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Reserve for obsolescence</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less long-term portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">97,423</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">90,594</td> <td style="line-height: 107%"> </td></tr> </table>

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the six months ended June 30, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Commitment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">In Excess of</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrant Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Derivative Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Authorized Stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total Liability</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Balance December 31, 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">82,436</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">679,036</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">58,456</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">819,928</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,268</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">762,134</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">766,402</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Change in estimated fair value (1)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(71,602</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">355,833</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">284,231</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%">Change in commitment in excess of authorized stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1,189,089</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>   (1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Derivative Liability</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrant Liability</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 34%; line-height: 107%">Expected term</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 30%; text-align: center; line-height: 107%">6 months to 2 years</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 30%; text-align: center; line-height: 107%">5 years</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Exercise price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">$0.0001 - $0.074</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">$0.02 - $0.1287</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Expected volatility</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">216% to 240%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">242% to 251%</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Expected dividends</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Risk-free interest rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">0.79% to 1.24%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">1.78% to 1.93%</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Forfeitures</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">None</td> <td style="line-height: 107%"> </td></tr> </table>

2100 300000 150000

584

4386

1652

584

723045000

15000 21250 -669

Consolidation   The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

Risks and Uncertainties   The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

Use of Estimates   The Company prepares its unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

Inventory Valuation   The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

Valuation of Long-lived Assets   The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

Variable Conversion Rate Debentures   Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

Over Commitment of Shares   Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes option pricing model and a liability is recorded as though the obligations would be settled using some means other than stock.

Stock-Based Compensation   The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option pricing model (the “Black Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.   The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards.   granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.   All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.   As of June 30, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 28,058,674 shares were exercisable. Awards under the Company’s EIP generally vest over four years.   The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the six month periods ended June 30, 2017 and 2016.

Earnings (Loss) Per Share   Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.   For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%; line-height: 107%">Preferred Stock</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 17%; text-align: right; line-height: 107%">3,085,000</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debentures</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,594,144,575</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">247,559,219</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Options</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34,168,800</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">114,750,650</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">132,875,170</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">4,746,149,025</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">417,688,189</td> <td style="line-height: 107%"> </td></tr> </table>   The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Three Months Ended</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">Six Months Ended</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="text-align: center; line-height: 107%">June 30,</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Numerator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; line-height: 107%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,251,207</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(88,182</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,254,983</td> <td style="width: 1%; line-height: 107%">)</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(2,144,516</td> <td style="width: 1%; line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Net loss for diluted earnings per share</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(1,251,207</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(88,182</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,254,983</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(2,144,516</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Weighted average basic shares outstanding</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Denominator for diluted earnings per share-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Adjusted weighted average shares</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,490,570,290</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">668,866,352</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,291,451,398</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">640,797,803</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Loss per share</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> Basic</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> Diluted</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">(0.00</td> <td style="line-height: 107%">)</td></tr> </table>

Inventory   Inventory consisted of the following at June 30, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Raw materials</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">256,163</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Finished goods</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">37,697</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">30,868</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Reserve for obsolescence</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">293,860</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">287,031</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less long-term portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">196,437</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">97,423</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">90,594</td> <td style="line-height: 107%"> </td></tr> </table>   During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.

Recently Adopted and Issued Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), an updated standard on revenue recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported by companies while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards or GAAP. The main purpose of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively and improve guidance for multiple-element arrangements. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for the Company in the first quarter of fiscal 2018. The Company is currently expecting to use the modified retrospective method to adopt this standard and is continuing to assess all of the potential impacts of the new standard on its consolidated financial statements and related disclosures, although we do not expect the implementation to have a material impact.   In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases (with the exception of short term leases) at the commencement date. Lessor accounting under ASU 2016-02 is largely unchanged. ASU 2016-02 is effective for annual and interim periods beginning on or after December 15, 2018 and early adoption is permitted. Under ASU 2016-02, lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The ASU will be effective for the Company starting on January 1, 2019. The Company is continuing to evaluate the impact of the application of this ASU on our consolidated financial statements and disclosures. We expect to recognize right of use assets and lease liabilities.   In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.

Reclassifications   Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

20000

0.08

0.12

-39397

132130

80002

80003

148634

180627

73780

101214

-993427

-1182761

-508000

-601500

815230

579299

266496

208347

-284232

-262621

-452019

624873

-38529

4691

-32436

13616

-12951

-9854

-8233

-5077

6. Contingencies   Legal Proceedings   On July 7, 2016, Oakmore Opportunity Fund I LP, a variable rate noteholder of SprectraScience, filed for a preliminary judgement of $116, 500 in the Superior Court for the County of Los Angeles, case number BC622542, related to a Convertible Note. Oakmore asserts that SpectraScience breached the terms of the Convertible Note due to not having sufficient authorized shares to enable Oakmore to convert its Note with a balance of $22,500. The Company did not object to the preliminary judgement. On October 19, 2016, the Judge issued a final judgement of $521,100. The Company is retaining litigation counsel and intends to vigorously defend the amount of the judgement. The amount of ultimate liability with respect to the foregoing cannot be determined, however, the Company has established a $150,000 contingency to cover the costs of litigation and the judgement. Despite the inherent uncertainties of litigation, the Company at this time does not believe that Oakmore’s claim will have a material adverse impact on its financial condition, results of operations, or cash flows.

950

868

993427

1182843

508000

601582

-1261556

-961755

-743207

513318

-0.00

25000 42896 13767

299000

500000

-428367

-84434

-22250

0.50

0.45

2017-12-02

2018-05-09

39000 3. Liabilities   Note Payable   In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest accrues at 20% from October 1, 2015 until paid. During the six months ended June 30, 2017, $25,000 principal of this note was assigned to a third party who paid a like amount to the holder of the note. The balance of the note outstanding at June 30, 2017, $112,982, continues to accrue interest at 20%.   Notes Payable- Related Parties   During the six months ended June 30, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remain $35,000 at June 30, 2017.   Convertible Debentures   As of June 30, 2017, the Company has issued and outstanding fixed rate Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share.   The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through June 30, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to June 30, 2013 do not contain such an exchange clause. During the six months ended June 30, 2017, Debentures with an accumulated principal balance of $150,000 and $13,767 of accrued interest were assigned to a third party note holder. The new notes contain variable conversion rates discussed below. The gross amount of Debentures with fixed conversion rates outstanding is $5,977,082 as of June 30, 2017.   During the six months ended June 30, 2017, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $472,449 as of June 30, 2017.   As of June 30, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="9"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Balance at beginning of period</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">6,415,305</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">6,174,760</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Issuance of debentures for cash</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">123,750</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">320,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Issuance of debentures for services</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,250</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">15,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Issuance of debentures for forbearance</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">16,064</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">65,282</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Debentures repaid in cash</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(669</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Debentures converted to common stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(164,936</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(291,754</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Debentures exchanged for new debentures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">38,767</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">132,017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6,449,531</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6,415,305</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Less unamortized costs of financing</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">249,988</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">203,444</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt, net of unamortized costs</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,199,543</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,211,861</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Convertible debt in default</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">6,068,243</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">5,991,570</td> <td style="line-height: 107%"> </td></tr> </table>   Secured Convertible Note   During the six months ended June 30, 2017, the Company issued for cash of $300,000 Secured Convertible Debentures (the “Secured Debentures”) to two accredited investors. The terms of the Debentures are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company. In addition, the Company issued to the holder of $150,000 Secured Debentures, five year common stock purchase warrants to purchase up to 8,000,000 shares of common stock with exercise prices of $0.02 per share. The value of these warrants, $584, was determined using the Black Sholes option pricing model and was reflected as a discount to the Secured Debenture.   Derivative Liability   Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using the Black Scholes option pricing model. The period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.   The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.   The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under the Company’s control. Therefore, the resulting effect on net loss is subject to significant fluctuation and   will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.   In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes option pricing model and a liability is recorded as though the obligations would be settled using some means other than stock. For the six months ended June 30, 2017, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 3,706,000,000 shares.   As of June 30, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Commitment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">In Excess of</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Conversion Feature</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Authorized Stock</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 107%">Balance at January 1, 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">60,420</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">495,473</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">64,428</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 11%; text-align: right; line-height: 107%">620,321</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">44,394</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">697,256</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">741,650</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in fair value at year end</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(22,378</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">718,458</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">696,080</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(1,232,151</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(1,232,151</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Over commitment of stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(5,972</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(5,972</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance at December 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">82,436</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">679,036</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">58,456</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">819,928</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Liability on issuance of debt and warrants</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">4,268</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">762,134</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">766,402</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change in fair value at year end</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(71,602</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">355,833</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">284,231</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Elimination of liability on conversion</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(607,914</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Over commitment of stock</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(39,397</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Balance at June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">15,102</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,189,089</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">19,059</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,223,250</td> <td style="line-height: 107%"> </td></tr> </table>   Debentures with warrants attached issued subsequent to June 30, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant. 83 137982

0.0003

Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities." These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

EX-101.SCH 7 scie-20170630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Liabilities link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Shareholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Shareholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Liabilities - Schedule of Balance of Debentures and Variable Debentures (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Shareholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Fair Value Measurements (Details Narartive) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 scie-20170630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 scie-20170630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 scie-20170630_lab.xml XBRL LABEL FILE Equity Components [Axis] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series A Preferred Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Engagement Agreement [Member] Related Party [Axis] Oncoscope, Inc [Member] Antidilutive Securities [Axis] Preferred Stock [Member] Warrants [Member] Short-term Debt, Type [Axis] Unsecured Note Payable [Member] Long-Term Debt, Type [Axis] 10% promissory notes [Member] Two Affiliates [Member] Convertible Debentures [Member] Range [Axis] Minimum [Member] Maximum [Member] Variable Debentures [Member] Derivative Financial Instruments, Liabilities [Member] Fair Value By Liability Class [Axis] Conversion Feature [Member] Commitment In Excess of Authorized Stock [Member] Series AA Super Voting Preferred Stock [Member] Award Type [Axis] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 3 [Member] Warrant liability [Member] Series AA Super Voting Preferred [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Plan Name [Axis] Equity Incentive Plan 2011 [Member] Options [Member] Third Party [Member] Secured Convertible Debenture [Member] Holder [Member] Derivative Instrument [Axis] Convertible Debentures [Member] Consultant [Member] Legal Entity [Axis] Oakmore Opportunity Fund I LP [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Variable Rate Convertible Debentures [Member] Variable Rate Convertible Debentures One [Member] Variable Rate Convertible Debentures Second [Member] Stock Option [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Patents, net Total assets LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable Accrued expenses Notes payable- related parties Note payable Convertible debt, net of discounts of $249,988 as of June 30, 2017 and $203,444 as of December 31, 2016 Derivative liability Total current liabilities Long-term secured convertible debt COMMITMENTS AND CONTINGENCIES Mezzanine equity Convertible Preferred Stock Total mezzanine equity Shareholders' deficit Convertible Preferred Stock, value Common stock, $.01 par value; 2,996,000,000 shares authorized; 1,962,785,579 and 883,671,222 shares issued and outstanding as of June 30, 2017 and December 31, 2016 Additional paid in capital Accumulated deficit Total shareholders' deficit Total liabilities and shareholders' deficit Discounts on convertible debt Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock, liquidation value Preferred stock, accumulated and unpaid dividends Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Operating expenses: Research and development General and administrative Sales and marketing Total operating expenses Loss from operations Other income (expense) Interest expense Change in fair value of derivative and warrant liabilities Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Gain on extinguishment of debt Income (loss) on foreign exchange transactions Other income (expense), net Non operating Income (Expense), net Net loss Basic and diluted loss per share Weighted average common shares outstanding: Basic and diluted Balance Balance, shares Non cash issuance of stock options Conversion of convertible debt Conversion of convertible debt, shares Non cash issuance of warrant for consulting services Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to cash used in operating activities: Amortization and depreciation Non-cash interest Non-cash issuance of stock options and warrants Non-cash expense related to commitment of common stock in excess of authorized shares Loss on issuance of variable rate notes Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Issuance of debt for services Issuance of common stock for services Change in fair value of derivative and warrant liabilities Gain on extinguishment of debt Changes in assets and liabilities: Accounts receivable Inventory Prepaid expense and other assets Accounts payable Accrued expenses Net cash used in operating activities Investing activities: Net cash used in investing activities Financing activities: Proceeds from issuance of convertible notes payable Proceeds from issuance of notes payable to related parties Proceeds from issuance of secured note payable Payments on convertible notes payable in cash Debt issuance costs Net cash provided by financing activities Net decrease in cash Cash, beginning of year Cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Non Cash Investing and Financing Activities: Conversion of convertible notes and accrued interest to common stock Exchange of convertible notes and accrued interest to new notes Conversion of accrued interest to note payable Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Business and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Debt Disclosure [Abstract] Liabilities Equity [Abstract] Shareholders' Deficit Fair Value Disclosures [Abstract] Fair Value Measurements Commitments and Contingencies Disclosure [Abstract] Contingencies Subsequent Events [Abstract] EX-101.PRE 11 scie-20170630_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2017	Aug. 14, 2017
Document And Entity Information
Entity Registrant Name	SPECTRASCIENCE INC
Entity Central Index Key	0000727672
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		2,685,830,579
Trading Symbol	SCIE
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2017

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 25	$ 3,550
Accounts receivable, net		950
Inventory	97,423	90,594
Prepaid expenses and other current assets	191,322	266,749
Total current assets	288,770	361,843
Patents, net	944,851	1,024,524
Total assets	1,233,621	1,386,367
Current liabilities:
Accounts payable	1,773,561	1,318,737
Accrued expenses	2,608,116	2,278,042
Notes payable- related parties	35,000	35,000
Note payable	112,982	137,982
Convertible debt, net of discounts of $249,988 as of June 30, 2017 and $203,444 as of December 31, 2016	6,199,543	6,211,861
Derivative liability	1,223,250	819,928
Total current liabilities	11,952,452	10,801,550
Long-term secured convertible debt	1,410,000	1,100,000
COMMITMENTS AND CONTINGENCIES
Total mezzanine equity	30,850	30,850
Shareholders' deficit
Common stock, $.01 par value; 2,996,000,000 shares authorized; 1,962,785,579 and 883,671,222 shares issued and outstanding as of June 30, 2017 and December 31, 2016	19,627,855	8,836,712
Additional paid in capital	24,432,963	34,582,771
Accumulated deficit	(56,220,502)	(53,965,519)
Total shareholders' deficit	(12,159,681)	(10,546,033)
Total liabilities and shareholders' deficit	1,233,621	1,386,367
Series B Preferred Stock [Member]
Current liabilities:
Convertible Preferred Stock	25,850	25,850
Series C Preferred Stock [Member]
Current liabilities:
Convertible Preferred Stock	5,000	5,000
Series A Preferred Stock [Member]
Shareholders' deficit
Convertible Preferred Stock, value
Series AA Super Voting Preferred Stock [Member]
Shareholders' deficit
Convertible Preferred Stock, value	$ 3	$ 3

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Discounts on convertible debt	$ 249,988	$ 203,444
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	2,996,000,000	2,996,000,000
Common stock, shares issued	1,962,785,579	883,671,222
Common stock, shares outstanding	1,962,785,579	883,671,222
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,585,000	2,585,000
Preferred stock, shares issued	2,585,000	2,585,000
Preferred stock, shares outstanding	2,585,000	2,585,000
Preferred stock, liquidation value	$ 517,000	$ 517,000
Preferred stock, accumulated and unpaid dividends	$ 106,931	$ 106,931
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Preferred stock, liquidation value	$ 100,000	$ 100,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	0	0
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series AA Super Voting Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ .001
Preferred stock, shares authorized	3,000	3,000
Preferred stock, shares issued	3,000	3,000
Preferred stock, shares outstanding	3,000	3,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operation (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenue		$ 950		$ 950
Cost of revenue		868		868
Gross profit		82		82
Operating expenses:
Research and development	128,660	194,155	259,501	388,162
General and administrative	305,560	306,213	585,292	614,054
Sales and marketing	73,780	101,214	148,634	180,627
Total operating expenses	508,000	601,582	993,427	1,182,843
Loss from operations	(508,000)	(601,500)	(993,427)	(1,182,761)
Other income (expense)
Interest expense	(266,496)	(208,347)	(815,230)	(579,299)
Change in fair value of derivative and warrant liabilities	(452,019)	624,873	(284,232)	(262,621)
Amortization of derivative and warrant liabilities discount	(137,618)	(94,735)	(268,026)	(236,296)
Amortization of deferred debt issuance costs and original issue discount	(7,978)	(62,920)	(14,712)	(125,450)
Gain on extinguishment of debt	161,573	245,908	172,124	247,074
Income (loss) on foreign exchange transactions	(32,436)	13,616	(38,529)	4,691
Other income (expense), net	(8,233)	(5,077)	(12,951)	(9,854)
Non operating Income (Expense), net	(743,207)	513,318	(1,261,556)	(961,755)
Net loss	$ (1,251,207)	$ (88,182)	$ (2,254,983)	$ (2,144,516)
Basic and diluted loss per share	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding: Basic and diluted	1,490,570,290	668,866,352	1,291,451,398	640,797,803

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Shareholders' Deficit (unaudited) - 6 months ended Jun. 30, 2017 - USD ($)	Series AA Super Voting Preferred [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2016	$ 3	$ 8,836,712	$ 34,582,771	$ (53,965,519)	$ (10,546,033)
Balance, shares at Dec. 31, 2016	3,000	883,671,222
Non cash issuance of stock options			80,002		80,002
Conversion of convertible debt		$ 10,791,143	(10,230,394)		560,749
Conversion of convertible debt, shares		1,079,114,357
Non cash issuance of warrant for consulting services			584		584
Net loss				(2,254,983)	(2,254,983)
Balance at Jun. 30, 2017	$ 3	$ 19,627,855	$ 24,432,963	$ (56,220,502)	$ (12,159,681)
Balance, shares at Jun. 30, 2017	3,000	1,962,785,579

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating activities:
Net loss	$ (2,254,983)	$ (2,144,516)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization and depreciation	79,673	80,789
Non-cash interest	16,648	31,364
Non-cash issuance of stock options and warrants	80,002	80,003
Non-cash expense related to commitment of common stock in excess of authorized shares	(39,397)	132,130
Loss on issuance of variable rate notes	428,367	84,434
Amortization of derivative and warrant liabilities discount	268,026	236,296
Amortization of deferred debt issuance costs and original issue discount	14,712	125,450
Issuance of debt for services	22,250
Issuance of common stock for services	1,400	700
Change in fair value of derivative and warrant liabilities	284,232	262,620
Gain on extinguishment of debt	(172,124)	(247,074)
Changes in assets and liabilities:
Accounts receivable	950	6,111
Inventory	(6,829)	(47,845)
Prepaid expense and other assets	75,427	71,073
Accounts payable	454,821	173,391
Accrued expenses	357,470	274,152
Net cash used in operating activities	(389,355)	(880,921)
Investing activities:
Net cash used in investing activities
Financing activities:
Proceeds from issuance of convertible notes payable	123,750	300,000
Proceeds from issuance of notes payable to related parties		35,000
Proceeds from issuance of secured note payable	299,000	500,000
Payments on convertible notes payable in cash	(669)
Debt issuance costs	(36,251)	(53,712)
Net cash provided by financing activities	385,830	781,288
Net decrease in cash	(3,525)	(99,633)
Cash, beginning of year	3,550	127,493
Cash, end of period	25	27,860
Cash paid during the period for:
Interest	1,000
Income taxes
Non Cash Investing and Financing Activities:
Conversion of convertible notes and accrued interest to common stock	178,565	88,550
Exchange of convertible notes and accrued interest to new notes	25,000	42,896
Conversion of accrued interest to note payable	$ 13,767

XML 18 R7.htm IDEA: XBRL DOCUMENT

Nature of Business and Basis of Presentation

6 Months Ended

Jun. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business and Basis of Presentation

1. Nature of Business and Basis of Presentation

Description of Business

Basis of Presentation

Going Concern

XML 19 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Revenue recognition

Consolidation

Risks and Uncertainties

Use of Estimates

Inventory Valuation

Valuation of Long-lived Assets

Variable Conversion Rate Debentures

Over Commitment of Shares

Stock-Based Compensation

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

Earnings (Loss) Per Share

For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	June 30, 2017		June 30, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		4,594,144,575		247,559,219
Options		34,168,800		34,168,800
Warrants		114,750,650		132,875,170
Total		4,746,149,025		417,688,189

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)
Net loss for diluted earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)

Denominator:
Weighted average basic shares outstanding		1,490,570,290			668,866,352			1,291,451,398			640,797,803
Denominator for diluted earnings per share-
Adjusted weighted average shares		1,490,570,290			668,866,352			1,291,451,398			640,797,803

Loss per share
Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Inventory

Inventory consisted of the following at June 30, 2017 and December 31, 2016:

	June 30, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

Recently Adopted and Issued Accounting Pronouncements

Reclassifications

XML 20 R9.htm IDEA: XBRL DOCUMENT

Liabilities

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Liabilities

3. Liabilities

Note Payable

Notes Payable- Related Parties

Convertible Debentures

As of June 30, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:


	June 30, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		123,750			320,000
Issuance of debentures for services		21,250			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(164,936	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,449,531			6,415,305
Less unamortized costs of financing		249,988			203,444
Convertible debt, net of unamortized costs	$	6,199,543		$	6,211,861

Convertible debt in default	$	6,068,243		$	5,991,570

Secured Convertible Note

Derivative Liability

fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using the Black Scholes option pricing model. The period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.

As of June 30, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

							Commitment
							In Excess of
	Warrants			Conversion Feature			Authorized Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402
Change in fair value at year end		(71,602	)		355,833			-			284,231
Elimination of liability on conversion		-			(607,914	)		-			(607,914	)
Over commitment of stock		-			-			(39,397	)		(39,397	)
Balance at June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

Debentures with warrants attached issued subsequent to June 30, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit

6 Months Ended

Jun. 30, 2017

Equity [Abstract]

Shareholders' Deficit

4. Shareholders’ Deficit

Common Stock

Warrants

The balance of all warrants outstanding as of June 30, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		9,050,000		$	0.0200	$	0.0005
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at June 30, 2017		114,750,650		$	0.0725

Exercisable at June 30, 2017		114,750,650		$	0.0725

Stock Options

Options outstanding as of June 30, 2017 are as follows:

			Weighted Average		Weighted Average		Aggregate
			Exercise Price		Remaining Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at June 30, 2017		34,168,800	$	0.02		6.54	$	-

Exercisable at June 30, 2017		28,058,674	$	0.02		6.54	$	-

Weighted average fair value of options
granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

Series AA Preferred Shares

XML 22 R11.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

6 Months Ended

Jun. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

5. Fair Value Measurements

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: uses unobservable inputs that are not corroborated by market data.

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2017:

Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of June 30, 2017
Derivative liability	$	-	$	-	$	1,189,089	$	1,189,089
Warrant liability		-		-		15,102		15,102
Commitment in excess of authorized stock		-		-		19,059		19,059
Total	$	-	$	-	$	1,223,250	$	1,223,250

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the six months ended June 30, 2017:

							Commitment
							In Excess of
	Warrant Liability			Derivative Liability			Authorized Stock			Total Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402

Elimination of liability on conversion		-			(607,914	)		-			(607,914	)

Change in estimated fair value (1)		(71,602	)		355,833			-			284,231

Change in commitment in excess of authorized stock		-			-			(39,397	)		(39,397	)

Balance June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 251%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.24%	1.78% to 1.93%
Forfeitures	None	None

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

Contingencies

6 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Contingencies

6. Contingencies

Legal Proceedings

XML 24 R13.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

7. Subsequent Events

Variable Rate Convertible Debentures

Increase in Authorized Shares

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Revenue Recognition

Revenue recognition

Consolidation

Consolidation

Risks and Uncertainties

Risks and Uncertainties

Use of Estimates

Use of Estimates

Inventory Valuation

Inventory Valuation

Valuation of Long-lived Assets

Valuation of Long-lived Assets

Variable Conversion Rate Debentures

Variable Conversion Rate Debentures

Over Commitment of Shares

Over Commitment of Shares

Stock-Based Compensation

Stock-Based Compensation

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	June 30, 2017		June 30, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		4,594,144,575		247,559,219
Options		34,168,800		34,168,800
Warrants		114,750,650		132,875,170
Total		4,746,149,025		417,688,189

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)
Net loss for diluted earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)

Denominator:
Weighted average basic shares outstanding		1,490,570,290			668,866,352			1,291,451,398			640,797,803
Denominator for diluted earnings per share-
Adjusted weighted average shares		1,490,570,290			668,866,352			1,291,451,398			640,797,803

Loss per share
Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Inventory

Inventory

Inventory consisted of the following at June 30, 2017 and December 31, 2016:

	June 30, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

Recently Adopted and Issued Accounting Pronouncements

Recently Adopted and Issued Accounting Pronouncements

Reclassifications

Reclassifications

XML 26 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the six month periods ended June 30, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	June 30, 2017		June 30, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		4,594,144,575		247,559,219
Options		34,168,800		34,168,800
Warrants		114,750,650		132,875,170
Total		4,746,149,025		417,688,189

Schedule of Earnings Per Share Basic and Diluted

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2017 and 2016:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)
Net loss for diluted earnings per share	$	(1,251,207	)	$	(88,182	)	$	(2,254,983	)	$	(2,144,516	)

Denominator:
Weighted average basic shares outstanding		1,490,570,290			668,866,352			1,291,451,398			640,797,803
Denominator for diluted earnings per share-
Adjusted weighted average shares		1,490,570,290			668,866,352			1,291,451,398			640,797,803

Loss per share
Basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Schedule of Inventory

Inventory consisted of the following at June 30, 2017 and December 31, 2016:

	June 30, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

XML 27 R16.htm IDEA: XBRL DOCUMENT

Liabilities (Tables)

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Schedule of Balance of Debentures and Variable Debentures

As of June 30, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:


	June 30, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		123,750			320,000
Issuance of debentures for services		21,250			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(164,936	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,449,531			6,415,305
Less unamortized costs of financing		249,988			203,444
Convertible debt, net of unamortized costs	$	6,199,543		$	6,211,861

Convertible debt in default	$	6,068,243		$	5,991,570

Schedule of Balances of Derivative Liability

As of June 30, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

							Commitment
							In Excess of
	Warrants			Conversion Feature			Authorized Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402
Change in fair value at year end		(71,602	)		355,833			-			284,231
Elimination of liability on conversion		-			(607,914	)		-			(607,914	)
Over commitment of stock		-			-			(39,397	)		(39,397	)
Balance at June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

XML 28 R17.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit (Tables)

6 Months Ended

Jun. 30, 2016

Equity [Abstract]

Schedule of Warrants Outstanding

The balance of all warrants outstanding as of June 30, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		9,050,000		$	0.0200	$	0.0005
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at June 30, 2017		114,750,650		$	0.0725

Exercisable at June 30, 2017		114,750,650		$	0.0725

Schedule of Stock Options Outstanding

Options outstanding as of June 30, 2017 are as follows:

			Weighted Average		Weighted Average		Aggregate
			Exercise Price		Remaining Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at June 30, 2017		34,168,800	$	0.02		6.54	$	-

Exercisable at June 30, 2017		28,058,674	$	0.02		6.54	$	-

Weighted average fair value of options
granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

XML 29 R18.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2016

Fair Value Disclosures [Abstract]

Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2017:

Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of June 30, 2017
Derivative liability	$	-	$	-	$	1,189,089	$	1,189,089
Warrant liability		-		-		15,102		15,102
Commitment in excess of authorized stock		-		-		19,059		19,059
Total	$	-	$	-	$	1,223,250	$	1,223,250

Schedule Changes in Liabilities with Significant Unobservable Inputs

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the six months ended June 30, 2017:

							Commitment
							In Excess of
	Warrant Liability			Derivative Liability			Authorized Stock			Total Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		4,268			762,134			-			766,402

Elimination of liability on conversion		-			(607,914	)		-			(607,914	)

Change in estimated fair value (1)		(71,602	)		355,833			-			284,231

Change in commitment in excess of authorized stock		-			-			(39,397	)		(39,397	)

Balance June 30, 2017	$	15,102		$	1,189,089		$	19,059		$	1,223,250

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Schedule of Derivative and Warrant Liabilities

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 251%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.24%	1.78% to 1.93%
Forfeitures	None	None

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Nature of Business and Basis of Presentation (Details Narrative)	6 Months Ended
	Jun. 30, 2017 USD ($) IndividualInvestors IntellectualProperty	Dec. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
Number of U.S. patents \| IndividualInvestors	34
Number of additional patent issued \| IntellectualProperty	28
Working capital deficit	$ 11,663,682	$ 10,439,707
Cash	25	3,550	$ 27,860	$ 127,493
Convertible debentures face amount	$ 6,068,243	$ 5,991,570
Number of individual default \| IndividualInvestors	83
Engagement Agreement [Member]
Maximum capital raising	$ 386,499
Payments of transaction costs	$ 36,251

XML 31 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Significant Accounting Policies [Line Items]
Options outstanding exercisable	34,168,800
Inventory raw materials	$ 256,163	$ 256,163
Inventory raw material sold		2,100
Oncoscope, Inc [Member]
Significant Accounting Policies [Line Items]
Inventory raw materials		$ 40,000
Equity Incentive Plan 2011 [Member]
Significant Accounting Policies [Line Items]
Number of shares reserved	40,000,000
Options outstanding exercisable	28,058,674

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Antidilutive securities excluded from computation of earnings per share, amount	4,746,149,025	417,688,189
Preferred Stock [Member]
Antidilutive securities excluded from computation of earnings per share, amount	3,085,000	3,085,000
Convertible Debentures [Member]
Antidilutive securities excluded from computation of earnings per share, amount	4,594,144,575	247,559,219
Options [Member]
Antidilutive securities excluded from computation of earnings per share, amount	34,168,800	34,168,800
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount	114,750,650	132,875,170

XML 33 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Accounting Policies [Abstract]
Net loss for basic earnings per share	$ (1,251,207)	$ (88,182)	$ (2,254,983)	$ (2,144,516)
Net loss for diluted earnings per share	$ (1,251,207)	$ (88,182)	$ (2,254,983)	$ (2,144,516)
Weighted average basic shares outstanding	1,490,570,290	668,866,352	1,291,451,398	640,797,803
Denominator for diluted earnings per share-adjusted weighted average shares	1,490,570,290	668,866,352	1,291,451,398	640,797,803
Loss per share Basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Loss per share Diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)

XML 34 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Inventory (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Raw materials	$ 256,163	$ 256,163
Finished goods	37,697	30,868
Inventory, gross	293,860	287,031
Reserve for obsolescence
Inventories current and non current	293,860	287,031
Less long-term portion	196,437	196,437
Inventories	$ 97,423	$ 90,594

XML 35 R24.htm IDEA: XBRL DOCUMENT

Liabilities (Details Narrative) - USD ($)			1 Months Ended	6 Months Ended
Liabilities (Details Narrative) - USD ($)	Oct. 01, 2015	Feb. 18, 2015	Nov. 30, 2014	Jun. 30, 2017	Jun. 30, 2016
Debt Instrument [Line Items]
Accrued interest rate				10.00%
Note payable				$ 112,982
Notes payable- related parties				35,000
Unsecured Note Payable [Member]
Debt Instrument [Line Items]
Debt instruments face amount			$ 100,000
Warrant term			5 years
Exercise price per share			$ 0.09
Number of stock issued during period for debt offering costs			50,000
Repayment of debt		$ 115,000
Increased principal balance note payable	$ 137,982
Accrued interest rate	20.00%
Third Party [Member]
Debt Instrument [Line Items]
Note payable				25,000
Debentures outstanding				150,000
Accrued interest				13,767
10% promissory notes [Member] \| Two Affiliates [Member]
Debt Instrument [Line Items]
Notes payable- related parties					$ 35,000
Convertible Debentures [Member]
Debt Instrument [Line Items]
Debt instruments face amount				164,938
Debentures outstanding				$ 5,977,082
Convertible Debentures [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Exercise price per share				$ 0.0745
Accrued interest rate				10.00%
Percent original issue discount				5.00%
Conversion price per share				$ 0.01
Convertible debentures exercise price				0.02
Convertible Debentures [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Exercise price per share				$ 0.1287
Accrued interest rate				20.00%
Percent original issue discount				10.00%
Conversion price per share				$ 0.099
Convertible debentures exercise price				$ 0.1287
Variable Debentures [Member]
Debt Instrument [Line Items]
Debentures outstanding				$ 472,449
Variable Debentures [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Accrued interest rate				0.00%
Percent original issue discount				0.00%
Variable issue discount rate				40.00%
Debt payment term				9 months
Debt subsequent issuance premiums				0.00%
Variable Debentures [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Accrued interest rate				10.00%
Percent original issue discount				10.00%
Variable issue discount rate				50.00%
Debt payment term				1 year
Debt subsequent issuance premiums				50.00%
Secured Convertible Debenture [Member]
Debt Instrument [Line Items]
Accrued interest rate				8.00%
Conversion price per share				$ 0.01
Debt payment term				3 years
Issued debenture for cash				$ 300,000
Secured Convertible Debenture [Member] \| Holder [Member]
Debt Instrument [Line Items]
Warrant term				5 years
Issued debenture for cash				$ 150,000
Warrant to purchase of common stock				8,000,000
Warrant exercise price				$ 0.02
Fair value of warrants				$ 584
Derivative Financial Instruments, Liabilities [Member]
Debt Instrument [Line Items]
Number of shares issued upon conversion				3,706,000,000

XML 36 R25.htm IDEA: XBRL DOCUMENT

Liabilities - Schedule of Balance of Debentures and Variable Debentures (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Balance at beginning of period	$ 6,415,305	$ 6,174,760
Issuance of debentures for cash	123,750	320,000
Issuance of debentures for services	21,250	15,000
Issuance of debentures for forbearance	16,064	65,282
Debentures repaid in cash	(669)
Debentures converted to common stock	(164,936)	(291,754)
Debenture exchanged for new debentures	38,767	132,017
Convertible debt	6,449,531	6,415,305
Less unamortized costs of financing	249,988	203,444
Convertible debt, net of unamortized costs	6,199,543	6,211,861
Convertible debt in default	$ 6,068,243	$ 5,991,570

XML 37 R26.htm IDEA: XBRL DOCUMENT

Liabilities - Schedule of Balances of Derivative Liability (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Balance at beginning	$ 819,928	$ 620,321
Liability on issuance of debt and warrants	766,402	741,650
Change in fair value at year end	284,231	696,080
Elimination of liability on conversion	(607,914)	(1,232,151)
Over commitment of stock	(39,397)	(5,972)
Balance at ending	1,223,250	819,928
Warrants [Member]
Debt Instrument [Line Items]
Balance at beginning	82,436	60,420
Liability on issuance of debt and warrants	4,268	44,394
Change in fair value at year end	(71,602)	(22,378)
Elimination of liability on conversion
Over commitment of stock
Balance at ending	15,102	82,436
Conversion Feature [Member]
Debt Instrument [Line Items]
Balance at beginning	679,036	495,473
Liability on issuance of debt and warrants	762,134	697,256
Change in fair value at year end	355,833	718,458
Elimination of liability on conversion	(607,914)	(1,232,151)
Over commitment of stock
Balance at ending	1,189,089	679,036
Commitment In Excess of Authorized Stock [Member]
Debt Instrument [Line Items]
Balance at beginning	58,456	64,428
Liability on issuance of debt and warrants
Change in fair value at year end
Elimination of liability on conversion
Over commitment of stock	(39,397)	(5,972)
Balance at ending	$ 19,059	$ 58,456

XML 38 R27.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Shareholders' Deficit (Details Narrative) - USD ($)	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016	Apr. 15, 2016	Mar. 31, 2016
Gain on extinguishment of debt	$ 161,573	$ 245,908	$ 172,124	$ 247,074
Total unrecognized estimated employee compensation cost	$ 93,322		$ 93,322
Series AA Super Voting Preferred Stock [Member]
Preferred stock, authorized	3,000		3,000		3,000	3,000
Preferred stock, par value	$ 0.001		$ 0.001		$ .001	$ 0.001
Preferred stock voting rights			Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company.
Dividend preferred stock			$ 25,000		$ 25,000
Convertible Debentures [Member]
Debt instruments face amount	$ 164,938		164,938
Accrued interest			$ 13,629
Convertible Debentures [Member] \| Common Stock [Member]
Number of common stock converted into shares of common stock			1,079,114,357
Gain on extinguishment of debt			$ 172,124
Warrants [Member]
Warrant term			5 years
Number of warrant issued	1,050,000		1,050,000
Non cash operating expenses			$ 584
Warrants [Member] \| Holder [Member]
Fair value of warrants			$ 4,386
Warrants [Member] \| Consultant [Member]
Number of warrant issued							1,000,000
Fair value of warrants				$ 1,652
Warrants [Member] \| Convertible Debentures [Member]
Warrant term			5 years
Number of warrant issued	8,000,000		8,000,000
Warrants exercise price			$ 0.02

XML 39 R28.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit - Schedule of Warrants Outstanding (Details) - Warrants [Member]	6 Months Ended
	Jun. 30, 2017 $ / shares shares
Shares, Outstanding at beginning \| shares	132,278,221
Shares, Granted \| shares	9,050,000
Shares, Cancelled \| shares	(26,577,571)
Shares, Exercised \| shares
Shares, Outstanding at ending \| shares	114,750,650
Shares, Exercisable at ending \| shares	114,750,650
Weighted Average Exercise Price, Outstanding at beginning	$ 0.0765
Weighted Average Exercise Price, Granted	0.0200
Weighted Average Exercise Price, Cancelled	0.0745
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Outstanding at ending	0.0725
Weighted Average Exercise Price, Exercisable at ending	0.0725
Weighted Average Fair Value, Granted	$ 0.0005

XML 40 R29.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

6 Months Ended

Jun. 30, 2017

USD ($)

$ / shares

Shares, Exercisable at ending

34,168,800

Stock Option [Member]

Shares, Outstanding at beginning

34,168,800

Shares, Granted

Shares, Cancelled

Shares, Exercised

Shares, Outstanding at ending

34,168,800

Shares, Exercisable at ending

28,058,674

Weighted Average Exercise Price, Outstanding at beginning | $ / shares

$ 0.02

Weighted Average Exercise Price, Granted | $ / shares

Weighted Average Exercise Price, Cancelled | $ / shares

Weighted Average Exercise Price, Exercised | $ / shares

Weighted Average Exercise Price, Outstanding at ending | $ / shares

0.02

Weighted Average Exercise Price, Exercisable at ending | $ / shares

$ 0.02

Weighted Average Remaining Contractual Terms in Years, Outstanding at beginning

7 years 11 days

Weighted Average Remaining Contractual Terms in Years, Outstanding at ending

6 years 6 months 14 days

Weighted Average Remaining Contractual Terms in Years, Exercisable at ending

6 years 6 months 14 days

Aggregate Intrinsic Value Outstanding at ending | $

^[1]

Aggregate Intrinsic Value Exercisable at ending | $

^[1]

[1]	These amounts represent the excess, if any, between the exercise price and $0.0003, the closing market price of the Company’s common stock on June 30, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

XML 41 R30.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical)	Jun. 30, 2017 $ / shares
Equity [Abstract]
Stock options exercise price per share	$ 0.0003

XML 42 R31.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details Narartive)	6 Months Ended
Fair Value Measurements (Details Narartive)	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Description of valuation of derivative and warrant liability	In computing the fair value of the derivative and warrant liability at June 30, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

XML 43 R32.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member]	Jun. 30, 2017 USD ($)
Total Liability	$ 1,223,250
Fair Value, Inputs, Level 1 [Member]
Total Liability
Fair Value, Inputs, Level 2 [Member]
Total Liability
Fair Value, Inputs, Level 3 [Member]
Total Liability	1,223,250
Derivative Financial Instruments, Liabilities [Member]
Total Liability	1,189,089
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	1,189,089
Warrant liability [Member]
Total Liability	15,102
Warrant liability [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Warrant liability [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Warrant liability [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	15,102
Commitment In Excess of Authorized Stock [Member]
Total Liability	19,059
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	$ 19,059

XML 44 R33.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) - USD ($)

6 Months Ended

12 Months Ended

Jun. 30, 2017

Dec. 31, 2016

Balance at beginning

$ 819,928

$ 620,321

Change in estimated fair value

(284,231)

(696,080)

Balance at ending

1,223,250

819,928

Fair Value, Inputs, Level 3 [Member]

Balance at beginning

819,928

Liability on issuance of debt and warrants

766,402

Elimination of liability on conversion

(607,914)

Change in estimated fair value

^[1]

284,231

Change in commitment in excess of authorized stock

(39,397)

Balance at ending

1,223,250

819,928

Warrant liability [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

82,436

Liability on issuance of debt and warrants

4,268

Elimination of liability on conversion

Change in estimated fair value

^[1]

(71,602)

Change in commitment in excess of authorized stock

Balance at ending

15,102

82,436

Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

679,036

Liability on issuance of debt and warrants

762,134

Elimination of liability on conversion

(607,914)

Change in estimated fair value

^[1]

355,833

Change in commitment in excess of authorized stock

Balance at ending

1,189,089

679,036

Commitment In Excess of Authorized Stock [Member]

Balance at beginning

58,456

64,428

Change in estimated fair value

Balance at ending

19,059

58,456

Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

58,456

Liability on issuance of debt and warrants

Elimination of liability on conversion

Change in estimated fair value

^[1]

Change in commitment in excess of authorized stock

(39,397)

Balance at ending

$ 19,059

$ 58,456

[1]	Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities."

XML 45 R34.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details)	6 Months Ended
	Jun. 30, 2017 $ / shares
Derivative Financial Instruments, Liabilities [Member]
Expected dividends	0.00%
Forfeitures	0.00%
Derivative Financial Instruments, Liabilities [Member] \| Minimum [Member]
Expected term	6 months
Exercise price	$ 0.0001
Expected volatility	216.00%
Risk-free interest rate	0.79%
Derivative Financial Instruments, Liabilities [Member] \| Maximum [Member]
Expected term	2 years
Exercise price	$ 0.074
Expected volatility	240.00%
Risk-free interest rate	1.24%
Warrant liability [Member]
Expected term	5 years
Expected dividends	0.00%
Forfeitures	0.00%
Warrant liability [Member] \| Minimum [Member]
Exercise price	$ 0.02
Expected volatility	242.00%
Risk-free interest rate	1.78%
Warrant liability [Member] \| Maximum [Member]
Exercise price	$ 0.1287
Expected volatility	251.00%
Risk-free interest rate	1.93%

XML 46 R35.htm IDEA: XBRL DOCUMENT

Contingencies (Details Narrative) - Oakmore Opportunity Fund I LP [Member] - USD ($)	Oct. 19, 2016	Jul. 07, 2016
Preliminary judgement amount		$ 116,500
Convertible note payable		22,500
Judgement amount	$ 521,100
Litigation cost		$ 150,000

XML 47 R36.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Aug. 31, 2017	Jul. 31, 2017	Jul. 27, 2017	Jun. 30, 2017	Dec. 31, 2016
Increase in authorized capital stock				2,996,000,000	2,996,000,000
Original debt discount				$ 249,988	$ 203,444
Minimum [Member] \| Subsequent Event [Member]
Increase in authorized capital stock			3,000,000,000
Maximum [Member] \| Subsequent Event [Member]
Increase in authorized capital stock			5,000,000,000
Variable Rate Convertible Debentures [Member] \| Subsequent Event [Member]
Debt instruments face amount	$ 37,774	$ 37,774
Accrued interest	$ 528	$ 528
Number of common shares issued	723,045,000	723,045,000
Debt maturity date	Dec. 02, 2017
Variable Rate Convertible Debentures One [Member] \| Subsequent Event [Member]
Debt instruments face amount		$ 35,000
Cash consideration		$ 20,000
Debt instrument, convertible, threshold percentage		50.00%
Debt annual interest rate		8.00%
Variable Rate Convertible Debentures Second [Member] \| Subsequent Event [Member]
Debt instruments face amount	$ 43,000
Cash consideration	$ 0
Debt instrument, convertible, threshold percentage	45.00%
Debt annual interest rate	12.00%
Debt maturity date	May 09, 2018
Payment of fees	$ 39,000
Original debt discount	$ 4,000

EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 49 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 145 240 1 true 45 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://spectrascience.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://spectrascience.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://spectrascience.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) Sheet http://spectrascience.com/role/StatementsOfOperation Condensed Consolidated Statements of Operation (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Sheet http://spectrascience.com/role/StatementOfShareholdersDeficit Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://spectrascience.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Business and Basis of Presentation Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Liabilities Sheet http://spectrascience.com/role/Liabilities Liabilities Notes 9 false false R10.htm 00000010 - Disclosure - Shareholders' Deficit Sheet http://spectrascience.com/role/ShareholdersDeficit Shareholders' Deficit Notes 10 false false R11.htm 00000011 - Disclosure - Fair Value Measurements Sheet http://spectrascience.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 00000012 - Disclosure - Contingencies Sheet http://spectrascience.com/role/Contingencies Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Subsequent Events Sheet http://spectrascience.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Liabilities (Tables) Sheet http://spectrascience.com/role/LiabilitiesTables Liabilities (Tables) Tables http://spectrascience.com/role/Liabilities 16 false false R17.htm 00000017 - Disclosure - Shareholders' Deficit (Tables) Sheet http://spectrascience.com/role/ShareholdersDeficitTables Shareholders' Deficit (Tables) Tables http://spectrascience.com/role/ShareholdersDeficit 17 false false R18.htm 00000018 - Disclosure - Fair Value Measurements (Tables) Sheet http://spectrascience.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://spectrascience.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative Nature of Business and Basis of Presentation (Details Narrative) Details http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Details 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfInventoryDetails Summary of Significant Accounting Policies - Schedule of Inventory (Details) Details 23 false false R24.htm 00000024 - Disclosure - Liabilities (Details Narrative) Sheet http://spectrascience.com/role/LiabilitiesDetailsNarrative Liabilities (Details Narrative) Details http://spectrascience.com/role/LiabilitiesTables 24 false false R25.htm 00000025 - Disclosure - Liabilities - Schedule of Balance of Debentures and Variable Debentures (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalanceOfDebenturesAndVariableDebenturesDetails Liabilities - Schedule of Balance of Debentures and Variable Debentures (Details) Details 25 false false R26.htm 00000026 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalancesOfDerivativeLiabilityDetails Liabilities - Schedule of Balances of Derivative Liability (Details) Details 26 false false R27.htm 00000027 - Disclosure - Shareholders' Deficit (Details Narrative) Sheet http://spectrascience.com/role/ShareholdersDeficitDetailsNarrative Shareholders' Deficit (Details Narrative) Details http://spectrascience.com/role/ShareholdersDeficitTables 27 false false R28.htm 00000028 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfWarrantsOutstandingDetails Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Details 28 false false R29.htm 00000029 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfStockOptionsOutstandingDetails Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Details 29 false false R30.htm 00000030 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfStockOptionsOutstandingDetailsParenthetical Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) Details 30 false false R31.htm 00000031 - Disclosure - Fair Value Measurements (Details Narartive) Sheet http://spectrascience.com/role/FairValueMeasurementsDetailsNarartive Fair Value Measurements (Details Narartive) Details http://spectrascience.com/role/FairValueMeasurementsTables 31 false false R32.htm 00000032 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfBalancesOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Details 32 false false R33.htm 00000033 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleChangesInLiabilitiesWithSignificantUnobservableInputsDetails Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Details 33 false false R34.htm 00000034 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfDerivativeAndWarrantLiabilitiesDetails Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Details 34 false false R35.htm 00000035 - Disclosure - Contingencies (Details Narrative) Sheet http://spectrascience.com/role/ContingenciesDetailsNarrative Contingencies (Details Narrative) Details http://spectrascience.com/role/Contingencies 35 false false R36.htm 00000036 - Disclosure - Subsequent Events (Details Narrative) Sheet http://spectrascience.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://spectrascience.com/role/SubsequentEvents 36 false false All Reports Book All Reports scie-20170630.xml scie-20170630.xsd scie-20170630_cal.xml scie-20170630_def.xml scie-20170630_lab.xml scie-20170630_pre.xml true true ZIP 54 0001493152-17-009154-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-17-009154-xbrl.zip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�XOK3);H)08Y7:*@!O3NGBORDU$8< MB&_S )?8?TN6V)GYJ0 $P@NTC#!Q@1KX-" DB,<3!WX]2Y\P6/& 9"!"0AS# M>WWY( 3&%(V&,YLAL*M4"UDV+VB1?V3@C M(__"JCAE4!TC77(A6*WA 0KN><$8_W)"DDP>: X7M7JA>E&8V(,39&@;A9X# M+2:;203;=YU<-DB7(TCX:Q:OJ74E;7NN_9L5FK7BV*'(XA2%R";%19:JD .A M:M&SQU:I.=TDC;HDYB$X"O]:$S%/'O-;QB^HAHM?S5]^DE4R%W!@C'+DJS!) MXXS3JM@Y,'_1KK'N-;#=V]MLE'*%;8&W9OST,[AK153#>01(_!E(!/0ES0A$ ME" O2"E]^$DB);$G]V=(SX4>^=;"^R4\E $(Z 46$/<7S$8@^-(JX.7<+09> MBLEK6,J:I/ZG40P6G[E^ LM!>P$""G",<<>)BR1:%.$G@_"P.,4(QDEX%"") MBA3LZ> $%?C0<_7A\*^J$E&%3EK'LBB!Y)_[2!1X4'B$#OXD"CSASN5#"1G" MM)9'66')8J1]1(-<]L/C[.Q1;->"ET1SV.! MTS;EVFX&/M *" M,"HL?BB[$_(.\IQ6F47"4P$@^%8%Z4#ATL'(2^5C4_Y>E \1U-^F(#V_1RAF M7]%A2-:4A#_XYL\?2">67%S<9@ P'Z7X&M\H4D%0 0$ Q\"8\I8 M*OSER@M"P0J^.9C>!1]#NO0R9("S&8SR?Z=OO^#9G^ MJ1,D>._X5PM(8)2+0- V '>P/W!O@72AMP;$+T +(Z9\ G1OKL7^$GY*F[@0 M\B (UV/\9(4H]251JID@H"'P8 1,N[S*JR\?89WGQJ!A]V_:^$X3<*%OQ<;^=7P9./YT7:/T+)@#T$02;3>: M?^_ ;XIC!+ZS)^!O&1C)\!Y>^NS$?Y(9^O =Z<3V@6:S.^AUNA(WK)QM-[@V MYM*!T;/Z]<,%..IN@J]^IS\P#H*N[D;H,DS+W(J,U_EFY%7H1E-&Y?3WH?6& MPTY7)N"2>;8$95-6.C/-@=7OF77 LBG[G-G&H.)B[14M&[',6<\P[0U!R>WH M'A70P+0MV1S-3;$%!)ORA]T?6L/A/B'8E"NL7J\[[.T9!QLQ@V4,.MW^VA"\ MAV#L@4X(_A,"?.24Z[#\[ M;Y3ANID*L0=?J5/R[%V;="Y@;JQ>K!_\S#PWF MQIJG:^-IR!&PN1$C]JSNH-_9 4KPJ)A_'U[2T;W[=%?F@N0#_,;&\,R=\WT_ MWOW MB2L;C#]GB'?E&^[O:'9!+@W9N2.U>WTF@#YQDY:IV?N!_#K=,+B+U$8 M54WV'LWRF6D-;=EE>G;&W>';6.L.!W;W<.!MS*0#J],Y*/8V\_ULH]_?%CSD MS$LZ0[]'OGTO9>'0\N Y1:_-YM/C\@N(] M#'A3I-!O=Y*U%\!J/^7:'_JN0^U?6?"D]?,[#]?.GW3@?CW#$WV4T">"Y&.& M&?#:IQM=<[0'L5&JQ7AR$48I*P]B;F>8410[M\";E"@V]O&\@E]H@.\"'P\W MXB< P[LOTA%^,'%RB/;R_!TZ0_'AI,(B M4F,IF9G%4^EDI3JFYO'D9TPIFCB4U9UDX[&/@Z6:DZ63*/;_QLQ0?DI%F12$ MS!P6?FJ(@U+>) U*F1 .03!R LJ[H%L>EF[S*R%E I'G>S1Y-/H?D<-#J9K+ M, _K#[5K-XWHQ'\HW7L!KH!G\LP4APX]@_+%_.S^!]LR\:+)0@I3S/!@E3+( M_-2_S_>&,]#69<*<2"1Y\.^CF*<[8VIPZ(FT!B1SCF4)Y+OBRQP*3'C&/$\I MRY#P!>B=22A 5^4^HC1[)T0,C($&PDP@$"\%Y@"K MVG02*-*TR,04&>S1@TB6=*.$'[Q*ZW?$TJ3%O <0_3RW*P0CATR"J0ET,$WI M(Y4QJL Y(G<7EL\S7+P(7N!+"WR&F6O(SX*Q*M>.7-S*E;(KI$Q9Q\,#"B:= M/",;EB?,> 8BDFB6'C#K^9T"%T_BQD'TN/S,>;69GC?H(OU\VWV_[XG_<^@' M_WR3QAE[H[W;9/A-W;ZA+6T5Y0-ON)Z7'+D=U[.1([;6>BZ!V:_'^26!>HCT MXAP;'X'TI//*RNC;+&]7FJVSO(T(M_[R_C,&003':>QONROVTN)>F&%CRDE; M;M+0FZ]K5Z*]O*[-2+;>NHIM>@>R*C,UV&@W3EEGB12CJWF_IF;8M;0^M'8_7O,_2,_NV73=8&^^O]+L= MR^@? %L;\91M=CKF8 NHYGN74._=B] 3C=^VXK ;&BE92)HYPRXQJ]NFS$V] M!TA?Y+G&0/HB&S8&TA??CY@[C?>SV6HG*,GQ-XX<)UP8I[^<'A M7?2%/=)W^]".EDT&8PO>U$"G;;;SX!CQ^XSSQAC-[R!3J M]'M] ?JZ\^X-V#7P_)(W*?8N$QQ12LAB+H3$WC/)CILQZG!8<6U>G'0O4&Z< M\6 8NT&)!U0);C!@'NN'[VC>,C^9X*8+3Z_D)U?_CGW,MQSC9SP;FI(QQ0P8 M->W%=0*AZO0D7V!OT!UTV1M[9H-N5\[,7<2^G]ML"_XZU5(=32RXBK:&$;5\'9:4>K$*\"@_=I' M#HA\@7VNFYNN3@PUJLM77KK6<%\F MQ8'QA,07>_O@!EFVN"X__!$WL3O=ZH"TN5M?-5\C_N)C [ M+K/,NA=9RS>(NKO8O[]G<<.O2LB;JCNN]#"(:]"%BJY](-Q]=@!&D#.L77-8 MM.1WW&A@T->&M6K),HQ-74V%R+@FF,<^,X:;K(G4"[C?W%GXR%::G6-<\>H, MR^"O F,%>A%12/JP//%J86]7RCCIG,N5 @Z2B5(%8"Z1XF"34\8&G1QM2"P!3^M+],!K"5A%C< R0Z"H-3;.#XHI"X1?LJ7*?6'"PSONV,Q$Z,W] MH3&X&&=4O#/WSWB"!)9X X7O)ZSJ2 VQ9H&XJINGD>35/(LL@AGZ6.)LO[Q" MC"6%HI!?JN7)!Y7T#P(.J[=A42,VX](O,EIL&LH? _ ^50 L:C*9 _(=R;W3 MX0F"@9["1#[Z9D#"_6B MDDMR+7>F?17Y5#=8SH@=)LFNH2IN'2D0,D5958]8XFH,MM))V?S%?$RZX;4D M!6/GGY-JQ'(V(;)A-LTX^LOLJ!\Z0LW,E;<$D,X() +!Y+'HU,>:5U3O*B_L MLT12,'V+JH#F8\]+RXFPOIS:5[J%!P3DN*FU%\2D.UW8268)8.4[2 ML6/_.]:'PWAC.28K5;$D!,NULM6DC!J6):IGJ>>%!7KY(+FG$ M+9-.Y>6*=,Z0<@1+AP)?][$B%4^K$Z=%\QY$.7?4<-B+4#MO\3>67[UG>^O M.4$0/4H4Y>7+A.](16**"C"8 >O[.EZ>G[GHC%QG65(:3UH;C5I=660P(UP)B:=M27AZ'86&-_:Z]8I58%DW:C!1K ZV M96(K.JLS)Z/Y:@H8U\DY=X:H$LB4;! M#H^BJ<@M%3XE0"@G?.P\1#%A6=0BEHISP]^PHGA?@/ED]S[_&M4&DH_=[ M?=I;Y_LKI>;G45D97&C5P$+:+R\K^87%.3HN,[_G(,DJZ>>8/#BT$!G5YAXQ MT!%\D'O,VY/*>S%EZX\R<=T]6^"9+7^1%U@4+$PC% M=9T%MJN\7HX*#-JJBY]<>2+A@8&F?K9=($R@,Q%!9'[B\L6,J\1NGU+[W:'DCXX M2#AV9%VP*A AJ5C>LB>/: L)7&+&ER'<(6L!1$>'+_GY^,%=RF66!4$R<_"< M& \;Z/<9>GCB]RHTYBS5+H%8H]C7M?]BP0/#[G @A,F9P*.1]]+)PBY\>,O MFNANY<*JG5G"?M;RG\H^<03+RH9S:31;VE(.Q@&PPW^^&>ZWM=US_>MD5G6I MMO@^.@WN>=0",59!O,UZ&;X 0[!#A[&*C-$:UF\TII"_(_(7U-F!";!G83QJ MB\$E=&Y"R\,VKV@+]MBR#:DP4#WKQUKD[#<12SIIM<\$=_4V%+KM/%E#DWOQT,UN.SI7=/6.X;=;"(HBFY 4;/?U?L;]ZW?D@A[TE'' M:+">YPVC)I)V-O/TB WQUP1C=Z#^VU9'[]N;\E<3\-,6#'=A6,LR=4O);IW:T6Z'Z#;,XL+?$7-B_+:%S'D@UNKI1J_.;O3- M'>% OK.M6P.K^;)['+,K[=SCN8U/G1^5I_P,QM[V>L/](&<7*'Y2]%F!F;/F MB_HQS'3U<%>D2\WET2F>6B7S9J^K#SN;'B4HN3\DC:RAJ??M/;E2]=#HM;@* M><*:M^1*\\$9].63QT/,<:!-I 'FZ;50!YP2D\T9&%SA3[TO]-*=>B('=1=D79^SIW M]D$%# >#%JJ DZ*2T0%E7> CH ML;&3!8>/SY6>WEA/&[V!;BFC? K$MO7AT-3M_H&3D=[1+;K*1ZTJSU(@GBK. MB(K7"TWG" !5AFG32^%Y20RY!%U'E*!;AFKY=CB.(]T0SQ]?<4$X*7P!+LPSA>,R8O=F5*Q.U';Q@E# MK.=1+8HCKL<.Q,7DO-Q>\9"?X(5N)PARD)PD8>E\Y:J7*XXLE&HK*C@(I!$8 MY7IU32K.(E\R+ZJN%'6)Y5(LO'[? =^IH1?7AFY4GTD1P6OJR*5&4&\R-6A MI;EU[0=[T-6I@EW915#+DIP9?R-=>PO+Q@EX[1&<#K^?1I[H@XBOQVP<,#=G M"JR(5U8?$LA;8*\3*<%55I0N"HT^'1",XY:[N/4Q.W6)1$DZ:4YV1)$#>#'( M4 '.UW[1M;E"/[R>IJ1*!*=2G1HQ##+D+$H2TH%+RML0#&6)&ZIS/L[HR[+& M.8ZY7CV;HAKYHPRD)^D'JA^9]Y[DY74(ALH+TIIR4(L2[P6Z1@PGBIF+?I*G MD>Q)I=YAF"ES$A(])ST*$Y05ZN&.+/PSQ-KT@G"% M8ERO_@"8N\0 M+$,.E:$"[X?\#"S[D/M!44Q 2*53ZN?B)>7BCJM([[CSDDU%)9@L(3^GL-LY MWTJXCMD,$KJK.SN4&'_$;I(>;L'@&:4I8*3BP]ABH<(:;&BLV_>#QC8*/!= M1ZX@N&)2[!S,&P=?)%1P&*4."P@#F[CH2&I<.>M"=5.S8_HDUY.(KC]96N6H M=0KVR&TN$NE)\@J3)"][S&L6SS6]J*C$ZY;O"4F JN6WH?^&) !HXV#S$UY MGX@D5RLX/. 4/LQ'IPIHHI:06%O9*/QYK:6O?$IBA)*:+K7.&'&ISKLE8]-J M?SSFY!4 \H6INHR%[!7%;*GW"E?Y$HYSII]KOU)IN4(5%4$H\=P-JT9QI9I+ MD'!)4:3'1$M%3 (4GPD6PQZ(W%#]R3C$42C1=E6OF!)8 M/UG)5B*,0?;7V1M/- ,L2+41'*_<[R:;G%< %_75DTA40%^!]848MC3UKK2#4#C- M5/8\L,HF-X"4F+JK.[.X+=5RF(1XCDGDU<2S&NX4BE/3)G* MRX 3,+EBSJO89A"GQ93V,'KB1,4O1%W<.9^$""_#4&R2B,*Z( )>Q+A"FS@/ M6$9U#"K'1V4K)@0PIXRE17P9C0";W"'@ES8+]9N%^99.-5*L1!6B$* ^I[LA M) 7J('Y(5);LX?!(@V-CU4:.4S4!LM4!K&%5VOD5/ I_0DM8F@;%O F*#01' MN$:28HJ0>?\) N&C<&]>*K"Z%/F>0'Y*.T\4E+C4VRTM=^I6E_B-REB[V$*# MQ^1:A3+VA=X27O="1[%J^-31^T9O;O?N)/7#.N4.\PWMQ9*'8O-X<=OL@ 4. M=T%M.ZH>JO)G:D7[7]&!"@V6S3S;=/!^= [8(DU&*8ACK*BM]WD[ YMO=O?])*,HF=3Z=GK@GAN M6AE!D;.QY+0,O6-M>M>XG0T.VN+A+=E(59>.%6H4:MJ.FL-%3G74I"I2,:*P M;!K*J\^GE?28&K>/CL\:._G"7;TS5$7G:_1FAGW=LO=4+UAA^,!EOIL[PF%P MV^^:>J_6AC)'=L!W0KIQJ %9NLX<=.'P,=;+73Q J*E0 ZCW-4Y M+8J[E.36WU]%MSJ6;MI[JC6IO ,E >W";3LDH,5AVW5Y1R\OLG"G5!B] MC1I#T4?1IRGT>6OKP_Z>>I>VRR=25&X2E5L=]TK9E?+=[VWR*VO3?[NL;]/< MGL,P]<#2N_MJF-F$B.'U4:C7'^J&(E&3263C=KRB4(,I-#"'^G#C--06'94V M@6W:E%K5W!$4:A1J6HB:5L<>*E=Q9Q1V=:NG,A)JS/GH6;K94UC;CM M]WIZU]C3YED3_>]=D*-2%;?=D>V;>F]?7+4+("H9815F.K:M#SIM['G7%@PK MLU5CQ_ !N+6=5]U9=Q?TJ%1%);D-Q>W;GM'7A^:>XB7E&RC^;Q=NV\#_+0[9 M5)JB2H-3]%'T:15]WG:&>F?8;[))4&0^"3*W.NJ5RT#*;6N:P=36N84E3H+1N61W= M.G3-FW?4IJWRT6MNR2>UVJ2NJV5;R31UW FV:\5VFAY!DV2CA/V5X29(&E4< MHH[F^1XUO,3NLMB(U:'&F_RT>Q9'#WZ2M_I]9-BNSW7!N\/6C-@OL>Q+B7T\ MTR=MRM()MI8?TPFY^))@@#F8G*4E-5+\Q[O;RZL//U^X;@P0YWE>/DO>^XD; M1 FL\@[0\%L0N7_^^A__"UGG'_3&%VH+>3V^"CW_P?)]Q*4H/L81U. SCXSAF?6((WH M9],X,\P_LN3LWG%F?^"KB7CW&BI^3SW0#1UK1M]OW\@*,-[^:G?YP8(DE MK - M8(O=K\A1UV5;3OY<\F\2>.9=0$3AW+/**[\QD((0GA50FNN1%9!PP^%;(*9Q M;A@&$+2)B\L1#WKPSY_'492BQ'R"7[3O]%'Z- -= JNGUJIOQ*=QA!IFDJ:S MG]^]>WQ\//\^BH/S*+Y_9\%*W^'7[_#!-V+X? *0I=PFX]9 1%T3)3%+MM$E.>!DU!4D/C[-(#/L2TM"\^^ MW;[Y%=1^D'G4P5VT8 8-$F)CZMO421D>CE"?WNL9J"F>*, ?1)=,>[,T]:W: M[%JRZT6& =CO\S?_>%=9_]'08BU!R]V$)0#Z%/T9;(\]@YG)14)WAMH0ZIH_ MAK4]Z=J(I8],M \O^DSSUO&X]A^X8>&MC]%EH4[<3OPG2\53H@VRZ'[]?_[W MP#+[OR1T/!6)7MJ(];D>RXGV5Q:ALR4('-D[1UK;]LX\O,=CXD<39)V\5^6= 2;1.529>4\NBOOR$EZFU:4IQ8:%PL M%@XY,YP71S,CFC[Z[6'N6G>8"\+H<:NWTVU9F-K,(71ZW/I\T^[?#(;#EO7; MK__XNP7_CO[9;EMG!+O.H77"[/:03M@OUB6:XT/K$Z:8(X_Q7ZPOR/7E"#LC M+N;6@,T7+O8P3 0K'5IO=WH'R&JW2]#]@JG#^.?K841WYGF+PT[G_OY^A[([ M=,_X-[%CLW+D;IC/;1S1 OE.K=UN[WUW?Z]K];J_6[_O6B=GESL/$Q#D!'D M(Z?_M7O2_0#_Z^W>=M\?OGM[^+;[9\D%/>3Y(EJP^] -_Y5#OR#"CI /]B\6 MXOW#-?ECBND'_P31>_$5??H?&5\=_'CWYX=]_&UV]_7CP1C/O_/'TX6]MXMN M![0S_?I]?O''Q:=@R2-AS_ <66![*HY;"77>[^TP/NWL=KN]SA\7YS<*KA4 M'CZXA'XK N\='!QTU*P&S4$^C+FK2>]UY/08"1Q1AEEB@"=4>(C:*7C'BQ"2 MP.\ZP60*E!2"[@>@1(,Z. ,GL+TS97<=F #XWMMVM]?>ZVEP7[2G""TBE D2 M8T4ZG) H[W,HG+E8%.*HF0(DRBCUY\7:<3S>\1X7N - ;8#"G-@1WFJD- +P M((>+N5,S!=S)_1,AB 6V/8Z$32"(8-B2\X[>6A!77#S'U#MC?'Z")\AWP8#? M?>22"<%.R_(0GV)/^KQ8(!N7HJFW#Z*4P2Z#R!*.R+'%@L V@H&_'4E_.Y3Z MO04I+/D!PHEI!0G2@9WH2X[[U#FE'O$>Y;;D<[5.RR+.<;O66U+HR<_(NI8 2TK0>RHDR63(.X+[(SHK^KS@F,!9!32.0R$B"'( M$B0;N;;O5L.)62E$"0>TSI]@A8_(E5O_9H:Q)P*UIX?,>MX%Y ML6$BW8G19+20F584AHJGS.9X6\X<,6F+3:R(N/7F,T6^0P!D:Q.0:32YF8&C MSICK0(8+CS=B$R]CG&(8LY7>5;22-%)RE7];X3K6&W]KL/0F&B Q.W/9OTN4D:YA/J(X]'DHR\(Q4) -O41"0)VN$K(&EBI)*S9 M;.]EP@5EE(/T(@(U,*:;N-(/6U M;>9#ODJG5^#O@*&W4SE8LZ$^9 T54E5A+J9KQ80M3?D5F^F$'684G4%^Q1I<_W*L^T7O=G$L7/:Y?L:[/$.&JVW6!D521>FX&VBZ>,NN[ ME]6W)!*TTZPDF5>L<N./!?[N@U"G=[$3 MYT;-VMW+/P(UOA40>-4:+I-DU$E,RB4HO;?U$Q3KC?[TFG/_L$*K]EVB=PP::#\L-D*^X:< MA*M9T7*OV;CEGNK%QJV):S3N;KY.KY ;;$U;V;1M>=;$\5W8I'V8<(CK2\7= M8-OG*A4X?;!=W\'.&6=S>:#(#W0TFIPB3H&0N,)D:T\-;\Z:*X.%LQ 9A-EFLVI0KE;CX&.\B@K">O'D^'9'KO %(2W(R9W: M,1KRL;P#F/'-5CZ)VR/JYM?FL1/ M6<3CQW$Y4+-%RQ[S23V2 \I;*V547YCE)G+3$-;I>Q'ZB%[+WB.'W:#>=J1" M^G,O8O:,7 MLF6;GFRT)>DA*C5L1<^,)G^WQ8Y5^#&:)3+(8TH>"O MQ)LE^D^?*1L+S.]D83ND"]^KXEI/HF_VJES[K(17A>Q8A*8\ZAXX2K76.JV MA4/YI?SCEB#R>HU6.#;C> )C8*&V_I[\7R#:SL/4]5S2 M7ZN0X'U5A;<\D[TFT2%+<\":*3GP51?AW]KJ* M(Q"<<<^BN=LO3'>A!+>XG#-;D3*@R+_:&J\MA]J]W?9>;^=!.#&G59B(U5"- M"8U7@XGB2UY*+J\1Y+KO*JVX[ Z8)0L7XL@/[1BY[/K&"V5,ZQGC',D,2\#1.DD!](Y>_M/9*8>([6Y2#D?H7=8 M>%+7>U5\-H$6?F[')#*,A#?Z!+G=8'CZ%Z3(=S)00N$*#_8)YAP[JFVJ:IZ6 M8EEEY68HXKJR]CUN>5S^K6Z'.H0(3)ASJQX402SS]-0XZ-4AA^<2&]0 :2/$;5\JX1-G_D*#$@ QB9?F]H3<$0=31PQI'P81 M%UK $G!-%3$L-F\QGVMITD,K&7=\?35)DD4]N@86E5*'0OC8.?%EO^U*K:Y: M^.*,\1,\]D83, !,#9CP(K/40:PIKE TUR"LY&D(KL#5[5"2>>D&L@J2I[*N MD1?MJE*0Y=TND 9BD9RV)<5U"Y,( \%'>3/@%40^K(\\%HM6"J^RW4))%?ZS MV2TZ'U3:?DLPFF3'N K73$/\FQ-_+HI%,\+7M=N:)-,<)<]U062 _\80N(.T M.Y"I%&13HWS,B ;HVN(Z>/R,TA9U[>4+G?Q;G&ML,Q#( M)2I8I-\;1J?F5"X@I%*T@IYS@0JA[65]:#U"CR ^R-! O/"RLV0@>=XE&JM9 M_<4-[,AOX& J%!=]F4]/%>C'QQCD"CVJNT3O$7=.O_OJ-E&]5<7(FV%^"^$I M/']R^@#// )80QIDL5&2^Z)+;CH]?G9II727_GR,^8LI.+7DSZO@3^H$I?:E MKYA,9Y!>]&&+HRE6D]KA5&[__.JOSM"FBXP-Z2(*!$TRT%*F?EXC)>+%$F6\ MD&'*,_+S&N.2J68I7N:7+V2*LFS4;""LRPY1/MB'#'D>L Y5UP235&FV&FS3 M_0+]W<C'%91G^F#N9@VV SYC;KQ\?4-KR6NUW=ZW*+'[R/;J)>>KGE MJF\@]7,4AYZFL8Z7#HQ_D[T'M" >8BKK'0WK+((IA+@I%JX?Z\];( T2Q MZ[YDDZ=@Q9],O875XT!&5BGW2Z3KU3AH1,DT7BW\."M\_IMZ&9&O\1P1JEXZ M4(\CV_.1*T\9[*7T_N)+;_Z$PYK?0HQHZF6E%^?@^4+K)59L;+M^S5J(7U4, MZ>F#C04\N>+D_1G>CU1]!T>GI@PS/<>/&,-_4"G_)@8X;? ?/8=$R M'_N(H9I:U<7L7N,%(I#@)3UPZ6Q3Q8E"@(R:REW4[62/N4Y*&< F]$#T0:\! M"T^TR9->L5F62%<9JPFBZG,VLHZ+CO)=,D]=H=6W;> ,'!#".A90Y5[B>S6G M1:Z-W=A@&I]BA*=T3@#@'E);R7GZ_'0I^,;*G,X/503ERP-M!J"Q4JWH5LVZT(8-,]T2&%/:OJ>W!1FRR0&][, M41 82\(V-0,]I5,4]#7Z4X[5APN8>/2058+N4._?^/#JE^8 MNML[]>W!M&SEP3&,V11[^#DB>>H*JX@E1FM]O+ MA*]50!N7(GRCDTDL,H,;Y_)V1KASA7C6VPO&-\ZK^K$0^68M_^#*NOEJP(U+ M\U]U=V>:\F$J#E8"A:%G[1,&^\*9LX^9J5:/KUIQE?_Q&ST MD"P!^<)V<;S#V:,\ZNZ/U3F@VH*>@VDD 5%*V 3T!AWQJ!-<=@,?_P]02P,$ M% @ 37<.2T9$2HV"$ <,L !4 !S8VEE+3(P,3O^OY[EK/5)?,(]_.!J\ M[!]9E-N>P_C#AZ.O=[WSN^%H=&2)@'"'N!ZG'XZX=_2O?_[U+Q;\>?^W7L^Z M8M1USJP+S^Z-^-3[U;HA%7.I;PV]^<*E 84O MXH[/K%LA^'ZCW/'\K[>C%=]9$"S.CH^?GIY>0J*7) VLBO_WYRT?\% M_AF+LV?! M/AQEU'PZ?>GY#\I5222QG=X-V[=\?1MVG3 M0LOG>]]-^S@]3L59<89OF:)]1A+!SD0DWK5GDR :9;7=6)4MY&^]M%E/?M0; MG/1.!R^?A7.4&C^RH.^Y])9.+?D_#)95KV)![< GPF8PSBD,D_FQ;'(,,(5S MRH-S[ESR@ 5+B9D_CT0&-2*>,Y]./QQ)TEXZ1&3'/V%H@^4"YHY@#I>2-^$ M@%9)U(ETX^G=#$PQ\UP'O.,%G3*;!6@QE=1=67-(Q.S*]9YJQZ*2J$WI;L#' M^G0\_1@*QJD0,#,_$L&@VXE/!0B K\9EU:M&\[GQ%\"FNR!,P"1@'>Q;2\$ M]$?)IX+L-)ZM$@@0\1&)8V;G<^W OZ1PC*7CYBS%35?O]SM-VYVN63VULG= &2<_C"86XH!;JC=NA'$_;RV79#ASI7OC>7 MN84P1F@\O20^!T9B0OUH!B4ZM6.@SL32:N%-V>3(MV$&7$CUJ-.5!9MUJ]5" M(RXC"L]?=F6+J@XZ6A^;N@\$:4>29FR49 [&TPMZ#\8"?RW=]#?B,[G8K#]$ M8M1J)WO37DC)?/88V3YMB1V6NW/N.#)JO*SA670L><:>WV77,MT1!E$*'68\ MUFWLR'=_.MX%GOUCO)!K6^MZXGB;HFNCY&?K'76^!UA/)^)C9F0C)IU+7^KE M,EXP:>NQX8SP!RI&/"/O=Q;,,A'-5^[= M"^H_RI5QQ"'6;<=8;?2\SY&U7C4A4DB<=#%@VG4 ->NELZQ@TQ4:1=QEUK#Y M3AE'KY(9'+0=NM'.[QI^SU'0YX!RV"&F?*30K1Q4PL>24W*P/+!Z5DJ5_1&6 M%"MF8>5X=*Q ^8%D3N(3$'-U5@0_P\AQ*!?4D3$V#(Y\)UC)9RLA%4B=BJX MZ]DY85UY .WY>= 36:-3YBD1]]%1? MDH]_/Q<"!!B"KP9YTPY<I5@1)OJE@9BB=^[;E^1#[?#@:I/T0W\X-H.+Q?]+B6,@]M633 M8S!&4OJI[\U5]DYLZVVC2A87D.+(>J+L819$TFO$<94KN*&*<9=OA4/E1"LJ M97H99_R)3Q>$.9?/"^F;8!"-(23WD;X 18R#ZE0K5 VL8!R"21Y.0)Q-611! MPGBK=^-**AQFK[1BAM';/+ BQ>I65U-6G2K+'\2\&/$ ]ET,QD4L+XR.^#0# M%L1/GN<\,==5+3<8:C.6H?3?R>6FWC@+KQ HI>ETH;X\!YK1\!@?&,6C$C3M AO23I].+K\_3/]\T_"&:6M5UE-2U1%IBSA+S94?#QCY#9W>D8C) M*7GEB$D:E[75FQY$C*UU%LV@,:4P:%4.\&!&U-";SSV.P:384O>V!0U(E9+& MH7'N.$SJ3=P)8,Z=)HMJ/:7N50JKVP::NVX]-::LFJBI M:+B#FGO)]J#45(6_ILW"Z-D0ZEQ[_.$+]>:5MKECI=)MB)>M%CO//G5==J2\RR"GT"J?0FJ/E3:T53^O% M5TY""'&H\[/&DJQ/OB?$Q/>FJO DUTAKB/5(>4@5A]OK%KJ7VQ+#%N*DO#;& M^>&A)X+Q-!%3M?_+-=,= -0;OE2O$NOW])H_<17\(:D94@S[DJ9:IZF@8$A9 M+W@!1G:]A71_B6BJN:LDTSVA*^$H3&N$]L;-]?@:,A>$/G?FC#,1Q+7;M:C5 M$NKV!UCQD&U4FW$(>"D MU[!0(7QZMK$Q3K"HP>9T*EF&C4P8X%6J'IG&Q0XW'O?R>M7Z! 6)WA)+ZE-1 M'ST4&NJ>*K40%&LIRS0U;VRMZX<^$<;E?!GS]6?*)RP0I+K=05/8T-;HOF;@ M?.[Y ?LSN3ZE[NE')J*2RHIS_"UYZ0X>T.CMH*.I\S*OSA7CA-M@!KG;%=$= M,;$"JD<#T!QT)UB;SM*FMC$/7>E=A'0O%!S,Y;-4/&1B%E]FJDZ1(TAUU]PU MQ1-M#>/V %>>#W+P^"S-7GX!-R.(+2V4KA\?Z13:?"'/U8@V8J*[$*\IMEM8 MR#B4HX?[M@C"Z^AP6+XU!DN<'8R##$VS!9]HYGV'4>9U%5[V)*61F[/,4KM M.,!TG)XB;R+/'3B^;GC@*,\;L\S_827LK1?A^NQQGR>JQ9$5?*T M(J:&'*G*9X1!IHGO/3(PUL?E5]!@Q%XH":ZZ26$SU;'PFIOLQ/? M__O3YJZG!2 W?56I/S-M ;R@"Y_:C,17^,K7T$BC[CU*E>3#4!JPL[_:G"T2KC6(]*IBX'4.@1MIID/ M_5"HPZ15JV.ABY.CEC%?.SPY\#).K@)717L<=K\<$':UQC'O[,>\D[UW!P)X M>\=_!CS?+4&1/K 4GPH6QT"Q,EET6GZH/32 MZ";8X_@A!\6A9?]VLNXAC):-RU&W6056I,@Q<&").[3-C(OR2B7?N!*R(> % M:B3FAY*@:Z2[H;!76&25N6BYA@3-5^L]<9Y-J2/B]\3FKAM6G%*KB RM+VD( MN%6&,AK=S%%L?-<-'N(*4D-K3MK# M66DRX\"^A=!ZF59[8KVTDLC08I3= $:8R;R=QV0E\N9YMB+B4!(96FZRX^2M M-Y-YV):_WRT^&=F,I*O!;L9%=_RUC<[%:MXV=BZF>?$*M60V3710PH[FJSNH MZV[$-#2MF9=2=F>>IA[9N.=];D@ L=MX^C$4C%,AJPZBEU6/IQ.?"C!3OAHU M]UC,6_DV6B9LUY-O.89?8F;RX9>47?22VHBA_#3/LNOG>^38$<0GJY?-IUD MU^39NNW]%W=Y1(/-B66M%9$;.6I.Y8Y]R+N$N5T(4%M^(IVGV)7^H\50H4UM4*%[H_%7#QSX5\=8 K M;F0-M:S#*M>NL/ VB8>L%TDGUJH74WP"2ON3XH+>P#L8JWOOSIY1)W1AB)S# M%PYS0RE>E/*,G$7\7EGJQ.<:\T48)-6\Z6LF8)L13=-$Q7+C%6*+!L:#QHF, MLG562FLMII7*:5\LJ-R:5!;YJ$5ABX$ M1EL;NL1FD2#1%$]$,=F*:0G24FFODAAM2WNM^LL816?]0B)-=!^HJE(AWTYK MR44BRBUY^DP"ZC/B8B3/-]>=W"PW?*%&0J&J<5G)E;17\GIF&/'R%>,89#;: MZ\XB-H.F5-D]/$.6]I^\]0?\_HW'[5S,H+<_.MC%E3LM?:>DVQ,W;Z*/U; MP02-'=L>%I027%1RFWI8DGUX&K4G+J0&3/^9K4#R;JNH, %%E M'N0;@; K+OY(/E3N% K9P:RN^:U ^BXM^''-/-HWI7UF/S=AN[!1"X.9D0H2 MK>].0M8^&5>56@M!X6U*AU%D&A7CYE7,%;N+>C+M]0]8.'#J[&VKE[T1(Y'IRO/A[STE MOORF:K^'(-1=OMD($[PEM*%R1]$WN900Z2ZX; .-#0OLTU_=1@\.RG>1BUFM ME\HWUGTAUI:^J4SC/5K\\MF>$?X07& MGL.&@?Q0>]JP1BY,--QI^J-Z\F2"O*^Y:[&$!Y<;PA;SZ"B- M*.J403B]I'0X;03*].+7E0S%HCV0>-%5-J-M4*A M. ACA:@C*^GI $TQ(=+[S6C 0*Q2NYSBZH";V\5ZD>M<4S'J>TZC()J,>(9-;ZS8):IN?G*O7MYFBCSY2.^" .U M20N5/ B3)E)8C.?,^02"Y*I_LJ)8L2S&6++^'ER5U0HG.+B!F E*Y+%&TFGI M\4_W]LG5_J."D]/"84Z.AZ9ZS?PS!3A%"D%EX1F#:F62H%K^RNR\N6(0D MGE"$PXO'SJ]?@*0D4F0#($4239MY2!P;#7;WUP :C4;CY_]^6KC6(_4#AWF_ MO-E_N_?&HMZ$V8XW^^7-MYN=T?27-QY[\]__]>__9O%_ M?OZ/G1WKS*&N_<4Z89.=J3D/E_M[X3-Q*_86>.2WWK MF"T>7!I2_H?DPU^LP[?[GXFULZ/1[W?JVA@]?=G=__/CQUF./ MY ?S?P_>3IA>=S6-(-U96I/X\%]T:,/G!S[, D>,DC?6[E:\'A%7:/=F3FD8 MJ)@K;=P:-U?$YXJ8T]"9$+<2:Z643?(IQB@5, 7CZ?A!3&,:T$J)6N%N/+V9 MR'TA:E1$UR=\FG8Y^.IT=1X'@T M"/C(/"*!PS][Y=. ,Z %?K5>&M5NM%@0_YFCZ[(JY M'%:J5G>E7IKD_\(A]X[KA!I,EC1M5),U!E,W(^B,.'[L+WRE).!V%H\+%6]2 MHB:Y.V:QD?!?:F!8VKC9\7 ?T#\B+NSIHXZ:H/;=C]%FQVJ;8U:/@UMR[S8E M3;ZOEN8?/89!@I;G(DUUJ@A;GY?T^-0@[7Z5/Z$A<=S@DOC">WNDS:SZ4*_= MC\BJ\FW7:_?R[8B=L!VY')(1_X/MN)%@Z(9.(C\>L*=/$S>RJ7WFLX4(0T0) M0N/I*?$]WE%P1?UX!*4R-:.@UM@RJN%-WH3E3_@(.!'B4;LM#5;[K%$-G7O" MHV#^'I"[[FR^'PMINGOQ'?$8K/^I29& MC7ZD,^D#P9GO/,:Z7[;4-V[9,ZJ\K.EWT3+G&7W^)CXMPAU1&$?;^8C7 MG3:V[+<[&6]"-OE]_"#6ML;EU.L;BZR5@I^-?ZCU/#,:G'L9?G]SPGG&H_GF ML?N ^H]B93SWN*_;C+*:^'*7EK5>-;FGD$[218=I6P.J]I76HH)55V@MXC:C MAM5WRGKT,IZ)/UFR7=8XRP!PZKD\?!7'G>]CON:\"W\2W=,=V^&V$<2'$.F' MLGI9]>)XX2YONINVV2WMH'V^5Q_;L=F".!69+E)WP''\I9T%7=Q3OR*[>=+V M>26N6XW#F*!]OCP6CJJRMJ3IU";IE$1N6-LHE^1YGOFO'<\1?MP%_]\3I"CN$#SN7J MI)C_S-<-FRN9VN*G@+F.S?]F6VE/5MI5RO62;Y=-=@52\$N=<-@^9MX<=C9VT_S3?Z2_OINQ2O7$#WG/Z[D-O MWZ6-R]KN(F ]#M)KL)VVVV1Y;24C?\E\.D0TYZ%D7'Z9'!U;*R=K%,-2CT*%61X* "^9S"7P&05J@]>3U$^! *: M-PI,T6M2H2)5.-,1 +G8*_WZ-SME\C0%$!+#V+;N7!;!&,A(1#?F07QAN]] M:7!TQ;NDOD_M.%#V-76RP9D0)KHK,\KM ,T[_@!8\J'#*K$/CC>SLV'"]G$= MJ$J)[@[[ A7,/@35(0:H1G6@*B6Z^] 7J&#V(:@^U(6J),!T?'ZZU/WH)N(N MU'<6GPKKX2#(-:GO/B$&I*H<$#*?S ZB41#PC>CH/N#[WDD(CYM\N[O]YET* M+6BTMTYE_$(0F'4.$DZ/(U\;;XCY@/ M'HD;>Z7A,?']9S[0X[,.&"8M1"B; M3P#C<$[]G+0P,AK$O0%,6Q8(Q_=X7 Q-UZ(WV%1 X8/A"2TDWLSA$W#",A_\ M2;HU7T!_9"IO=>%:8QA5@L*$,UJ^V'#<8IT'W%% MGL4F0GOSE&^/ ;CJ>Z=.$_-FM]1?B*E ECQ1:(P!G+H;,5 <$"NS(9%CME@X87RQ M2AS&E=4O*ENK0*(^8Z<4"\2P;A@$R(3Y2O_\DWB.1Y5A*=$<:-U+))3R@$?! M=0,9 095R:??@.=T0LJ.5'W@.AJDU43 <2@X82P#=;US+\76B[E&52KV6!" MG3 YPL!X$VM[S2#Y@=DX@=[\M3Z5-C]O5=-WX5B]XJQE.DZP6#!/!YK-EOW" MI9Q[$!3#R0VV':N0N%?$L<^]8_+@A$1RD@X0] LBJ1 @4F;# ->B%(%'[67A MM-%D$BVB.*B[4;*V")J:ME_XZ1BM7B^!=G5H$UD^YGO\VU"88:A,,M0G* M11YJ$W0$U%";8*A-L 5 0VV"H39!Z5PXU"88:A-T -50FV"H36 "D!=2FT D M9)Q[?&L?U_[[YI$%\T/G3VJ?.$&^@;C"I)(#SKY@X OG^>J1/GT;&I9P?G7%\^)7Y9<%?0J<@0HZ'/ M/KC_PI)34]U-U"!&#%U5(2 S:8"9-C7]PXE1+T"K)I?:/[Z0(YME5,($/00 M(!UWT&QYA ++6KZ@C*J',&E[@5G)NL_'6 D8C*?C!^I+WK$XU$O%6/=HL:FU MZM/ZZ9M'(MOA3?[6]AL7*Q;&4]E;\CGIWE>43@B7[?RO5MJ]]5.T%A1!7D#! MH3,DGM1./*EQ[EK[R#4]I>SQ8>M: IQ37<8+ M5R4H%)JV,(@:3TLH9QK$PG#UKO)K/2I@I&1]R,A2"P N168!V[S'HT*JO/U= MV5R,#"()Y^ *8S@):[M+2H92KBILA$I9QGDH72&H58P%H4>BE&.6>SZ,S$0<5#K.O MZ83-$E!D:U4G#* WFB[U@/,T/98C"K/97KJFC^);-89D:FW>&C3[[:LY5!$/9UZ SO3X&_%]XH6J M<\S*7:%'O9Y$./,'+FEX[DW8@EZP0#*.<\W0 U3D5B,GP.Q)IGC95Z2,/+I>'H4!1RF0%SXYSZ4PV6\XI,BYTUR8/N1BR82 M[%T6\#[X_R2="6&6W5GM^[/6';8K5J8V0SGOGS=YSU&TK'/-P_#] MO8*"RTZZVV;WC#A^[ M^I43P$0_%=OFL*>._L)H">Q3+(4[F YKA3N*0R8LMGR+ I9L%+YI'U;V[Y3P&9Q*%SY:%ZU8[,I'O) MP6';B00>)AI^B\X0QIB3QEJT@T[3R$Z]&4D%F/DT_D&:/0:V-Y7W4G>0,5V9 MP$'9Q,0;T,G;&7OY8UVE#Z2S4 U)0$#1X*E*SB]K:\:1KJ%W&#CD-RBV0PCEC-@>BIBG MSILY\\/EZW5B"Z"X25;>'/>$*)4175+;)K.JX042&+H])E6V ACDLUY3V&"> M_QK K]/M_F4D]K7CZ16?""2I7*)M65-3-6SU"O. '$/:;4FYV10Q;367$_5# MX1+>FXY: ZK_C?F_.]XL3<:#WS<2C4O;XE8TS'*;<9,M;CF28"X>BN7_$7=E M'HD;A^?"8^+[SUP0U7MN.N1X$:LL!*.BC?2P]11'"W4M;=! M,O18J;F'P*I[7T+ANYU[MBCH&,6K;+HUD+EMA?9X5:YF&])UYLJ"@:QYK>Q# MK5RK@V+6<(4\Q(8RK:!Z'C+I"IANUO30)&ZT (DR&;0.LVBRJJJHM3C.])73 MC[RK*Y=XEV2AB'?F6W4?YJRH>29AONE]:[,PJ")IF^W,!#=+-5JN=.2AS'IZ MQQRXK(Q-MUE)<8&-<^X'>&*A%9SP1OORS"09C:&25H!YLPI$-2P9!48&IMZDU2 ;!ZC;T)"R;L@?)I7;ID%1N:RJ*5V#U3\@L. M$#2E%K,%?H)K&E#_D=IGS#^+Q%6K9810 M^Z4-;IT\2-^+?/N"+%G!(EEYW'TV4U MU.5+36E(OCS87ZBX42'8SQNG/(K662ZM-9O6DD]+(&YE.!5$2UXMSFQRX7YU MA#!1P)F, M//M$*(G:TGA4H:QJ[7A426@I9B2N$YBRD@DVH2@/FE'B*JXI55=)A=>:ZEI] MKSN=9(J"ZF4F%RK!YLJ*HBKR*!+TS[T@]"/-,")(8/BVQ9HG14"QM#&:J*(" MCY(;%X#@_8@O9N^)J$LPE+$JYB&U?^I"[?*,?1G)W;ZA>Y1;:C['/KA:'S:<'Q/OS47^59$CQ5O@"KJ[ M_<_88="4 <3BLUG?Z83ZSF.\ISMS/.)-'.*N'<0@LPM4A14K=G1W8"CRJ(?L M-D*!WICAF.2U2(A4W(E9-^G!'J4@$+I;+()!Y2/AV4:&[JT4%%FB:.15XJOJ M&O.VH@(>F(_!OW)=+J*%"I1<,U,>;YF),P6;H&]K=M;Y2IZTU)YM=F?(S])0 M>X%-2.V?\5Q9?)EW4JLOT$-QZ^$>*FJ$4'L!/;^'>CMW_.3CTB# 9K/.;\FH M;9XIN(4T^K[A(-?M#S::3OF6DZC"MR4M305O-?4*, R&;1L.8?TC?HU2JM-L MD[L#0[DS>MHLL@K.WOMFO::>E[37]X6&NO8=.D!#77NU@)A='[1U[9N!,#Z; MO"+/8KH8AW/JIS\K@^P*0D.W!E0CB%65 3PL092S=48FRC1=B.+NP)"/NTVN MUB;[$$@-[R+2E&]A7H!?EFF!7;&E[+9I[\R5I[\ M-BYU$(1"B)3/97T,>N4[I35J$D(%'79@*@C1]%$3=*9>7OD]J8ISQGPAV'@Z MI>)/4#GU^'RZ:C_8H=I"**PQQH=5R7C!N"Q^E6^)'2HIVTWO?,#:+1.?QJ5_ MN#%,G ?B'A%7%) 2?DCJ>@!#1X<4.P35Y #68@"C/+PF(8UO$ME\ M\(OZI62FG4,OZP,[HC4%@J"M^Y!!\SLAO6U/3^ IL@Q&,LV.K8C>LDQ0T:'! M<>3[5+JM 6EZ HY* BJ3\TN31M#."UL**YAB5V6&,K PJ0FQ Y$%2D@-#XC M6I0RZ9_)CR(,%F\:]G77)$D7V-&L)P^X[VTX@J#+UO)2K=:@4W>#';3Z,H' MF8W/Q6'(U1-.G'WN^XRC, B)9_-]H"I8IT6.'=3JLH!@FCT77#JTJ0N5+L\C MS[YDWD3EH&@0]P1(;4E &.O&-BKY+-^)[PC^:OLN91U@AZB.-"!,9L][-XZQ MRV/MY4?>/8BZ*Q@',:D;]= :.C?1?4#_B#)6<^73A1.!CZSIDF-'H[HL($ - M/\*8!I27U[?.F"\>SX6"@Z6-^Z!\&>>@JNM&*12G>NPJ\B=S$M#Q-/,"@.*@ MKYRH#ZK7D0"$H&[TH:'G+%P2!.-I*L'8OW9F\S!W/+;Z8Y#^-9#L?6MUAQWB M[64#P3<;[#@CCA^_.3VR_Q4E)Z1K$6"0I60] 5-#!O!$V'"BF.R0=+W!%U/0 M:M^_KK(FV2AOU6]/8&]"2- NC!:=R]Q:SA1%2T\$XP/:M)8 WV6N-C*K7TIK MIKV751'+%T5+OR=^7'<>%Y!;?C/[>Q.%TXK*B8^OEQ?"ERWE5>0^5-9(D*AD M^9D5P3.*YQN&XFM#\34,?LC1\VIT!,>6,+MB.EC@W'N(0OYGYDWB"T%._BTF9L- M>H8 &$_;.*!S@5^R!6*^OX'22C'?"*E5N]W,/JJ[V416^[WKUR7$L#BC1%G2 M#&AMZE6)SL%2Z0 $K7'4%@LG3%(C3Y_XMHIOWD91.&>^\Z?J799$!DUZ4T]9 M&$*VBE9TXA\FG8)47?%]#R><%[04Y-44Y)6ZTEG,OI8>++Y,)VQG8\ID^\4+ XH&+31+U^:+P;7PG M_NAYW>8JN2*EUM*O\=BEV1HBPV.7>'6->;5^(8]=OIKG__1F MJP9>_C-;='AX^6]X^<_8E-CSE_^J/J:&^F6Z J>0%IM^DHX[W@&W(MD!7+JC MRC4S]H*REC9+N84T:O@AY=5*=_I').[&L,4#\\1)HN*-.CD9[H5;2^8B4F:K MR&_PJEH,@.:&GJK34CC3$0#I.MT$.IA7Z\80Q+R]R92I4P>]-IJ:.OV2#Y/- M*%<9T^"(:OJQ)^H[-!B-;B(^G7]GH:@WQ=M3W]>YJZI)?;=OZ!*R%@Z5!0%# MQ8;+D#?X3."^H5)IVBG1Y99RBO/,J[32[W*(KT]* MCXGK4OOH>;/HK\2'WJYCQ.@V*6";)P=H7L[%"V4%_G'&C5HI:XT7+WWVP1!W MPXXB\\33 V.^VR-B\4P=5N@%#*@Y8I6KV09CWV9C=HL'ESU3RG?DCWP0EU^N MN63QT*?)#9K@EH7$S?Y=O+Q\R<+_I7&]J9FWJA$U?HB/LR0QP"X^C]ALNE<# M9(9FWQW(1W^2XNOK>F.P_]6C?Y=R:6'[$R7T'QML10!&52X8B.$B2B?IO2IA3F88B.+U^FL%8#1RT-S>5&H$4DN0L MK7-;@G$XI_[MG'AIV&P5=DL.K;:80YIBP52:G;[OV*DF((-$OG[5UL&O\:[N MW$M*3YNPQSP'K]@<2Q31]/0()9*V)M,Q\:@XBY<86)S"V1D#>.W+@!Y ;[TO MYK7,&3!G7P4.7JN!E2L"],Y[9F$BE@*Z;)TH=LW!*[>P#45 %E8WFZMS"UMY MH;]1<6I$[=$C]OU1+UE=-12E173NF&O/$?S=II1?Y>J\76 M45/3.6;=V&ZIA-S[G<3NKP%CK<#0J[+.JGII.M<,UU2ZJT&6T4]2)/63#I()QR]U24(\X%R)8MXS1REID"+S]P5 MQ);YETW(U\W^^UPG^R_^D)5^:4@!'%( 7U<*X/ B3IG$V+(VAA=QAA=Q,*?) MO:(7<3*.B2H#KM#44!9?!3)GO?F/O7AC@F1N.M<'ASF=,7]*G?@YF!9S&.&/O7AS@F1N.K&G0;_C M/ @B:I]$OB@$&7.<7(7/1DM6\7F%8U*I+_S&4$\D"&NS5;2VM6R=S*Z&!E&/ M4KA:E1@R)+/UG!ITWRH>AS7O/_;SW,N 'II.;C%]3['*H?2VYM@<$_TWR89U MT722"Q*S+/$B#=EF14Y>OH'644CC*2Q(S'0IJ6DCK<3'RS?1ZNH #;3?P;/Z MB5?-N_4OVR0;U -HBVW<@;I7RW1?V7N^ID+Y_/?+DY&(N*+&]CM9AE^WG."U M.),* 4W/[".9W:OC0#$E=LL,7F,UK!/07A$$B+90![Q:0.K8;\]>:S#SXNVU MKDY >ZU[O0^'FYD9ON=<:L<+G$E;6<^J3_;#]EJ3'+0P! &A9@9<7NAN)KZ- M;_;#QMH372<[L%^I[U>O/53[N-_RZBP%36M;C%\ MI41($@=44F8NB4]\D=)6KH+]316(OJRX,RO;VTHX:]6A&;$R^!\15UP5#<;3 M"X?<.V[\[D_:UAZ%*_*Q=RV>!1*'W7P&=@+9W8AW![H*R5O%DA?QLFO42C(<-^CT)(96X[G MBNF2J75S/OWFL?N ^H^);_$0Q<_%>!-.%?LHFV*K^;^.; MR/4S:?$67XJB-OW=IU<$;#6M0%A_,GM_(+/^K7[\AT-]SN+\^8(^4E=[KR*E M[\VF14,+V*X4E4:.BG)H^X%ZW1C?5>@@!T()9[7^6#2XA,^]N5ABB :;E4R"?Q#-,'=?!+B5H8L48!S(H%!A'Q0?BN M#H0ID:E3VK8@S(H%#D(D$!X]9X0_\^D?$?4FS]J^,$S<&T=8)3^VF]!E5KMB MO(XS5" V[O$J(5'[-H!&>N'D-HEF3QS:YA'OA0^;77A6T1OME51"C1 M[SUH2#L:THZ&M*.7 MDG:T5T)[0E DN0OK%.'[>7PGRWLW*>5%4S6CE/)U!0#X'WNB)+NX03Z>GM#[<.39Z?ZVS.43''3' %YC,J"'_CB>6RCA MELL;3*D?7-*P^9E+XZ-X3:XCV4'?YB6965+(]=R;^+P[>D*3_W9F<.6??VVF M)]$"9(1UW_SH9BG5B 9ULZ1J,(+7V SJ S*[3,%2;&E PE=81IW7'D,F!BI- M^3FL5W)H_4F+>+:5?C27 30D]PS)/4-RCS)@/B3W= O4"TRM0!"&QY,V@3]B M_P(ML"D/7XLZ&W$7- M-,'MCA9DP18@CQE4S96Y1F;;.0^@MQ>'O+ M/R9?8&PL/ M&+I6H!A=VVWJI9<"D$3,1T$0+98/^8@C2FJ+)\@TPHT Y=V^(5>C>IZ#5 (( M."1QYASO6L_S*DG[BEQ!!.2'5"5F]YVY?%X1X:5KKHIZ@R_?1U_!A&7!N1F3 M27'B/#HV]>SZF&9[Z#>B14EP[BO*9+AV@M_/?"J>MZ,^#<+J>);UT$\\84D@ M/-M*ZLLP=<;\*77"B#.DRL KIT*,A3;WD/Z-9K>)EVT=;\9_N\WD]9R?>2>"TRZ&7+0AAPTY#EH 9V\G;''79LZ J!#\8/ Y3"#"__5W06= M$?>4FWL(U;_EK0J-D$85RUAMTS7757+"#QB8XDWR+3H.$4K4Q@ .6XT%MJ-6 ME!&^RJKOM(S/F/R^8#X=/SPP/XRXGI[/(L\^O[B2IG HJ+H^C(-LEU7B&.<. M_X(%P=I9>3XA"S*CP0V+9O-0<5E726KJ'2_].JQ:$N",JG&^'ZD?.GP1NV0A M#:[(L]PG @C0@R3CNT]C*GY_GMJU!E66%CU@FB+@C(U=<"7.XG2[&QJ&R>HK MXD&>["ZFA @_6@K>-4)>W6_1;Z+[("Z/'IX^BG,LO5WZA\U=^KH;*^EGV*D/ M._7^[=2'_*"F\H-,^PU#?E![,0'3N*",'N#.#P*""M^)[X@A+\YQ,KL#SA&7 M41PN2(,+FM2&,G[UDGLJRM&TJUT7E[$'I\)KB;3JP)1;W2 \>5G D\BN,;H1 M=X[L[6#*]G'WH?=(%<2!P/J X%[/<(FJ0V4/EZA0ZAJSJ_6:+U%]0GNAI\ F MI/9//;Q']1FMV@ML0FK_;%;MJR7K](\H*=[UP#P1,)2OM@HRW"NPELS84B$W M>%7MU('F9E9J/84S'0&0KN--H(-Y;6\,0VU@-W/")1)O0E![7SZ>]/O!CV0=>7!NCX]),(=Q$W_%C\:: M2YR.>'Y.SAPHW?*O!'/FVE=\H\+_1&9T/(TKO7[Z2,/+%I1[IS7B8!C],*M[!,ZYF4TZX M RR^/YZ>4?"N>ZX-8LT"O(+'5HCL_9M'%HROIW^*PA;!I,J6N(04,4;51 W MR1GQH L.Z>_%O^Y)0/EO_A]02P,$% @ 37<.2T@6-O*S40 =XP$ !4 M !S8VEE+3(P,3;Q_DLWSOY"S M:$F_(]_3C!91E1=_(3]$BS7\)3].%[0@!_ERM: 593^(#W]'OOGJ[;<1V=]W M:/<'FB5Y\>GRI&WWKJI6WWW]]O/W3FS^^?T/>OODO\E_OR.'QV5>/7'[];LW;]Y^_7\_GE[%=W09[:<9#%-,/VNXH!45W]MOO_WV M:_YK0RI1/MX4B^8;[[]NQ&E;9K^F!OJ>)&7Z7[#(%_22S@E7\[OJ:<606Z8 O,_JO]T5=*X6 M9E$47P/_UQF]92.>P(>^A0^]_2-\Z)_J/Y]&-W3Q&0%*!D>M7M\.VJJ9OO8M M[ 4MTCPYRC:3>LP=2'PV=XKJ&0KT^;VK<)U7T6(CX?N,?GOZ?9 MLD(WZ^D>YT[$KF21)W>ONE\7\,=3]F\#$>ECQ=9+FC1"0A,&"\R_P!>&NNVV M]3P>M+L :YX72MUYD_.HO.'MKLO]VRA:?0VKYM=T497-7_;A+_MOWM;F^Y_J M/_\,"R1=TJPZ^G6=5D^P6V#[CJPJ9X]IV7R0:_O7SQQYOAYK ]RSHE$I*F)+ MO]047\]K-:6':RF7"\8%&T>:[7^Z^NS?!"GI:,E/0/W?__IU]X6 .&-+ BT_7+ F M:5%0MCCD\2\?Z?*&%KH^,'%XQ9A=] '"].1X\&65<8PNP4$^D):'<";RDV!# M!;.#R3#3P#22)" Q^=9&/0"#J40)DE20KNGFAQ$:7) M2780K5)VBC6"QL+C$T!.XO?!9&1 RP7*<<@ZW@(,.V?9*1F0P:Y2UI%:4:3 MHZC(TNRV-&)-1^P39&:!^^A24Z*!E5$\"4]QO%ZN%^!N(8=TGL9IA0Q(U^P# MY_-943"Q^9G7X'G0T/J$D5'! NKO/!9]0_G24#B\]!M)QH+K8FN # M#N_\=?7ZHG;W3O#SXG;O_L@/3^J3BX;&)UB4XO51,B! P^55&-5%=4V+Y2&]J>#4;0K"4--ZO4HRB3NX1%(1H@&,23KIX@AH]RM&3(!ZCW#? M"*;UZ"RO:'D1/44W"WI>W=&B_G>S@];*Y1-7CBKT$69A08,U-SG'J/N4E;#Y MH>!RJRBI>9 9K],\NZW<;)>:U"?$3,+V<:6B0P,F@W!C! 'I_O5.S);&OW'! M^CLMR[QXXIC7NS@TA-Z\'$9!6T>'DBHX$JRBC7'P]LV_D%5+3S)@V)H=T2#A M^B&?S>?I(HV,.%"2>4.!0<@6 PH:' C0"R9=Y3SDI"/=]<@?Y-D]+:J4+5;, M[-"L8FN8 0%&%5!(>!$V0'<3;B5N(MSCV$&^G;"+> M(L&$JX1C?/P0%6F$>@]Q2(OT/H*KI>,TB[(XC18G65D5:PA1*4^9]&R7#-=- M1NLRN16?]F=#%?L6:F(3P?'Z/+G'*.Y:(6TSI-?.'NFUA S?QU%:\+(''YX: M(9\.%E%INOZW\/C$KI/X?:0:&=#@TD7*,0J!1U2P(!^>6L0]$L/Q0 M-N281F#%;4NO@M3SJJL5=K3@2G3!,>(@G/JT#M2D)M_]CFRY3"NP?B?9T6-, MR_)\/EM7=WF1_F8*@IC*[!$U$Q7JXMK'E M* L- NMTO]G5>D6+'_(JS6X=@G"FL7I#WT1E6NPY\N% WC1A=>KF["$J$LLUZ(C&:WBD2KQ!0&.?(#B*3%))08- @R\NH[?Q:__U;RDM6$_> M/9W2>S;43OMR(W.@#;J#0IJ=NH$3#>@FB:O?N^^1E@DG,$^RU9H=C4&A]T:? MAY$C" 3UHBMQ)Y/C YM61A/"!-,>X6SD_:YW8G4897LBU6^\=)3>]EEF4=MM ME9HL.#KLLFDB7,FB]18$W)5OMB%'M1??8!N."3O.?./:=O?6ZH\T*M<% M3S@]+NBO:YK%IB1.)\Y ^RN;*IK-E8XM."2GRRI=/W;DI*7'N:WJB5I>0AAO MP2:0V_[*R!H$BP[**,%HX,.'1KNPICU8GWN/M/Q8#65OGZF^5W?B"+WK5]RM M.Y#C@YY61O==_]L7@+1WDY'V#@O2WDU#VKL7@+1W&R+M'3*D73"YH>R_89JL0;I!RV_L=#5H40DDIMNR_^&,+.Z[XPZL;G[!NSB < [[*B R18!8& M?Y5_7 3OJO^8J(/#PEE$36WJEHEPU #;KMT2YRM> <90865(X*^XBDJPKJY* M_U<5>&G)I>BE.C_B&/H%1*-1UF0(#L==+&\70#O95K^8C@MF%G"1'+K MA5>';URNCRL'+YK>?NI,*PNKN1Q2ODF" W M>?NPU";='28U5A^"7:X7E:Y0E(;&9]"U4KQ^M/6 (+CY,4FE&/*:;">K64GC MKV[S^Z\3FH*%^0;^!2#P3<^PL#_]?$IOH\41.SHKZ] J*7P P" :#+_BY^"# MKY=)*ID"5$20[;@4;/3+,B_H^6J5%]4Z8]\[7F?)R>F%P6MA8_'GQW 3OO-L MF.F# V2"D)+W0W"1'AL!/G)"3B^0[8:OUCFHO9:;,XL\ M*#BG)@T.+C?YI$-S2TTX.;[@YI$^QJVNAC8@DO3;6B4A5A29'2]C#.UXU]KD M?U]&%9U8!LB9U=L:-U&9=JUSY L.J V$U>;[ [O:O;?SDY)5@_/,X#>>PHT' M>9)*[N!K65\(_L;R;@1!UDAP&%Y1-NR&H.B)#> !HTHQ=SSVN5\()!4B;X1* MT0ZV(P*D58H;7?.&3J;S^P2X1LSAL]\CHN LTDF;>!XDJL@W+4%.\QC[EB? M98GP?YQD\[Q8\H<=9C=E541QI9HO;GS>[-44-5HSY<(4'#Q3)96N46I6PG@; M%U>/.X2+4TAQ26]3D#RK(*1,X;M3D_ER=IJ$;#R>*IK@@+$()K_:QB'1T?(( MOW"P.&!8+:""4T(?_Y,^:963Z/P"0R/F$!DC(D304$NFP49-3#@U8>0AT-'8 M,7"(*=0:_NP+"RJA&@CT?T,Q\@J!M(L%T(0+O-"KTQD!/Z@L!-F$;,.CH4.#"(IP4 M+R'(B: GP!#4.(C-RG&ZH,4!$^$V+_2;QQ&5WZVC4L3AQG% @@(<>KDTFT9. M2AK:@.>)?+G,,^Y2X6]3EN?KJJRB+$DSU1+BPN3YI.&@P.C88>! !"8',74' M$LXIBL'M$<%,>MPAT'9=1/#IJZ?E3:[2>?2[+PPIQ6K@,O@1!3)4$DE9*8*& M"**0IQ2Q](F-\3'[FRI:ST#K^[2B%7=\8I$(46##)IWVY%+O4.H##&<)CQK8 M+[EAID<9!C&2J&J\M&0(T3*6S885OIO=.E*>0,7C-K[I2&1WZLY ME8##>[D^17",&,62;^1J(O(3)T-S;5N+=9IF](3]JS:H4T$8!!V2H$J$M%3X M4#(6S8 4("6<%@E<9F5)JU)SJZLC\EJJ6"G@H%;Q@ (-/)1B23ZUJZNCZRM, M4*A=.$Z(D&C] T,CKHR/$2$RF*BET[G7(L[S'0[8'$3EW2Q+X!]0Y^,^6C 1 MRUEU$!7%$SN3\=I!&N4=>;UF/TY19Y #Z<*(!G93I)5@R)AP8&\6Q_E:E.FC M3 >V"SNC53U+=//-R.+5@#D(/[!C!GHTN'(04EH#:Q92M#Q[)*,5#HB=9) O M :]K4QVDAB0^(:02K@^9_N]H(*(0:@R)E@0'!BX*NHK2Y.AQ1;.2,K-Y7MW1 M8K!R:W1UXO1:A\Y=E4%Y.CL;&GRYRRH5LQ.C!#>_08+]9P1?)]GB6UIM%LF80*QID5PA+I31!&VV,T M.IB,3>\)7+;6\OOW.UX K!1E/RV>)'=VGXB9JE0?4ZZ\:(S/1(&E2BDGLP\G MIR?7)T=79'9V2*[^-KL\^MOYZ>'1Y=7GY/#H^.3@Y!H=5MW\G":&0'AT\'CJ MJ3%B;IKO<]$Q(G& -OZ+B^@)?!=N[J8Q2GD+C;G;)X5HA/V!MX(/ ML^[8#(Y!1ZQAQI0=.[A6RE'15C-8=,0!Z^@:(*.F1(,:HWBF*KD)H^9^*9+/ M29*6]0:,_<<_O_OFV[UO__QG$O'__(]U1LG[-WOP)LB?N-?]G]^]>;_WS3?? MU 2'-.8E+\C[MYSHCS@PV=6C=M[ F5G"%!5WV\:9Z-%@U4%(0U'Q]KE<'/!R M!E5H*+D!*#!LK(Y79\0,;WYZ'@D,AI3U.RCQ:+'$@1](I4LK_H(IA(CE&;SY3+.8 5R[ M0S!P^-US644?;KRTY&CP99=1VH*=?_QX;OW[1_?[?WISW_8^\.?ON5.YS__^?W>'__T=N_=NW<-0UJ6<-'+ \&[ M8C):MS52/_4L25*H[!LM+J(T.Z*],%FYT*#.V=1%>$M#2&NK9N\#77>KX8^ +AM_'$<'ZWRJ0^1)=X]ORW$ MV7XCI&'#%)1NN7-3\N "G*.T:OCU[N'X7@PQ'.&2J'O ^E,6+7-V\&&[TL,Z M2$)[NVWE\QM!X*C&,(S PH1F_7255 HHZ")=,J17?,-3^454G!>\2E'"SUL7 MM.#^&Z>:+C1 /*2>(J$IQKMTI]:&[/RQAA*8JXSMHCNU./ MR$SA8*A30 ^_,0=2V&G$M,)-\L+@A=T)=_Q,Z(V&(33O080>9XC!V""^D9 M5E++>(#54@<%E_[HJB'%"RKCH54)*$PGU@D/9+FQ!(65Y:"*^FFL"4(ZH0S= M^?0DB_,E;9](L 3X:JG]5B0TBCPL0J@D10,KLWQR65Z@)KWW+!H&)*]97-)[ MFJVU:6K=SW[CC(9"#:.)Q&]H #$2:(R ^F<X#1DN,QHK8)!SCJ*5O:ZHA MJ>YX24O*^A >2SEDUFZ1KV#G4VNE742-/'XW'P[B#W%WW2 $WFXY;;-P[;!)_-QSX'/;U%91S6& M)68M3&C6-5=)I>,@?W0K%?[F+VJ#]24.Y)UD%67]9#D#2E2>WTQ2B3AZ'JE/ MX@="NPP\:,0HI=6J4DP?$Y#WB(RGZ5H&Z:Y42M8S..S-9!2_7MM MN:&X+>2-P]@..^,XS:(L9IL-N*&"'.(V%U-C!=S9O18_F:C4H!J*(R\62&\H MMQW(=;PR)-WRX"K6'B4Q-"?*^13I;0I55GC@%3)4PY)4PII$V:IT] C;YW5: MWH&[&F:\MJ"S Y]7C["K&@.?L(T)S1;"55+)+\SX(#><#E@$:K%DB!_G!4UO M,U$(/7ZZ9LM R],:L$G*C=0K8_/">QHD#I=9DWL MUQ<+1OLE@'(CXEX$K0M"YQRS,'EU.#HI,/ ]&CG0X-%) M3#>G$**'CZ="#0G*)@$,![:L+NZIV#J#76-[0](8NR.$&*.5]:)D1.,52RKQ M!OCI$R##C$(T"2>4'8;9SSC T%3V:[+C/D1E&O/#TF)=:9-_K%P^ >.H0A]" M%A8TBYR;G&.$<2H1HR3H.-X(LTTBAP,'\GYD>[\[)MSLGMG,6WJVAJJWYW.N M9R\UQ0V0FS;F$Z?/4[@/W\U:0H/J9XD_!GO3&(E$:R2NDY:D;*7OB#0Q3#-A ME\%'F];V?.=U#)G!2//DJHJ*RK3H&>24+=,"?&@X#)!K7F+@9$2G#,2P:8>N M0'%,.ZQ1TF0T;K.-?6XFS6:)@?Y$O;]W)?,Y\?YBGLU+N%Q ME#*MZ!4M[M,8BA*PGKND<7Z;\19UKFU?7_=;H-UKEPX+OGOY-)HEUZ^^JJ-Q M')5WW25*/A=9Q>S$C,C;QW45>?>'ZX(9**$@+Q\BWA8I^=52[YT1_G8CO]4T MK8Z;M^F]Y/ASU9=V,)LVB&;N;$,+]4LU97W3B+/"KT9OL8IO>3HX-XI@/DSL M (<)X=@BMOOVK6@S;6:\O#UA'4]CK*6S03O8]FE*-:?NN :-H+'_FTKNM MJ MPJ/F>0%@+]<+?GU0B@V6$>=X?/!^W1+&:'&E7)NXX#&Z?]X'.-4?9?8U0"WE M!LX??&Z4$!XW6Y=KA7P1CI2V]@_;%S!K>+S('VP%%LPL?K>$=N&'DUA/C\9H M.@@I)8^V!9S8&@9,A'.A*^?$+#U(=U'D4%0V^?#TJ:1LU6[3UV9QE=Z+UX(L M25\;-.3YUGQ#14?+^L16T(!X8]'U=42BE@5))9'>3I1M)F$O><)F(=N5@@LN MB],%'>Q_KO/M8'_WGPUTFMEI)VH./SOY)II9Z$E1^<73]K.DRDG1? R"KD3P M _LK/WNMV1<@\RK'.\L/Z8HID'+O._OW!85_@;HAO?P$3?>[L?I- 7179I@% M:.=#@_H)PAJ33D19H:XM''@4CH[_3+.D29;5=(.*T.N;'EI!!Z]W2%1H<*05 M3>%*VA>NI)H.!U).:L?6^9R[!;ILPO(X+^H[P_*\.%A$Z5)W03"Q#:\Y\9NH M-\B8G]( &E1N(K4>L+H;X'ZR*!9/A?)"W.2541![#Q72"BPYNB1*-) SBJ?% M5IW/P;9_XE$9V//ERV5:-8Z*N%?/'#:!])$AMX1?NK<84/G*K.F!(N?JQR*M MV/2+:>:I#_JNGG+;:/*BET:K=,2AYU;1S;=>VV%5-6>F+3JV_B M[Z,BC>#REAVVV&DLK[Q?:06O^Q#^AM1%?8-Q-Y*SU@%;LV,EA++@N(DI93]W5L5.(0@XL$ES"%XP!L/ M]!-_UN-LPS80A+.9U7,-YY0:P +6YPAOPO#@+($/RR=97%!V@#JDXI\GO=^1WY?;\:-(4E4:/*+FP>EV][VEQDY?4A-EI8OLI,Q?R6+?1<Y]7!DO87VIP;"&M_;(J939".&\T98K+(:@M4@@F*&-KK M@T+/T""Y<945G<7B>'1)8\J,YL/!3B&_&78\!/^!D8>6Z9X+B"2N^+@JZBM*D M04AK>\N%8VD=JN*WK-1/^4Z]:8.V*OA)DB*%7K-D4W< +HV(- M#D"-,E8,COA>! S5,BN0"(3(GDERCY _R#/VAS7[VWG[9H^FEY[;*,X<"5,' M;)8OH6H17>W"Y^NBRK2TQEVCGAZP>R^WD2ID; C!-'!0U 'ZAE;0^+4V%EUU MLBMQ)A&XZ_A\8^_<*$Z4/]/8.[;X M'_'#N?*J8&ZIG1AL@\U\X;&T(P QP4 M=4"]H17L2+>+/D9WRX'/SC/E8DJ3\I@-?:_,CN&!%R.'UW0=N^B#O!T].1K$ MV664_6>"0SR1F@X"3+K21SQP%I=?HZ_JI0BXOXB*ZLD1>3)+*.CIA-=A;TR/ M$GP:(=W1-T"B#\K>&;!HY/")0@?1^_@SD&.[\;*+*D&OIH=@ M*^U"#.<<./3@0-Y%J^(X7T=WG#=R^$W^2&WJ89O,8%!Y G&A6O<_P0UIB=)KAZ M]"C$I)JO5HM>!'-:-'4W3S)YGFQY&NBK2:J*[?7%,-I*@V2"]U8 MT3@UILDKU4_M<1-(QE[DY;J@@VJJI-<0M+.Z+<(I*LB MPS*.-BXT\'06564N"0_I37B:+*GN:&TV(1X^T!+'U09U#*L_1LRH11X&R?1)$B%#) M)2."/WI= 1D.5#3&KRE&VP:Y9(G",]$MQ);E[/G-^CZY;Z,3QH>)Y[2)!ME; M4D3UV M?2GLQ@NP(TD62S+!%DO0*9+S5[7D')(%JE[Q5P;'_.QIH*81R?^U* MW#0!9J(ZFZ"I]=K4-6RJC^RHPM+18\S3MP=79F<@%50V%C(U6X#K_(P^\-]& M7?&LEKS59GJ>JFWAILV:"0[7Y\L^1G73V#1,9_3!7B'P&8#NOT@G:\0^K,X% MG,CK#;13U6EAZLJ( Y@3I34;6"7LT,60G!>W45:7WF/RE_DB3:*ZI/P%$QN\ M1H.Z?M&B?8_'YHC94ML^U_ZM=D=_T["5AH//DEUH([V)TVM[CPQ:Y^:\WS[, ML_8+I/L$NK>A/JS+-*-E>4C+N$A7=5=]B,JT/)_W-;JFC]4')L@OFI[?I"&? M$VAS1?NS97HK:*;&QJ)+I[JHJKWT39,<_KPE^&N_+1P@KY/BH=XAF[*QPV-/ M!@:O'GJKX //O)8:#0BM(FKJ&8"SH.% 9T.OTMLLG:=QE%6R?C:[Z#A0UDJ M2C0P,XJGC'WMW89OS]II7 )R18_NZSKK-871FS-@DB+=@P8N7,&A-%E4Z6$* MM\JV_LR1>"C;8H;&1#[-CUK OMD94@3'B%$LR3W)B?#MI>#AH<%3ZNR0TKV$ MU*026'=5DYOQ_D35!DI*CU=-: ,-.C<47-I]]9KYG!Q2MOM*D41A'$=IP<,Q M.^ML.W":67QBTT7X/@Y-]&@PYR"D5.X RL5SGMYF#-_94Z69S3A:>$*CS6CV MC RH\68S:#W ?:01L' [B -F!^T3@G 5*I*7;FD63XH7FM:&U^"@3=0;1 )- M:0 -3#>16KY;;-O@;N!!*[LYQVX'TO#V1"?L4V^F:GK+Q. 3K';!^\C44Z.! MH55$Q7UVAS$<:+I:WY3TUS6;!D?W#C?0>G*_F2IFH8>I*6I:-"BR""A[;QMR M(NC1&:BQ0M8SKYX^)*C,IU@=,5I8V6\%1KC" :9+RH19TTL:Y[<93XKAEQ-/ M-E Y\/DMS^*HQK!(BX4)#=A<)1V#KN8C/48FZE/)3V?'Y55NHSD8'X=D4\(J07LHV9(@08H2K'& MV&!$$%/1DNWJ\>SF12KPN3FL3ZY,_A[3=E6@>U3;QA$<*)/$U+XQ1EI&' ;E M9+F*TH(_;5HEW'9'FS7E-<'W&76<:A:(3TLHF@'=(UA,/:GN91UKN5$-II7<]* M6K_N?(.X0T^^@C XP%RDDS)I&'Y(1\PC:"&< PF NF 4)B,\7B92AIJ4B1-^ MV&$V^((I98;71BUYCT3:3%4I&&E:,VB N[GLDNL7$M'W>5.DWQ8.5!]%!13N M@Y*-7&6W_::5RVM$IIL*@Q!-,PL:%+K)*05QUESD"[A#_9(P;F%)<4"N/9 Y MGFVTY'X+%)F%'E8J4M/B>\;3*"?RQ[K/Z$,O.Z?(,_:O,>UM,]S@-;T9OX6U M-U-R6$I[6AMHK-^&@LO78+!6+Y[(+,E7\$X+.)A%[9E!6M;@ S@P?E&D>2&J M*3,M%E%9\GPRO@E)_F==\HUR+W57TY'3F_'[Q,MF2@Y??)G6!AJ,;RBX N,# M7B3XO8KO:+)>T//YC$VR)%VL8<_,G[?A.4='C_%BG=!$/ JV7*V;.@SCC8\U MRF4''_)ZXMI91PT.9%O_"IIYM#/5I.-<_2%P3_0_1;IOD>9CXG6FWN?X#5:S M.T>V+>]Z<-PE4,,A9H?>0U"5)M?@[W.?D!-;"S/K-E)9/;4F-85P_FPBOVF2 MR'CG14%BO@VK&\4V ]JCSL&Z*-B_382\C3T,QMV44H/:S(L0Q4X"FV"+[+0[ M>IO-"9 6'L_A37;Q1P%.>@8T>'.1T@2R#]&B>;>QNR_CAK&]5\-VC]9-L4-V M:KF/8._3JR(PJ]HLMXE&JTMM" _ID*.,R'4DR(IG'2M/YL M6ZR):U!?]HC+Q]FZNLN+]#>:?,H26IPUET B2?TD*ZMBS3U&'YZ.'FD1IR5E M9_J87D*55^,4\/MI;Y$4GCNS#<'P]-W@TS" LJ8I^V-4%!$D2IVOJ[)B2Q?; MZV-;J32]!1>SHFO*NN3\T\0U:_.&PZQ>S^T(]3JV::O!I]+653%-%-X(J5O! M-UO:15M$$+(#?V]-KTL/).?9)7BY"O$(!+,L1?.?O,ZGT^S9Q8>"%*?8>D8!8S+J?2S;OY5)"9NH/.4L[5+7X'WVS=OG+:^7K G\@HX37@ M_EQ]2*N[05'5_O<(_R"V:2I,7-=?DB%KX_BO:7R7I;^N)Q1J>F;C 1?-9W:( M8:'WM#B?'X15>P0*N)P5$=< M-9TW-X9)S-;GH"(*#B6;9%+E?DX*F/CTU=579,4Y=CWZW2.LKCC0<7A'A%ET M"1MJ*K4TA-Z08A2T M!8B2"@.X.'_,UF$6K'5]@S^L!_T>7R._(&>NO1 MKH[F$4@]8W#L;2+M&(X?H\=TN5ZV<"RBM$3C9&O*&)_/6Q7!*W&0EY4.A686 MKW&Z#L(/8G(-]&B@YB#D&&$-"ZR %=LTEU',8_MBX,&!,_ZT!)U'ZT4%N>$5 M+9;PI]D2@MTU/6'A\?[$ATU\Z:4/'0,:K+E(J7ZD4;P1FG0A(O,H9NL3X5BV";2PH7$#0Y MSHOC-:S-S0Y2&S$ZN1W?)>\W4G-<]GY2(\$1_5S)]4MRR?E)43> \SJ*)<9 MW #<\O37#T_2TSNSAZA(ZNB5.FP,%@.AJ>X<9'T$RF M76DFU0VJ0ZKR+J2*T(X7QY1KTTDNHX>/$3OZI=%"Y_+1T 8I=Z$25UGKHD^( M!H(FZ?1U(HOH@2P;ZEW7&>U)=I4OE#=@>EK_544UXLK%1$>$P2'A(IT;)$C) M.'!8E6?F.AO]@5MJV^O#Z-OLCL$;ZMMH./@4V(4VTLOL_93XLDN)IX.4^'B8 M$D^;%.$5VS3S'?/>EIR;VRHU5)UD3&8*];1F]U&ZX.&G>>^X4+\YR3.;-=T^ MN16_A88V4G%89VA2$VBFPV9R2T<^6I$%:X#,\X+<\ 1W&=8O#OZS.ZYM M!R>D1VIN!NJZD1<(ZZ'D1F G@A0MM'^DZ>T=$W!V3XOHEC97*<*+T\NY,=GI MB6WXA/1&ZO7A/*D!-%#>1&HI3*EN@T2BD=I&U_ZY'%LZEE+E>J)*>G>5PJ9T MH$MKP<'MKK(5YO:F< />6?XQ] ]IEB_3#*!J,>+[$6^+_?8PGBXEHE+&'.PY.EB)@D\XL6/>XFJI0^+'L%W5D*+%D'GK M.4*10[$PO"[Q=VBK/RO%E J,;M,GON4KE>,T2\L[FGR?YXGU3F5$'.1212FP M$D(#2C2SV"C>&#D-#;D%(F30^;Y@)L:F94T4!"H# 940X11>H5'E5;1P,BU] MV;27*WOD%LB0(:--KZQC/ZPH43 $08Q6<"5Z)&H_2/I6("FCMVQ-29RPI)-4 M+H7-?^8GG?RF9)\I8\JZ;]<7N76A25&M(A;_8;R#5#/XO](U"2[?ZZJH<5@? M9SEUE@CNJ6I*GA.=05*'^&]DQDF+,"-E$'.DQI2!#-\NQPJ@4\K.*0MXA!%R M.L@J+VP//'GI>6KILA1V.13^O\)IUT>PQ50Z$B@Z?B\HHI>PL[,_P/0(,Y"=@03FUCZ/8 M''^G)P\WN66A];.[HT4ZO24!E?,[[:T4N\^ZKJ* MF'2_!1]FC4!2)$!=Z@ILQ38M0TGCKV[S^Z]3MC\M*[ +[^M_AX%^W[,(XJ]\ MMRLN;ILBRH-ZS"/M7)E\P&*: @ 6-X[@$)HDIO3N:DU#5D"TO= H7;ZLNDJ* MB \XS@LP7^?S.86?5!5&-FW$7Q;MI@IV";536P@.P&>);4A#Y,6G174NDO V M 9^L41$1 BM=7K>(J9#))5VU!5I :\W"+I/YW"/IA.SOC<8TP8%F$4SVJM=D M@": R\[4(@@V*ZN1L_';F<*CINI MDLK>NYH55DG!2V[J9Y RQDU6@AV'_1F>&$XRMF=D&X/+J*)7%=Q<,<,,CPM' MMVX>/W,#XL2R#QYT%P%;J+5[1/3I8U YM!=/8UQM#<0 M'(G/D=JQ\BH=.'EQF,^KN[RHVG*R(F&KGR!FNF9TY/5;=VN".L-:6@Z,P4&Z MB;2*J\D&D.A25YNS=7UN5?9(+[Z MN60% QKTN4@IU9E@/.0>F,"./M3$@?)PC!&T7NV]U(ZI&P<7KT'=M$'7@0]>7#D MN,LX 3A0X@8X_8*'_=\-C0K%\V;.7*%!I%#!!J0>"VHPR7). -2\8]Z=K[S^ M(.22I,E)IG-?ZBA]^L$-HO:]W@HR'!@QRF:()B@X-4FS7:Y-W??JK1I-!G7I MS0KI> + PRR^ BAJ!FR0,4II $_<\(%73!N.CA[C.WA5#AYH/*,/G4A& M/0U<_K%D54%&DY8%&9YL(#;*IHH@-T M;&B,EKNLRCJ ZXY'9-+#;GO>< ?R1X_FAB&M2DV)K5"@14K;5-]C:PG/9)<& M*]#X@!*'=!ZM%U6_Z)796:9EP%?)RTUN)7I;I":T8&?./D)JYD]QI2PFE155UK-?I(HY+M&WE1G[2Z^Y3E-^!%@]C2 MDVRUKMA!&0# ].!5IN$_F56I7Y4J6Q5Y6[;>V^ZW@EPH[Z*[E!-CFQ_R.IW$ M1=%5%165TY3:@:(N=UH[VM9NJI9&*WXA7"HN0W?],6^;YYUW6+O?WMF7<&S1 M=ZV>?G7+LR[8MRZ#Q O%NP2;X%_Q-/TCPC.:LCV'5/QSR\9NXK=?PHJX47=N M8X6<]&%LSWWX5%HZ;G!?(QPRYETL&5M*GVA4$)HAB0G9B?GS,QK-MU[P]!UV MUPZGJ_C0*Y^> R6E;HH:G!$487F*H\<5S4I3_+62,D3Y"86HJG(3/3)L?F6]B(&J2HAT@4&B M7AOU1P-AW4)=<<1(L%33X\C1/[=)>PSVTU>%[G]"ZP9GBZ-QE\FFQ7#_VL MJ=VC=4:6Y]WDSIXJ07-W.U%>37;NMBO;Z=;=G "6L3MEDD-8?!)[B*=7']8A'^3O&%@X! <.-:SH^5JD3]1>B728'CNZ =X M5( MYB G/[6N[._@GKYD_- O7R^H## 3'UJCR#,](M=YA_>.I( M+D2)2;Y4'_VZAAO-[KG8\^J.%M=W45:OS.W*+D[&F@[U^'V_-;T]=^NP+KBG MCV.,/_6M_'BZB[W-'NF5-M]J?"KV:?\]]ZZ<9"(4R?L@C3__.B:]NE/]S/GA MM]&LQ)X5UDUS3OS\TXCNS>.=*7D0913\VYJ)ZOWK_EY9]MZEW?/,WCX=?):& MT5XT LU3Q>=?P435=JJ'F2I]^[5/59W"NKG:TH=Y,'DAT74'U+H5\U" M:IYVKTDXU^Y\MMY-R-"%->HJ_F- 8S)9N%=@5C8<$ \&9J)DKWW+L5EW3+8T M+\IMK.R+UJ?FVY),DN:EFHX-NGQ7MF*"**_2.$S7?[(U>+G^::.Y;%UY6#<; M.@%?JM78SL"$WG2HI7N5MF4K73+9W(1RL6,X&J([NB-RQ*/JC^<>WE^H\Z_G MPL3C_G,6ZA4LG!,'P*_;'XT3,.QEP"Y\?SNY.WA9P9HJ;\=A5-&VCDK@4#P' M^5YCN*?SL(2(![4*%]PL8>T1JX7B+_QRCJWY"P/;H[J_>CNUW>2&Z+_S(NR# MK9NV,L]U'\%TE[AK)7]GN1M*<_5]D9>Z9-6=?.DE34%#5VUS$BH^@RV!>W<.\Z+.4WY0VZ[2HTR?>DES3E#5VUSSBD^@ZWZ\.Y4W'FBQ)9F'>1) M\Z+)R>$:ZG$*)82T_2H@K4=;UY,;-.1USFRLZ&!*3&X%W2JSJ0:O+IL@[!D MT:7$[I7<6A8 8AP9P]9W]I'7B".]DEZCTG%L:WM39,)ME?>OOZ3M[\0NW=$Z M@.:BR;^'Z"4%EGNR N6DP_TN+,$V)4!E#;;?M9,LPO8^C^XHX5WU4$'@2(R MPML0PA),%N-%F8,-.WFK-F&B#*_.,&RF?[B@<"3VH=$OJ'68*,2+L@T;=?!6 M+<,D"5Z=7=A$^Q<3N_T[.MZ^0J?55-5Q!%_C\'%M%I'M_>NHEJKM=NF.?-1H M%B???NL7$SYMRKZXL7?%S61K>$F740J.N8,\JXHHKM;1XIH6R_?:4'??8OC- ML C3R<.<"K\R! ]7#JRX=>*W#9!>"P2:*.$I^;_3J'@9$91>N_>=R:K[EL3[ M5B%,5TO;!K]B!+2)*79$F>T=7;M"0; MB/%J+,GFNF_)DOP^0G%.6 >D69G&.TG:M'_O);DBK-VV(P_D\&.OS]U@4W4\ MH6>WMP6/B")BWVQ ME7I)!.QVSY)^RA):]+(.+ICBPU?&+Z%7>P:J[D23@_5#XPKY$"W@AG_:5 \E M8GCC$'9P[.8DC'S(CP9!.T6*Q^?/O.:B04*;"XP5M$&8<24E2+NC.XM#9KSO M69_FO:SI.SGY^<][N$+:@ M='L7\(RV@D^2+2D@O2Q+R[A(.9Y)/B?W#2/\1])^C;")1![$]\BB_N 3CG58 MI?]A6L:+O%P7NI.KC O,ZK:$%.MX4QC2EMY?E( M(Q &MK _IM7=IRR_*6EQ+_:N*[:&7%(80B8+GQ;LO]9%P=>),BU;*<\S2#B% MA>-\?DAOJFYV*BVOSZ][,]3^N[2UZ_X^C27@,(S:X[G:LA*V8*0ULU@Y;JK^ MFE'B6"JVW&'73+5R3HORC%8:$[C3+_I!3I90K.ON\+P*;"H&UR$QJ M6FPNPYY:EVGYRW%!(;B%LFZL)@)3S1X:F":E;,!4\:(&ID'@,3"!='_.:-E! M1A"3@E'OVE'1$[97*\1X^M.Q^'(SS^F)V")INR(6-X6Z92Q&[,^EQH4.ZC2$V))8+*24HI426.BS5-VJ,@#@Q! ML-9!&[Y1K]XTZ5X;%"'TXDT,7:[(U$9\8FXS!?M8G-8"&B.WD=ACT(HG!N#V M%6YEF?7C.0HE#]C#4AGT("KO='M7_I/7C7]/F,$NG_T=#31ZPDC[=_83Q'.5 M:4(+ON#A&&1 !!ORN[;I(;V^U+WP^ MNU7?EFP+73 V;<]H$@V@MZ.'G-]R R$H3;-[=9PC;WB/5$W3D+M5MXUGKG26 M_YSIF&;10O11Y[,6@=I.BX>MB7#KN9MR^M7OC7UJ5&;!**+2""QK.I+L[BZRKNQP/C^FZIO' M$8&W>T:E8.VMXN#7X,.L%4FZPA$T<$R;4_.MH;?I]2F+ECG;*_T&(1QE#*Y8 M^RQ3,.&S[NXBC\>I6;A%CEM2DWL>+HZJVAG5R[+MDFNOZ6/U8:$*DG?B^CG) M8V_#Q;[%1X&?5%739XK(.H]=CYETW.0GX">\@?\.,H8"=UQUV/H9T_M5I3/MRE\1V)HXS<4+!0 M/*3%H,<_<7H!6QT)^$DQ!-K(]D2ZX>2_J-5L*9'(@1SL^>EGU)2U7$9]U9<53 MW7F6.\Q)$]_UH/6@N](5MM3!227?VJB%5$D;-/::='>.*/*3575I;&V&ORL\)_74=:D?> MSK2CQB@?Y\49?>AFH 1S.PLNJ#O+JW!*"H+1BI71!W"4U,QAAZULXR>N\YYW M7S]H&@:D0V:65CM@97,CRA=\ W>;6W[M>T$+?B^C&KY)#: ;SDVD M5UX2=.V0_HZA:TD\O$986^3*5K?4SW@W%<@:#\\X"\V1!?.8&N2UC.(>:7A) MPTPN_=_^&G3Z(2I2V QL,'PJUIWNUOBG9%JNG M']OR+M/U4KFW<6+$/(A6J97.J];/&+'_$_= 7801*=LVNY*(J[I5!"/5%?'_5>>N>'7G9$WM>3A!EW?H(^R2#UB@&$7#9$58R',EO *_U7]1!@;>T&XSU\L -]H^V1!^$'>=BH^JH%V$]:0 MDL]W6VSU;KC)NN1)/=Q;Q=^(RGJF.^P ;J>F'\\0*9="V(0A%'"Y[@G+&@!IQ<:BH/,% MC:OA=4W^D/5!WMV"=W\LR3(J?F$[DE7$MB)QNH)BW>0A7R_@D]PM"Y7,V+=? M\"PXOZ=%%UU0YP[L:!XHO_4:9X))T=<^%TC.E._'DC!EPGE,FZCSY((-#HB] MJ!\Q@LL;1=$*9R9-2IQ[,L.6,L M[<$=:$)X%$-][Q1F$/LO M9]07*VS#R?[OAD8%_"*/I)4%V7"ZRJNW_L)5)BZ^X79PWO$&&;6/]+??(G:: MH^+H* W1Z'=?7_=@G65_;PQB>4?9&IB$\D>/ MU)K=E/PE;MO8-'2HQV@DY'BL/HY&AOS4, 0)Z1%U \[G)QFOR;F&9,5YM%[( M8Z&EQ#4:-C'U]S5=S$O:\C)KQIF#S)+S+,[+.%^QC7JL\=S))+A&0RN?+F 8 M!@)V[-P3Q^,>FS"E$",P# 5K*MR6)_!.,EO3%'EI%@9]B(9(>WX7U;FZ"PKEOX47.R)E M>IM!Y>7ZV[#+;KS<$7DHTJJBST7+?2AB:OV"=C#OT\#^ BAX^LTRRL)LVZ_ I0'/#&L1/"2 MSB@W Q=HLNG5,N6S.?*]G#&TY[)9!U*LKD'G(00,?A@_UC[K+CX_/'4D=7([ M+_W97-,V'M_R'**^K^^B['SPS@HXY,2.74:$OV\C0Y5WQ55!,MUIB'9<9!DE ME"3K@F\K[OA=>9HGL,"+L/Z*?:R7UK#.TNK+)FF8'M]R[/6^<::IU[ UJT$ MED&<2@0"-\4?_S%?0\Y7*.0I7D_U/S.[;__.YJ"DN-,*QZ;*/]:W8//E>_Z& M?#-N&@N:A%KK-I#N]S+G-N\:MS6P$(S_6 )?UY3F/Z*3YO M9FM^M;0J\CG0QG.M<$G%;.3F153&B3)#\B5F,E*?%BY>+JL43 MR6\6\':,"#SC!J=+$VF[G]]XL5$KX;(Z*DM:B1I76=,NZ]&[G">!06P;)(+! M6)?\0@Q"67F?%@/3$1=IQ:Q91#(*M4%C=^U(3_%.G:<.0$9D.=SMN&M:RLH M9N+4%I -ZH;B2V/,CQY#7T7MIZCW.V"^>89$7C?'*T^$L;K7#_EL/N>9?]IH M204-KJ'3"[A9I&3UP YS;8-!QJ6I-G20UR6\H-Q0EX_#+<:3_NPSC1W7:&XD MNU11:W "B3I;N^+L? ZVQ9GBKE :+QB0]$JMBL^1P,\'-'T"73&E-JXC'TX MN EM+#L.LWR1PZR&+3-(,F9H,UP@993257A'IV/V'%Q;I M(E!B1ZT$G.=T@P"_H>SYGF#Z9*:FFP'[O\,#Y8]Y\0OLU<2C;(>4[;M3.:5- M285LS TB2AX(0=L^19<(ZK )[U"$@FMGV[98.7 -C*NXNN3W)](R8MEH-*F3 M%VSM%<42J1RTIB+"-3(&"2W/R70182O.6Y_D@DR@1HM9DJ2@:;1P&A8U./D;\4F]QE2_D\=(1XAHIBY1ZVU9$#_!\)6?@U3O" M)% +'[\N=[K_*ZY^5XDFO5%8US,*FNYUS79ZR454:$\T8P)<_:R13@Z38&2$ MTX7M[K_Q%S(T7=W_$5:6.0:B%( M\W'Q"%"@ERF,SSRWA6I;=]@UC>^R]->U\JFUC=O"A<#G*R(_(U3&1=J^#GC? M.A>KAA,B@9>TNLL340H=BMN75;KD"1CL@UWU0,M;V6F@>_$M5_<^SP;5+JMN M) RE\W?^:5PX]:[W:Z\J_1HFCL,C[KN>0 XBO.J)Y*Z_?D+U2ILS?%+>"@^8 MZ4+RQ4GP'Y-MDM,Y^F69%_1\!??ED'GS=+S.DI/3"YT;VDR/"\9NPDJN:L%% M\HZ-S(&/+"["NOSJF,\FNN@X+PZB\DZ^K5&2X1H:HXS234T=HMI6^X,H$*BU M'L:AEV<@Z_F*%CP.\^@13D"*_;^.$-=(6*24_&_,SD'7L^E1,_"*^,"!J0V<2TK'U5^%7/ MFB!PGNG*>KNSXAJTR7*/1[%I@#\DKR[W71+62-!:PU8MK\ QHBO_/8G[A0VO M0O2-1EBT$W20ZSNK\_DQ51C1P:^X!DDEFO0N1GTA!_YIZM\\KLO]VRA:_3S$ M4,6K_/-+&WGJ.++\_.[GQ1.A M?@M028!H+-1R20YG3K5':KJ@G:SO773=:NG/0-W8NZ,V %:F0M2]!N'&7=TC M#85?OOA,?<+P??#.-HHEA5?GD*TV?K(P$,+YW=D=CT8NY>[64_W\3?!.=Q!. M6;"B)OV<"&(RJZHBO5E7?$/)CN$744##W9N#LRQQ&QT;#TYK9!;58)NX-^PH MY*3YOLC+\H*78E2-1^]G1%VODFKIGO6QR2E-S =:0 MAN[SDRS.E_24@<#8ZQT9QGY72*?O>4%,O@#R+P-U?^-%KE&@ZOH1":)NUTDF M)TO6CNZ:,%!?G^59/@2*H=>UQ(CZWRZCX@(^E_!?,X6: J+T6*\ZI7(7.B9" ML/.WRZ8,?F<'K!YMJ&U,E&8E&#YPJ1\] A[6:7DG''_@-?I YWE!?X1RS>?S M.?Q-/-4'OS57)5 ?3KD)VE;CB.;:]G62-F!0!%LL1E!U?/@-\+1"2WODAG^' M\ ]!:;WF%])>8,%77NH58OA9[2B@[OI0X@AYN)?K//+ 7/%GS0!MU "BB;J9 MW.KREG7LH&B'B(;V>#4;NM?\"-?$@<>:+>0%C4IZ2,4_3[(NZ:9W>%9O+IU8 M$8WO5(GES:C@(U\T+7P)455=(Z37"IH!K_'D353^% /I4%PRHATTEI^-X]5C1C-.%"+9L=G#U^6B6)3P'5G^_MEE+ MJ$=VD@*.0UZWV7@#N$^7-T>"7OCIK9$BEM&9"?7HZF2=:FMK?DP#!Q&6D_<^ M,A_VX=.)ZSZ"/!0U_);GC%80"']1Y/=I0I,/3Y_XT[:MMW86L[V9N,KF#UFM MV=_J'_-,.;S/:Q'1P&])$D\Y-W[>^1[@ND M^T0@R$ "Q9.H33$?!4NI\& @1S38+E(J"D;6/. ,&L=_!1J=BU:-L0=,.5L- MY(A&QT5*3:QDJ7;4(;.WQR(!>HOVUK%%1(.\)44FVMNV>;3V%H1G.W_X!X1@ MW$<+@+7PBHTW)RJ 3.%'!(>-Q):"?BJY9(R/%S'."*< N,X# 4S]#XG#-W1;5VJ2PK9 M8+JCI(X:XP#HA70IX=\P!2TZ7HV1X!9ITU)DI:86&6]+-:([^1""%:*(O>!\D#^R+I?Y*(;Y+11_=(^UG"O[O7.KC%1B:4!=]R:3P>@:+< MC^[D0XBLTV[UVS(>37#<:[V!X0XZ@R!NG?=<088(#R;I;-'H>R&]Y+NK-G\& MRW')MDCBT0/5F'K[.**5S+_.VZSOSR79:[(7>\+4 105$X?4\O#]EY"(_2N7 MZ14\"J#J\%$]>J\O TR5!T'R+*IN4,Z.<'*]M&6@UJV74+(#5[9O7K;17D[LX#.(=J&[U&Z7,!3?Y:&9=8I#R)N7 MY_;B<5[,:M]KA9UX1%$W:[1**O>]V>,250B62./F/M=C-#D*-L\FM M8(+1YL+O$B7-UQ!@9'O[#M=3C.=/O\Y-GI/&WK9^EL?,L&*[G+2?V3J^M_=Y M3!8W@-9;?://OKE\I6A7;)F\0WZB#*\)]YNJOE/P*[>SKW8&M-NR8/B?),%K M0O]FBN\4^XI-^HM%OEOOPQ6P[UV\XZ=?$M:WK+&'@RC(\EJQW3NHG&15D69E M&FOCH';VL5>$7[N.WLZ=[?>#1D5QL6_L'7IC-PC##GVKA>A.OH8-H[M5TIM9 M#0O2W]%SW.$=?:$T5@7\^1$A<-!?G=!@2"-04R(R=18!M=%_-;TI<:#_IU/V M;^S/S9_8_X )8W_Y_U!+ P04 " !-=PY+S<&??%4T !)H , %0 '-C M:64M,C Q-S V,S!?<')E+GAM;.U]6W/CN)+F^T;L?]#6Q,;I?:B+R]67ZCF] M$_*MQC$NRV.[NG?VI8,6(8E;%*GFQ67WKU^ -Y$4+@F*$)(NGCC1[;8!,#._ M1 )(9";^^6]/:W_R2*+8"X/?7AV]>?=J0H)YZ'K!\K=77^Y>3^].+R]?3>+$ M"5S'#P/RVZL@?/5O__N__[<)_=\__\?KUY,+C_CNKY.S_.W[*?A->>#Z))J?A>N.3A- _Y!_^=?+AS=%'9_+Z-6#< MWTG@AM&7V\MJW%62;'Y]^_;;MV]O@O#1^19&7^,W\Q VW%V81G-2C479/9^\ M?W?T\[N?CM]-CM[]Y^0_WT_.+J[?/"TH(V=.0MNP/__/]V?O?J'_.'I__^[G M7W_\\.N'=_\7^,'$2=*X^N"[IW?%__+N__2]X.NO[!\/3DPF%)X@_O4I]GY[ M56/SV_&;,%J^??_NW=';__/YZFZ^(FOGM1WV5_+ MICLMGQXBO_S&\=N2G&ID^E=/TKY&2>S]&F?D785S)\FT3/F9B; %^Z_79;/7 M[%>OC]Z_/CYZ\Q2[KTKA9Q*,0I_$/F2>3$L:ZO2Q5A'_X72-_D>4/G M3NPQU7\U>;L7K2>.SZ1[MR(DB57$<1L;H^;&B:@@5B3QYHZO11JW9Y]TLHE' M&$SQ;#';,-L$@%;:R0AUL\7=BHIB%?HNM8YG9.'-O01,IK2W*6F>.O'JP@^_ M*751VJE/ZJZIC8W(;'&2QEY XIC.S!,G]NAG;R(24P) X.N-TJMTT_7:B9XI MFMXR\"B(#K4N\WF84O,2+&]"G\)*U.+6&J5/^J\\Y\'SO01 )*=IKY+L,)D. M,X,N'"_*-@&?B1-3/JR3D+H^#>>?#[XJ8YEB'[ R-8V,&P+0**4]71N%V"T0GH>OA5 M_HPDCN?'UT[$=F^/I)]57S3JX6>D+G_[C7IX_EZSXZV;^A22*?V#Z_DI(^B. MS-,HF[#G3W,_=8E[$85KYEM(XQZ.Q[LDG'^=;=C:UCN?L+&Q\*KE_.S] M0\;/ -OIY$20&:DUB''JN5:N9@6+MNXTJ;K/@ENVFXNHX+,3 %"E#_3YPTGL M=.4$2Q)?!C5Z__"256U'\R4('V(2/;*5\3*@>]U^A-7'EP^I6=M5D^X4"B.] MNV':5X'TOF+,*ZB[0H,ZF_0:ZI^48?UE-&]J/H,K^HM&%_*4D( >$L;NN*' ME .712#)A=YJ"I3^,4;I<[FV <.44N,RBBY\9\D7?ZL)4.P?,(F=RZ4-<9_2 M0P\CPXOI\?:_B!-)%5_<&@C"CYA 4/%N;^'-@C=/*2G+,)(NNZV&0!1^PH2" MA&.+.Y]PO0Z#S#.4.8_JCB'I-DC:#PC/S_C@@/X0^'YA6 M$R &OV#"@,NES3U2;C+S/<,%_5W,%[VD.1"&CYA@4')O'Q*VBH$!J34&G];P MXK'#.@>-?[[E.HH,>Y'X8>$-M]'[R>M)%;%+?SX-Z5>"F+CLISCT/9?^S9T4 M(TV*H?;5L843/V1XI?'KI>-LF*+]_);X25S^)O,SU32N^/6?M2#H"R^@-'ET M0H2QIW V%=UAO?>>0CVPEP54 1@IVJFFT8YB]CN7M,3;G$X"ANKS'@,>=$*2 M2_HCS[ZU6:BU189+0ZM$"-3(K]PV2% X_RO-]X2;,&#.^NF3!P&$WVV(V/ Y MJ;DT+:+4HNTL7#M>($9'T!P9*C*-:X$D8&CK]+D<0G-W1($D7$S0Y4 MG\GZ@422^2/K9,WG*)]S![TO3*==8!)TLN8>ZPR3E'M,,$V[P"3H M9,U!TQDF*??[PB2X:2Z^/+U+-R3Z/ M(=5GM78[6Y?KDNTQ=WKP^<,D^^+Z 0K!3G-K-^QR"?-@$+"* PV6'3T-7/8O M-N4?'3_;82:G3A0]T[F)T0%VMW8U#P(B[,(2)A"+-(_XELR)EP4H7I.D MX%8RLZ2];.^M=2"#\(\#J2KGAA(H1J;9RMH5?P/SAD#S=E&P$B>-G+2W;N\0)EAZUR#E[U"SDZ:IT(?T4ANXWS^?=7%?6!-+;]KD5M!74 M$02F&:>::A9C"O1WXB]E5M5R,*CISD[918)7?FQ7GZK@(]AV1(#/O+I"P3'+ M:E2#C\2R/O9B&;K"($01];FY/'+<.,_LO $^;+7;0_$RYL@ ")Q_V.)SC@:= M**4V?8DDD@&.ZL3P<+\F*5+ +.EXM6-X* M)ND$A %1>IQ8YFS9@'01L;@T:MOTU8D0RMB@W;:0F%PYC7H-,&B\.YE\&IL_$21W*A+NP 1<:8ET ;&07O. "Z987< N*69:>G M\WFZ3C,G;NO!CUVL('VAL!ES(&C#!I<(#@1W&=39,\ 1,N84Z&%W\%+V@:IM M4_=P"3C.6#T)4-GTJ@,(*A+P*QPWRA,<=RE/,/FA,?+_&LL5C.4*^.9Y+%= MQG(%YE 8RQ6,Y0H.B\I8KF L5S"6*QC+%8SE"L9R!6.Y@G[BPAZ2RX >!K** M?U\"9QU&B?A%#4 2P$':$VUNG&B692QZF87">4#A- + M+7%_VY40P/CI"00CB'GUWVF:K,*(*1X4O-U^M@LB= 1-) "\8%W&<:H+5-G' M]GY]+Y":C.,%2%Y;7,)@E^+B!N_Y]X#*<#GQOO"Z\N@FR\U$FO^!N=6UHC)D M(]@^=75$4"T40QO[)AEGWJ/GDL"-+ZFP(N)$/!\?ZZ?N9KMF@AH(&!^8)E(M MC$1_(PCJ;/LT#)X^&J) AQU\_R?M9+MB0A>L<._\=@A5;?N$'6P[,KIC@W'# MI_F2C(BU+EL]T9GO1]NLB".G&;9PB+M9MLA MIQ9^>\$!2 $'8)](0'GS*:53=^T%V:/9K%J"$C)E1]L^.%W0@)+ =L=\>F8 M2TKL9R?Z2FILR@(@Q'UL^^ETP5+SCP.G';XTEBK[?CA=5(3F/;;KJ.NXU=?H<.Y748A$WNRKK5RLTDH*MMCY\>S&!9X#"FET%"J#S5 MV\F=AM;=?'!)[U1ZYK&L/PD_YI,P($OF3K,_#;=UN3XY7L ,S"S8_D[ZH &@ MJ_5"J%WQ!HO%T$7P- ^#RP0U6VR_3#=:?SA1Y# _=97;)PD89(-U',MZ@51M M[/9@]J5,YR;[1?)9L&3^/Y8"6C(LJP /'L%ZV=6NDUM72,-7"V;$8F;%"+5C MYT],8*D7K_(417E5/$!7ZR5=NRH"6"PX]ET7842\99#7:)P_WU-K%E/FJ)3+ M1>J$+&B;>^=)C*?6(-8KPG9%MH.H<&": M-2_,)]Y#Q ]E"M->OI8_H:H4PVEJ._:WR^P0$*GCL M)83NN1Z].4MMIRS>DGFX#+QZ9B5OM3P0 6@,NDKC#@P)HF4AS^D^2R.V5<_H MS0HEY(]@Q5E,2NU!K.P!ORQ:2;&"=!_6=H:(WF*SK_A0:T)NA_M7!?"XMA-0 M]M4%30$./[0+8D>+R$=5_8P.0]G.C.EUN>&*"8>Y,!IQ8+\FC2K6P+:A[GR2 M^_.]_5R4/S@'G 0)3N<]93@-(!$5JN.0; M)^99M3)UY=^.&WK30: ML0 _=:ELP\:<9(,B*6U3NV*N^-6Z^.?TLKN@,8)NHI 5^7-/GK]00"Z#*N%Q M.D^\Q_SE*G4^8(>QL-3'EJ"YNT9VE!B.A=1LT*2Q&-CN4A_,%J>V-[X.@SEE M-UM;[D/F1PGFGD\:Q-^'OW)67H)&P<>L*_!5*?-F*[E6*&K;9]$M@! M27OK-PHV)KM2?L._E)<%JN2_EJL-(-Z%,XSU:ENV=KA=I#U\):."C C=UY^1 M_-^7M0IEM>52A#M?K3Z2Z"&,B7V5PE$GZJ5Y7+N4F7HQ M-JD25Q%D!7J3!3R&_=)C?=WOZ$L.Q[EGE^[I/-^&TTE%J+&4IO/#>ELO0]8! M'!6Z8BF]1"MP&3Q2*8>1YGZDTN*TO5%4-!-E/+2DL^PS^:<%F- MZ-F^XU&7UQM##3<#"B&0TO!U K[Y/@T#^HN4_JYZLE(>@[C7N-;KQ/49M=B# MA(=>-5(@!;9YBWL*5I:.!=4G\^4 ]@Y7!L@,Q[D63G\OM@4\+E07S%7=[PYL M5PT!VA9\VE+=4?9@(:1C0;7"? [WWA8"(#,.%'R#$=QMQ<41G.%VTW *)(./AQKL:XLX3\/ M0(.!*>@*1=28I\ (HE(YX8#UEFR)@(IH'+ M_L5J7SPZ/IM:>219VZLJUBJ]4: ZA,FOTT5.+U,WIG3:1-$SG0U9I*&N4NQT MAVJ#^6J1^VJ#0#(OHY;D(91!H]K,L?E2CCVKPPLK*I1N-GXF)LH;QWV$813N>LGJ71HH >*(5]8?WAT* MJ3&GDPE(=:6'YG'3:R>AK,T6)VGL!21F&LC>8XUGBYO:MRJR&X5-?YZ\GFS% M0_\C'XR5+RV'FSB!.\D&9+]M#&EO09E%2R>1M"MHY>G%/=>Z$$O)5+(TN8UDNCMJK?K06\.ZB16,R M[M+UVHF>9XL[;QEX"V_N!$D1]L]RWZFTYO4H[X;)^*5M,HK!LO>/M\--MN-- MJ@$M.F1VN ,X8B1];&ZF99@!IC.TO^4IK$:LO;'6D@N:N^U]M9.ILKVB[*9D160@O6U/"OD4F\4Q-*1!9K9D)4:+!Z0 M."-T-GL)=U8-866HB+,@*W&WQQS)8"++& M:(]D>5[QT>+5P>P@'S2SZ\+QHNP"]3-QV+3)R.7/KZ/V_&)])UGG2:.W/76M MN-G2"=C5R7M9G'T\P@!33='-\KR"8-2:92 YH)E2>4#;DOY2M($[>M^>2LT^ M%B]MPO7:RXL9L9"+.E5:-S1ZPUB<8JR"TI:^YYJ"B;F3];$\N3KAUYIM:I&@ MF6IWZ4-,_DKIH.>/XH7K>-<_47:;%/ULAOHT68#$]HAZ6(U8:A(%V1&*N]A^ M2$F!R4X\DH)W1/,%XN63>ON./G3W]DU^*'^R^>C9"W+\W1*J<"FI/4V=D?<, MF'V KD-S]X&E@2,$HG$+ <9-WLOVRV;:F$&$@ :N.15 GJ%RZ\5?3R/B>@G[ M28J6N)/M9\2Z@*42 0ZLOL1DMCB/$V_M\,-7BH;M=M9?[])%A,^HJ1KU15W! M9W86!UJMK#:[NI_UU[3 @@>8_$ MS>O[@1>@;J-9?R%+=V;M(S1#\^]W)_)8O-%I6(0EW=))?T8>*(WL= Z;C+J# M6'_@2FMF=A,1CFEZ%3I!S7^3TRKS0G&;6W]'2G>B2=G&@0S_M;-9&>ASF>V* MJ%6X\9U B5NGP:R_WZ0=>M%=9#@P/W>B@+++DI S7L#KH[*C]8>6=+$$B@(' M;M7>#+ZA$?:P_Y*2]JY%P?U+*,_ZK2:5* SHCW-26SK N.N/9/\M)%U]Z"HM M''/Y)O+"**\"<4OFOA/'F7,Y$W?UZDHMZ%:,M?Y(]I\GTL6ZJ[0&=CMQS_;W M@KN)'_>YF\@''F\F^MDRSU?$37TR6TPI<:[GIVRWEY6$RR(/SY_F?DH5)*_E MN-ZD9?1]>[,!N4@T\*VAW7V8DS>.I6#+7YM@EF8QSU[JI#P3-YO%6DJC.>#@ MKECV%!TV_*LM[FD:,7'I ZX:87#W,KK"0;/BUT+19.NB/:7@ZU,-Y7<&@,)RXH6S48$5ESLC"2.Y\?73A1EIVS^'F6GD(E.L;')#\5')M57;.YA MQ@)DJI--283G/F5OA,U@\D$N.D/1 .!*7:V*[IK\OB]ES9:\WC8.D4M"XC MDOT@!">KY"MN;ST_K)OV->H4JZ31Y[DD)O,WR_#QK4L\-L4^L!\80A]J,XO^ MZL\KLG3\\R!AGCV^=:.M=AKAF!%RF\:CNW96.9B$\^^?A6O'XX5)TB;-%I9E MRQ/;CF";%.]I//I*R-^^9UN?CR?/];_(5W"=,88P!3JP5;.C2, 4SAP.=TCF M4 >Y*X%#-=GN5F&4W)-HG<5KT*_)YY6@.0Z48*<4/@>UY&A,:*BFC+ #$D1D MVJ4"IJ=Y(MC17J=LPS9;W%"="9+\Y1#!9I;?U'9]):%CH;Y3E7%I*,.Z_.3V M128-$8LZV;[WT).VG'5#J_+;$+6AK^X( )F4IHSAN MA'"]2VL/+CU^,"%8>T_J+&673'E26$;I-?F6_47JR@5UMUVR!8R@ECAP(%C6 MC9XM*N*=8$Y.PSB1 "?O9;L""Q@O"/,X8,IBC\G"2?V$%89)B@W@=,W2-\0X M*;K9KK@"!@K$ON&=VF7@>H^>FV:+*:-$L4GCM+==,45O?R9D&$V "R-%Q0@ M\'[W30>-A%Y4X0$H_*?&O!K()TQ'&:URLC!>%K[TOZ+F#LF @=0*[0 M7,U#9:R)S!6ZRWM6WNC:62L\D\U6@\2&RPF.*_N2)I4_LMT.A^'B:9! Z&:= MCF5F3:UP%VUT)+]*E_>Q[1GC:T;CMAS"-([#R'=V];B7F>IP%]G+;?UX%XGO M+E)@[F;!/(SGX8;0R2^U<;R&MKV;8FVI&SA-%%RN+%2Q>1Q"NM/Y2M.S*=72[?8]U5;#A0YV=LUB+?3IYW'MB;?G,B MM\CG+-)]F?7/?2:R&^C>/V5M2[.WVAB3.PZUJBKCW#K?/E/C&'F.+]D)"9I; MNV7<&UXI_Z8?#*A]\R[T11?IXN;6UM/N8IO>BLP5GEF^SW?GG5$- MGR]M7-#(6M>IG&S)G)1T3AC0DQJEK%-)ZX02F]=)J3S)W[W_>$P$ZU*=;[:T]#>O+,'T#NYC'ZT0'IA5$YX'!^\RF$N,/5/7$@?8 9!%*;'CWP M?55/+PK\9ZX 53XBO[5M#SU4?7=*H8M9-W36:9:/)/E[0U+'H;2'[7!67<$K M&3(J_,(%(??3-MO8=M%V$3"731SNE3^R1%1Q8FW1KM7,=@QI1_/"918'#GNN MAJK0Q9Z&M[VL@$,<>Q7G<-T]BL+Q4G?.^][<.1S/3$9(5B*H(&7TU?3]W%)R M&5#%(5=A'$\?J62S*GEA[9*I*".<02'F3WN@H;W T5%2.)8-./'%/.L#Z&HH MV\N!0:Q;XL*!]A_$6ZXH55.Z77>6I PMSZ^)9VD2)]2B%L7I)%-:AX]X.0M7WQM/.@(.$T,Q+:&C00%\, MKMB[\ (OIK/H4QBZ$%1;[0=W2I$SCF,YK&C\%-&C% "4HMW@#A-\1CO/KB1, M'!_1W*I*F!=1QA H.7T&=UI0"T ?XH\YQ %9LB#^?4!6Q646KT3FI43G^7^H M@C/Y?89S5 P\\+FIA3;MAYW !7/"4/",K+E[IJ P" (ZH'L@0(Q,YFL/U8+ M*U[Q0?IL+:KJ%"_@!5M&TO;=/T5H,;&B9\+G $Z;9I4X7FBMKCP$2F70I0S*9TWU!* MO3C.MH>)(CA3T!:X%_O%U%Y,KBGU(XZ4V1<5 _O1OK#M1;YRORPORB+O O5R M&COT[2GUGFNSB(ITL5A EBF]2X%4]H!^8,^F?0# 4L!Q^#XCD?>8';6J)]IJ M#X4WGOB41S%K#P3%U)A[#(9I5_8P@9P]\*ZH($:2: M+XU&.$2^HR8\0??T+ED_DO[L!=XZ7:MDW6IF>P_%T8^6I+E\X; EGYTGD,B; MS<#WQ!9ESF,,A\R_LS)V^BO ^(S66+I.?CBY7WE1_AWI662WF>V;)EC9.A%[ MAHYZ]]_"Z6)!=[R.RF?$;6G;8P24J9A)0V+]]RP_0BK/9A/H&+46"W@>42RTM$4^;FWP$PT8&6.O)>HAP^-P^!F-9RFY#VON*(_$IZH$#UD?VSY* MS=FFY-XFPH+EKV4BBIFN13OF/ M,95P=O8X@JY[TB&L7QWOL^X!A&-H;PFEHRP\ 9IJD&&@>&%P:705$HYYF'DM MJQ>F\](\]3H\"C\?L#L43]ON$#VN,.%8;HZ+/1DP ;GH#>H,Q="VLT2'IP-: MSW))_MV)/$90YRT*?P H.K:=)+I\89ICK>?Y&JY:>W[4J1L'# "7.7 M/L3DK[2F(3<167NI\(UN>'/A(!=_X4T:S5=.3&:+6NE3Q5V@J!-4ZK;=$!!>,"T'I[X3Q[-%0?(L MNF7U+1L79]4?X^*OL>0XVW$X*+JVG13[<8D)]PO'BUA5(K(M4KJE68ROHIOU M]#0]'$%"P(&7].9T>TAGEJ8ZNV_?))"&:NC2?5+:4'2'V7U:9H51XOOL1^W@V?O+I3?K/\>0U72%U#1 MIIE7*Z%]IR&"X#5P"1L!ESAL-9X"W4=X+0QA>YE('%GB!ICB$N#R5O.KG$9%TL1<1LON2BE+>J&(2)-5^YR$9A&X/QI MOF+)RRZ=8=?DVY8L%0:2CAA"R3114(H!Q^:HM7.#W.!)NF (+.NZ:<54/!AT M:?$E<-8AI?]OJF-YC9<\&AMT92'NC"&0##S7-,2!@[I1.C+R](PRL);94OYBT(_ M:3OPXMR#5WZFZH#C):$7X+.3)*:/5:CM W(U5J%&4X6ZNIH[>:[,4';M*J]+ MH>@V-)04[. H4%T1V2C^Z##3X,Z"6W9[%A4/H<9?@O"!O8##>+X,-FE"_TR/ M1UEM&8I!FTU5Q8L#?!J'RH"F@TAYS D'136.XL)>57NCU MM(S6GV87ZA?$498_%K:V?2US<*BDTC",V'KM)7FBZOD3/1+0@\L=N02-P43-\5822D;"["L]_LY MVR:_8W":"9EW]IAL\GBIQ(D2 W[HKCP+6,X"O6)!> S[H,'OV5ZT-.*5C4M] MV$9,P&8>.5A6ZS@C^;_[-VJ:G[>]K![&R'7"1-_H]??8*DH5SF?JP52V_!R& MD!-K*MJ4N4V5-+H&S^CA9;O9G2UDP3)&OX@ASN:@Z[!4\L->B3$=)_Y\CR-Z MR/*!@HFAER/%>= V9G:N8;-4D%56IYON81?>W$M@#_K^W+YOK8_TCTDQ%K*G M?<__2BF2ZLO4=CNKF5!TX0/=OF)B^>FG&R92=P;WPGN';6@$K^)KZ&0P>X^KM3N\@$_R__MM+8D=FD M^A_B@K+O-T*WN^Y;+_XJM\3R7C@F)<@PRQG!\>3DEL;3,,CV6)"74^2]<$ $ M43XA8#RV4)C#5@3W-M=>92"5'>T[PM6:* ]G%PEC^#6*VR\.RPTHOS6.60DR MG'P&<#S *'_\60T&+B,I4RP%*&:?7>0^1P\(AQ+TL!W* '\&'L XCLV=J95( MPU&,XX5W #\O91T:XGOPH!5G]REXRX\9CD_!'TS2W^4;V;!9H?\\]H]XP!R? MQS[ \]BF7AZV_(2SB8>'Q3O=./43F8^SV!>VFMG./(=)4L0>CDUL90;S>T;F MK T#YIY5/.&]691>#>UI]I M 6&@Q1*F%:89=LFG<> 2@JJ1W&=R'=RN'1#'DE81.(]G.1%*CVIDU3-/O$[7R\548QR2> M!>=/S)JG7KS*@[#EDQ'0U?;& CPUP6(PM,LH']_@/VQ4?YY#YSDC*>/+!WC"]"3"/O4A)O,WR_#Q MK4?M;YPP;3@N?F9Z<%S3@_RW=.O!_I4E%!3D-5Y#X<"<=U3VLYUAH481R(C] MS#?&6'E7\&0]R(LQHFUDF!6\GM'#HL.6U6+S*RI_+&YNVV4-W! JV,6Q M )ZO-W[X3 @]R[/2^_PXV>LP,P\D#X:-[UEYT?K?6379ZS#Y+Y+5%5D&52V0 MV2:[)Y&X!@_S>=NN>?#\/"@<.#2PZ3+*7S+:EI01JXZJG_4ZL6#081(8_MK; MY//&B691)B,W6Y$D[Y=SY23N#T7>OA](3R(8YVON]E6=AF1]K/N[.Z+%XQP' M0F?>H^>2P(U;AD7@F"N=Q-)>4)3L.W @W'-P0I.M72N>79V5M\_>2TMF_P)+ MX6X6SRX_,JE]!47![#&W>\SM'G.[)0A$L^2%8GN5TY0N(LJ=U-^J;.'9>B/A*%$WAP<%=N%<;$K\Z?L MK',9Y)4V;>ARFP+KYM.^+O-!,17&:8R-4R<@[));HEU9V.0!"1A&[-3A(1F< M;I77\?:4BT,!_J"N@XMDW!+:V?]@R%)'L))RI-++OG"WNND@S"7SY A5]""V MH4X!_I"^@XMDH*MQ-Y6JX VR&@2*1U/?N(D"EWV"Z!A XBT12WX=3 M5KW1/Z-X51E@]N\^ 21"=?PE^W0[XCJ0&.=Z8A(TSOECESCG[$.3XDMCL/,8 M[#P&.P\@X!9QL//XFHKZ-17+D='C:RI@ME $(-7> X:'[_[O'AF,+/+]02V#!^W)?$M8 M1 +]?1FFD#H^>YKG6!;K?FA*H,J*(5O>#DJ(0D0.*H#W"E-Z:&*@FHK$26P' MJY>AK.)U122 (W/*VHD8J++:?ZK((E:(E+6?W?PEY=,+8F]N*O-'_4FHX@W ME;NOW%_,J:F?V=D4TF$,YLXWP1%Z.-33J.1[U\_AY9W=9)"M2.+-';^22ST) M[?B=H22TR0^-CX]):3W8I3SB:_NFUA>J3%%- UCQ[^:+E[=L-M7P*2"3>1-. MR-(+V+;BQ/%9.1-M2V:+2MMQ\K!4/%0B$^X3[9BZ*OGW,W&8-7ZGP/=2]1K1<+Q^"5MVKUH/T<,_-VD:D M,"KQ;%'CL&CK3I.J^RRX98]I1YD=BKU8EB%__!XZJYO;DY(6]G.-FK*+.W&2 M^DAA,*EHFF1$H3WTGCN5I]XIN M \)&P0F.Q/N*2,Z:UE[(O@3A0TRBQ]PCL4FS5ZN#.>V5B;_-IBI[_P"?QJ$M MH)D@4AYSPD%12&"[@;SP KJE\1R_5F&IP;P\IT1[(-N'Z8/-/&%U"2V)&RJ* MV3HS/ MA9JU%C6VGH!T<2IDPC,)U&J[77L(TY3(X?Z('$'H:VCIU,G^.%$&- M_K8S"JR JBU?'#>@M16N^O'?/1)1NE;/5^21^.!-G[0_CO5<=_9FIBC,6CU3[*VDG-'LI'?45(2F6 M"C)C6R/T?1?XWFO"9RQNWA1\[X<"WW$7^(XUX3,6+6X*OF/4\)T\U]B]B,A? M*0GFS^!]CK@SCE51=Y,CYJ>F?AAPXQ':95^STQD';AKZ"=C*[#"):P-3-SC5 MB0QL2Z6],6YI!/H*V9(*I(/#IO)NC+>W4&(D5?UL8P@.%80)8" WY:4#'Q@L8%^3=*R*1&R:1.RB2G M9;P;'^_&Q[OQ\6Y\O!L?[\;'N_'Q;GR0EYTOY][:_&7G=Q+*8-Y_^UV',N"[ M&S?O\1WOQL>[\?%N?+P;?]%WXP>YG1O>0#X% ZS"H,(L9WG8F4UUH!HV%8/ MTQE$HYRV_6J9QB30RSD$2Y4M57D+12D/:8#.AVY5++:?G#B!.RD^VHC7&4-Q M>F=G#,490W'&4)PQ%&<,Q1E#<5Y^*,YW$MOQXUJ'+$4&4$J&]EHA$/:.QK"$W1),HH5Z[,7>.MTK9)U MJYGMU8:C'RU)<_G"848^.T\@D3>;V;YB!8BR"%## C!GJ(%-#5]D9N3]#D M;W^B0RW7L=]#G\J7'7)O*?/=9EQ[#-N[PUXF'U\P^ $]\QX]EP1N=SB;(]A> M$'L!DR<4O%#>>O'7BXBP%[0(E7:B#R5_!-N^O+V@E G%=-Q6C8R+,%H0+V$W MN*H@*U&O@45$R9E'4]^%/;?I!4OZRVW@QS7SXXI?)_JQ'0'2&*/Q)E$^C,V MCFU(63P-W":W%0_J" _-83"$&@PRY*,37&,,"#+?E?$8D)C,WRS#Q[3YSULZ2Q'=ANEPEBBAM0->AN-G 4L !&B7UD42)1^WE M=9B0^,9YEF^"A!T&XU-3L(P#%[X:90]@$[?3;&KV'8SG#"X(),!YB;?,Q'A' M$GH&9#PRYU @R\63=AJ,7PS .II#_%WZ$&?E@I/S1])X95AVCO]IY['T:IA) M/@ZRLWR;3?6Q7=P#PT%PD"=T%0CC81S+$?%0A_$QI*>/D![+61=C2$^_(3V" M8__O3N0Q#6'7,+6M._TX98I=$$B/_^#>MH\OL' <+9:,7EDIJ9@%XE!F$!NU M 6Q?9/4(SHY8;.%SQU(6W/T@:HX!1.GG :#$$PZ.\^68C7%028_9&$//QC#V M!.Z8C2'>)(WI&+(3]/E?:5ZZ9Q,&F4- :LX5W7 8';US-9\3')D:+=I4ISI! MN9&B#, MLT:UY@N:VW:0*/5,C@K�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end